
<html lang="en"     class="pb-page"  data-request-id="98f81555-339e-4ad3-903c-1b587b3d227c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b00654;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV)" /></meta><meta name="dc.Creator" content="Koen  Vandyck" /></meta><meta name="dc.Creator" content="Geert  Rombouts" /></meta><meta name="dc.Creator" content="Bart  Stoops" /></meta><meta name="dc.Creator" content="Abdellah  Tahri" /></meta><meta name="dc.Creator" content="Ann  Vos" /></meta><meta name="dc.Creator" content="Wim  Verschueren" /></meta><meta name="dc.Creator" content="Yiming  Wu" /></meta><meta name="dc.Creator" content="Jingmei  Yang" /></meta><meta name="dc.Creator" content="Fuliang  Hou" /></meta><meta name="dc.Creator" content="Bing  Huang" /></meta><meta name="dc.Creator" content="Karen  Vergauwen" /></meta><meta name="dc.Creator" content="Pascale  Dehertogh" /></meta><meta name="dc.Creator" content="Jan Martin  Berke" /></meta><meta name="dc.Creator" content="Pierre  Raboisson" /></meta><meta name="dc.Description" content="Small molecule induced hepatitis B virus (HBV) capsid assembly modulation is considered an attractive approach for new antiviral therapies against HBV. Here we describe efforts toward the discovery..." /></meta><meta name="Description" content="Small molecule induced hepatitis B virus (HBV) capsid assembly modulation is considered an attractive approach for new antiviral therapies against HBV. Here we describe efforts toward the discovery..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 15, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00654" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00654" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00654" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00654" /></link>
        
    
    

<title>Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00654" /></meta><meta property="og:title" content="Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0015.jpeg" /></meta><meta property="og:description" content="Small molecule induced hepatitis B virus (HBV) capsid assembly modulation is considered an attractive approach for new antiviral therapies against HBV. Here we describe efforts toward the discovery of a HBV capsid assembly modulator in a hit-to-lead optimization, resulting in JNJ-632, a tool compound used to further profile the mode of action. Administration of JNJ-632 (54) in HBV genotype D infected chimeric mice resulted in a 2.77 log reduction of the HBV DNA viral load." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00654"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00654">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00654&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00654&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00654&amp;href=/doi/10.1021/acs.jmedchem.8b00654" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6247-6260</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00643" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00661" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Evaluation of <i>N</i>-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Koen Vandyck</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Koen Vandyck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#d3b8a5b2bdb7aab0b893baa7a0fdb9bdb9fdb0bcbe"><span class="__cf_email__" data-cfemail="701b06111e1409131b301904035e1a1e1a5e131f1d">[emailÂ protected]</span></a>. Phone: +32 14 641712.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Koen++Vandyck">Koen Vandyck</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0923-8301" title="Orcid link">http://orcid.org/0000-0002-0923-8301</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Geert Rombouts</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Geert Rombouts</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Geert++Rombouts">Geert Rombouts</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Bart Stoops</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bart Stoops</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bart++Stoops">Bart Stoops</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Abdellah Tahri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Abdellah Tahri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Abdellah++Tahri">Abdellah Tahri</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ann Vos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ann Vos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Vos">Ann Vos</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Wim Verschueren</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wim Verschueren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wim++Verschueren">Wim Verschueren</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Yiming Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yiming Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, China (Shanghai) Pilot Free Trade Zone; Shanghai 200131, PR China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yiming++Wu">Yiming Wu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jingmei Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jingmei Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, China (Shanghai) Pilot Free Trade Zone; Shanghai 200131, PR China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jingmei++Yang">Jingmei Yang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Fuliang Hou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fuliang Hou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, China (Shanghai) Pilot Free Trade Zone; Shanghai 200131, PR China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fuliang++Hou">Fuliang Hou</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Bing Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bing Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec, 288 Fute Zhong Road, China (Shanghai) Pilot Free Trade Zone; Shanghai 200131, PR China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bing++Huang">Bing Huang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Karen Vergauwen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen Vergauwen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Vergauwen">Karen Vergauwen</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Pascale Dehertogh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pascale Dehertogh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pascale++Dehertogh">Pascale Dehertogh</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jan Martin Berke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jan Martin Berke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jan+Martin++Berke">Jan Martin Berke</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Pierre Raboisson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pierre Raboisson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pierre++Raboisson">Pierre Raboisson</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00654&amp;href=/doi/10.1021%2Facs.jmedchem.8b00654" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6247â6260</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 15, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 April 2018</li><li><span class="item_label"><b>Published</b> online</span>15 June 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00654" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00654</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6247%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKoen%2BVandyck%252C%2BGeert%2BRombouts%252C%2BBart%2BStoops%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D14%26contentID%3Dacs.jmedchem.8b00654%26title%3DSynthesis%2Band%2BEvaluation%2Bof%2BN-Phenyl-3-sulfamoyl-benzamide%2BDerivatives%2Bas%2BCapsid%2BAssembly%2BModulators%2BInhibiting%2BHepatitis%2BB%2BVirus%2B%2528HBV%2529%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6260%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00654"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1902</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00654" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Koen&quot;,&quot;last_name&quot;:&quot;Vandyck&quot;},{&quot;first_name&quot;:&quot;Geert&quot;,&quot;last_name&quot;:&quot;Rombouts&quot;},{&quot;first_name&quot;:&quot;Bart&quot;,&quot;last_name&quot;:&quot;Stoops&quot;},{&quot;first_name&quot;:&quot;Abdellah&quot;,&quot;last_name&quot;:&quot;Tahri&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Vos&quot;},{&quot;first_name&quot;:&quot;Wim&quot;,&quot;last_name&quot;:&quot;Verschueren&quot;},{&quot;first_name&quot;:&quot;Yiming&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Jingmei&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Fuliang&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Bing&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Vergauwen&quot;},{&quot;first_name&quot;:&quot;Pascale&quot;,&quot;last_name&quot;:&quot;Dehertogh&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Martin Berke&quot;},{&quot;first_name&quot;:&quot;Pierre&quot;,&quot;last_name&quot;:&quot;Raboisson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6247-6260&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00654&quot;},&quot;abstract&quot;:&quot;Small molecule induced hepatitis B virus (HBV) capsid assembly modulation is considered an attractive approach for new antiviral therapies against HBV. Here we describe efforts toward the discovery of a HBV capsid assembly modulator in a hit-to-lead optimization, resulting in JNJ-632, a tool compound used to further profile the mode of action. Administration of JNJ-632 (54) in HBV genotype D infected chimeric mice resulted in a 2.77 log reduction of the HBV DNA viral load.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00654&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00654" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00654&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00654" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00654&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00654" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00654&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00654&amp;href=/doi/10.1021/acs.jmedchem.8b00654" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00654" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00654" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00654%26sid%3Dliteratum%253Aachs%26pmid%3D29906396%26genre%3Darticle%26aulast%3DVandyck%26date%3D2018%26atitle%3DSynthesis%2Band%2BEvaluation%2Bof%2BN-Phenyl-3-sulfamoyl-benzamide%2BDerivatives%2Bas%2BCapsid%2BAssembly%2BModulators%2BInhibiting%2BHepatitis%2BB%2BVirus%2B%2528HBV%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D14%26spage%3D6247%26epage%3D6260%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/jmcmar.2018.61.issue-14/20180726/jmcmar.2018.61.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Small molecule induced hepatitis B virus (HBV) capsid assembly modulation is considered an attractive approach for new antiviral therapies against HBV. Here we describe efforts toward the discovery of a HBV capsid assembly modulator in a hit-to-lead optimization, resulting in JNJ-632, a tool compound used to further profile the mode of action. Administration of JNJ-632 (<b>54</b>) in HBV genotype D infected chimeric mice resulted in a 2.77 log reduction of the HBV DNA viral load.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26243" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26243" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Despite the availability of a safe and effective prophylactic HBV vaccine, it is estimated that about 240 million people worldwide are chronically infected by hepatitis B virus.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Chronic HBV infection puts patients at high risk for developing cirrhosis and liver cancer, with estimation of more than 686000 people dying every year due to complications of hepatitis B. Besides (pegylated) interferon-alpha ((PEG)-IFNÎ±), multiple nucleos(t)ide analogues have been approved for treatment of hepatitis B. This current treatment can slow the progression of cirrhosis, reduce incidence of liver cancer, and improve long-term survival, but the majority of patients will not be cured from HBV infection. Therefore, chronic HBV infection presents a major global health concern.</div><div class="NLM_p">HBV capsid assembly is a critical step in virus production, and it is considered an attractive target for new antiviral therapies against HBV. Capsid assembly modulators (CAMs), compounds that modulate the kinetics/thermodynamics of HBV core protein aggregation, can block encapsidation of pregenomic RNA (pgRNA) and will consequently inhibit the synthesis of HBV DNA and infectious virion production. Recently, it has been shown that capsid assembly modulators, for example, JNJ-632<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> described in this paper, and JNJ-6379, currently in phase 2 clinical trial,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> are also able to block de novo HBV infection in vitro.</div><div class="NLM_p">Prototypical examples of two distinct types of capsid assembly modulators are AT-130<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> and Bay 41-4109<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Both are inducing aggregation of the HBV core protein, but the first induces the formation of empty capsids (CAM-I class of compounds), lacking the pgRNA-polymerase, while the latter induces the formation of aberrant structures (CAM-II class of compounds).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Two prototypical capsid assembly modulators Bay 41-4109 (CAM-II) and AT-130 (CAM-I).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Originating from our compound library, a series of <i>N</i>-phenyl-3-sulfamoyl-benzamide derivatives<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was picked up, represented by compounds <b>1</b>â<b>5</b>, that inhibit the hepatitis B virus (HBV), evidenced by dose dependent reduction of HBV DNA in the HepG2.2.15 cell line. In addition, compounds <b>1</b>â<b>4</b> induce HBV core protein aggregation, resulting in the formation of particles of regular capsid size but not larger aberrant structures, as indicated by size exclusion chromatography (data not shown). A preliminary compound optimization was initiated, exploring initial SAR while generating a suitable tool compound to assess the mode of action in a relevant in vivo HBV mouse model, either by oral or subcutaneous administration, as at the time of this work, in vivo data was only available for the heteroaryldihydropyrimidine (HAP) CAM-II class of compounds (known to aggregate the core protein in aberrant structures). At this time, with the publication of both our own and other patent applications,<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8â10)</a> Campagna et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (sulfamoylbenzamide (SBA)), Klumpp et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (sulfamoyl Carboxamide (SOC)), and others<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> reported on <i>N</i>-phenyl-3-sulfamoyl-benzamide derivatives for HBV.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial <i>N</i>-Phenyl-3-sulfamoyl-benzamide Derivatives<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0005.gif" alt="" id="GRAPHIC-d7e347-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0006.gif" alt="" id="gr5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">* HBV DNA HepG2.2.15. # HepG2, 6 days. $ Kinetic solubility pH 7.4 (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a> for details). HLM/MLM: human/mouse liver microsome stability, expressed as percentage metabolization after 15 min of incubation (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a> for details). SEC: size exclusion chromatography. The aggregation of core protein, expressed as a ratio between the area under the curve for the observed amount of core dimer and area under the curve for the aggregated core protein, as determined in size exclusion chromatography after 24 h of aggregation. Determined for both the compound at 20 Î¼M (cpd) and a no-compound-control (ctrl), (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a> for details). ND: not determined.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76345" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76345" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The formation of a capsid containing pregenomic RNA (pgRNA) and the viral polymerase, is the first, cytoplasmic, step in the formation of an infectious HBV virion. Only within the viral nucleocapsid, the pgRNA is reverse transcribed to produce relaxed-circular DNA (rcDNA). As CAMs accelerate the kinetics of capsid assembly, preventing encapsidation of the Pol-pgRNA complex, they block the reverse transcription of the pregenomic RNA and the formation of rcDNA. It is hypothesized that CAMs should nucleate misassembly faster than normal HBV virion assembly.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Therefore, it is expected that, in the case of CAMs, the kinetics of the compound induced assembly will be indicative for its anti-HBV activity (HBV DNA). In this SAR exploration, in addition to measuring HBV DNA inhibition (EC<sub>50</sub>) in stable HepG2.117 (and HepG2.2.15) cell lines, the core protein assembly kinetics were also monitored in the fluorescence quenching assay<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">However, it is expected that the intrinsic capability of a compound to accelerate assembly, in this assay, might be clouded by a low kinetic solubility of a compound. To assess if a compound targets the capsid assembly, even if it only induces a slow assembly, either due to intrinsic capability or low kinetic solubility, the assembly was also monitored in a 24 h assay. Here, the assembly domain (amino acids 1â149) of a recombinant HBV core protein (Cp149) was incubated with the compounds for 24 h, and the compoundsâ tendency to assemble the Cp149, is expressed as a ratio between the area under the curve for the observed amount of Cp149 dimer and area under the curve for the aggregated Cp149, as determined by size exclusion chromatography. This is compared to the same ratio obtained without addition of compound, as in this case, also a minor amount of empty assembled capsids is formed.</div><div class="NLM_p">As the eventual goal of this study was to assess the in vivo effect of this class of compounds in a humanized mouse model and the initial hits suffered from low metabolic stability, both human (HLM) and mouse liver microsome (MLM) stability were assessed. Stability in human microsomes was considered relevant for the humanized mouse model, whereas mouse liver microsome stability would allow generation of PK data in a relevant nonhumanized mouse strain but also in the context of residual presence of mouse hepatocytes in the humanized mice.</div><div class="NLM_p">Initial SAR exploration included the synthesis of bioisosteric derivatives of the sulphamoyl and <i>N</i>-phenyl amide moieties as depicted in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, respectively. Whereas the kinetic solubility of a compound <b>1</b> and close analogues was low, possibly hampering further SAR studies, compound <b>4</b> demonstrated higher solubility. As an example, as compounds <b>1</b> and <b>2</b> were clearly impacting capsid assembly as indicated by the SEC ratio (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), they however had limited impact in a shorter time frame as indicated by the quenching curves (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a>), likely explained by a low kinetic solubility of those two compounds. The higher solubility of compound <b>4</b>, however, together with its high potency, resulted in faster kinetics in the quenching assay (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a>). Compound <b>6</b>, the <i>p</i>-fluoro- analogue of compound <b>4</b>, showed slightly increased metabolic stability versus compound <b>4</b> and was used, together with its cyclohexyl analogue compound <b>7</b>, as a starting point for an initial SAR study. Inversion of the sulfamoyl moiety, as for compounds <b>8</b> and <b>9</b>, retained some, although slightly lower, activity. Interestingly, this specifically improved HLM stability (compound <b>8</b> versus <b>6</b>), but not MLM stability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Variations and Replacement of the Eastern Sulphamoyl Part<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0007.gif" alt="" id="GRAPHIC-d7e458-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0008.gif" alt="" id="gr6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">* HBV DNA HepG2.2.15. Â° HBV DNA HepG2.117. # HepG2, 4 days. $ Kinetic solubility pH 7.4.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Variation and Replacement of the Western <i>N</i>-Phenyl Amide Part<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0009.gif" alt="" id="GRAPHIC-d7e476-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0010.gif" alt="" id="gr7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0011.gif" alt="" id="GRAPHIC-d7e478-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">* HBV DNA HepG2.2.15. Â° HBV DNA HepG2.117. # HepG2, 4 days. <sup>â§</sup> HepG2, 6 days. $ Kinetic solubility pH 7.4.</p></div></div><div></div></div><div class="NLM_p">The methylated derivatives <b>10</b> and <b>11</b> showed reduced potency versus there NH-analogues, <b>6</b> and <b>8</b>, respectively. Replacing the sulfamoyl moiety by an amide, as in <b>12</b> and <b>13</b>, rendered the compound inactive without any CAM property indicated by the SEC ratio.</div><div class="NLM_p">Assessment of replacements of the western <i>N</i>-phenyl amide part was performed relative to compounds <b>4</b>, <b>14</b>, <b>15</b>, and <b>16</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). First, when looking at the impact of R<sub>2</sub>âF on the central scaffold (R<sup>2</sup>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) in <b>14</b> and <b>16</b> versus hydrogen substituted compounds <b>7</b> and <b>6</b>, respectively, a limited impact was noticed. For isosteric replacements, both R<sup>2</sup> F and H (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) were used. Replacement of the F-phenyl of <b>14</b>, or phenyl of <b>15</b>, by either a benzyl (<b>17</b>) or a cyclohexyl (<b>18</b>) deteriorated the potency of the compound (as indicated by HBV DNA EC<sub>50</sub>, SEC ratio, and/or quenching). In addition, inverting the amide of <b>7</b>, resulting in <b>19</b>, or the related compound <b>20</b>, diminished the activity significantly without any indication of remaining CAM properties (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, SEC ratio for <b>20</b>). <i>N</i>-Methylation of the amide of <b>6</b>, as in <b>21</b>, also resulted in significantly reduced activity (lack of quenching and significantly increased HBV DNA EC<sub>50</sub>), altogether indicating the essential role of the âNH-phenyl amide. Additionally, replacement of the â<i>N</i>-phenyl amide by a phenyl-imidazole, as in <b>22</b> (compared to <b>15</b>), did not results in a CAM compound as indicated by the high SEC ratio versus the control. When for this scaffold, the <i>N</i>-phenyl was replaced by either a â<i>N</i>-heteroaryl (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <b>23</b>, <b>24</b>, and <b>25</b>) or a <i>N</i>-naphthyl (compounds <b>26</b> and <b>27</b>), no relevant CAM property could be picked up according to SEC and/or quenching.</div><div class="NLM_p">An early assessment of the substitution pattern on the <i>N</i>-phenyl, indicated that switching the <i>p</i>-fluoro of <b>6</b> to the <i>ortho</i> position of the <i>N</i>-phenyl, as in <b>29</b>, retained activity. Reintroduction of a <i>p</i>-fluoro (<b>30</b>) or a <i>m</i>-fluoro (<b>31</b>) both led to potent CAMs. Similarly, replacing one of the <i>m</i>-fluoros in <b>30</b> and <b>31</b> by a <i>m</i>-methyl, as in <b>32</b> and <b>33</b>, respectively, maintained the high potency, both on HBV reduction as on the SEC and quenching assays. Nevertheless, when replacing the <i>p</i>-fluoro by a <i>p</i>-methyl, as in <b>30</b> versus <b>34</b>, or introducing an <i>o</i>-methyl, as in <b>28</b> versus <b>4</b> or <b>15</b>), potency is significantly reduced (EC<sub>50</sub> HBV DNA).</div><div class="NLM_p">In <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, the alteration of the Sulphone amide substitution was investigated. Introduction of secondary amines on R<sup>4</sup> (<b>35</b>â<b>40</b>) rendered compounds that were still showing CAM properties, in the case of <b>35</b> and <b>37</b>â<b>40</b> (SEC ratio and/or quenching), but nevertheless with reduced activity versus <b>6</b> and <b>7</b> on HBV DNA EC<sub>50</sub>. Introduction of the basic piperazine, as in <b>36</b>, significantly impacted the CAM properties according to quenching and SEC ratio while maintaining some potency on HBV DNA reduction. Interestingly, branched NH-alkyls like -iPr (<b>41</b>), 1-ethylpropyl (<b>42</b>), or <i>sec</i>-butyl, with a preference for the <i>R</i>-isomer (<b>44</b> versus <b>43</b>), displayed good potency, and for example, in the case of <b>41</b> versus compounds <b>6</b> and <b>7</b> also improved metabolic stability on both HLM and MLM was observed. Slightly decreased potency (HBV DNA) nevertheless improved metabolic stability, was observed for the <i>t</i>Bu-derivative <b>45</b>. Introduction of a NH-<i>c</i>Bu showed similar stability (and slightly lower potency) versus compound <b>6</b>, while the corresponding oxetane (<b>47</b>) loses potency (HBV DNA) and gains in metabolic stability, both on MLM and HLM. Introduction of an extra methyl on the oxetane (<b>48</b>) returned potency (HBV DNA) while retaining metabolic stability (versus compound <b>47</b>). The introduction of a heteroatom also improved metabolic stability for other ring sizes, as observed for tetrahydrofuryl (<b>49</b> and <b>50</b>) versus cyclopentyl and tetrahydro-2<i>H</i>-pyranyl (<b>53</b>) versus cyclohexyl (<b>7</b>), in addition, an improved kinetic solubility was observed. Although introduction of a nitrogen in the cyclohexyl of <b>7</b> also increased metabolic stability (compound <b>51</b> and <b>52</b>), a decreased potency was observed (HBV DNA).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of the Sulphonamide Substitutent R<sup>4</sup><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0012.gif" alt="" id="GRAPHIC-d7e849-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0013.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">* HBV DNA HepG2.2.15. Â° HBV DNA HepG2.117. # HepG2, 4 days. $ Kinetic solubility pH 7.4.</p></div></div><div></div></div><div class="NLM_p">Using some of the optimal substituents from <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, taking into account potency, solubility, and metabolic stability, R<sup>4</sup> substituents A, B, and C (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) were selected for a further combination with the optimal substituent patterns from <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of <i>N</i>-Phenyl Substitution</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0014.gif" alt="" id="GRAPHIC-d7e883-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="char" char="/" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center">R<sup>8</sup></th><th class="colsep0 rowsep0" align="center">R<sup>9</sup></th><th class="colsep0 rowsep0" align="center">R<sup>10</sup></th><th class="colsep0 rowsep0" align="center">R<sup>11</sup></th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (Î¼M)</th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub><a class="ref internalNav" href="#t5fn4" aria-label="c">c</a> (Î¼M)</th><th class="colsep0 rowsep0" align="center">sol (Î¼M)</th><th class="colsep0 rowsep0" align="center" char="/">HLM/MLM (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">82</td><td class="colsep0 rowsep0" align="char" char="/">26/51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">0.78</td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">25/66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">2.22</td><td class="colsep0 rowsep0" align="char" char=".">3.30</td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">17/69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">3.63</td><td class="colsep0 rowsep0" align="char" char=".">1.91</td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">37/68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">5/42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">13/27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2.33</td><td class="colsep0 rowsep0" align="char" char=".">2.66</td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">20/35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="center">47.5</td><td class="colsep0 rowsep0" align="center">41</td><td class="colsep0 rowsep0" align="char" char="/">26/80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">2.59</td><td class="colsep0 rowsep0" align="center">28.5</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="char" char="/">31/88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="center">25.2</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">18/60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="left">iPr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.40</td><td class="colsep0 rowsep0" align="char" char=".">2.79</td><td class="colsep0 rowsep0" align="center">29.8</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="char" char="/">31/96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="left">cPr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td><td class="colsep0 rowsep0" align="center">35.2</td><td class="colsep0 rowsep0" align="center">31</td><td class="colsep0 rowsep0" align="char" char="/">27/61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="center">47.1</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">7/65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2.74</td><td class="colsep0 rowsep0" align="char" char=".">1.65</td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">0/77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">3.06</td><td class="colsep0 rowsep0" align="char" char=".">1.91</td><td class="colsep0 rowsep0" align="center">>25</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="char" char="/">1/78</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">HBV DNA HepG2.2.15.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">HBV DNA HepG2.117.</p></div><div class="footnote" id="t5fn4"><sup><sup>c</sup></sup><p class="last">Kinetic solubility pH 7.4.</p></div></div></div><div class="NLM_p">Combination of substituents A, B, or C with either the <i>N</i>-(4-fluoro-3-methylphenyl)amide (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>: <b>54</b>, <b>61</b>, or <b>66</b>, respectively) or <i>N</i>-(3,4-difluorophenyl)amide (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>: <b>58</b> and <b>63</b>, respectively) led to compounds with improved potency and/or metabolic stability versus <b>6</b> (and very significant effect on quenching, see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a>). Further introduction of a Fluor on R<sup>9</sup> (<b>55</b>) or R<sup>11</sup> (<b>56</b>) versus compound <b>54</b> did not result in improved potency or significant stability (in contrast, the potency of compound <b>56</b> is significantly reduced). In addition, introduction of a methyl on R<sup>9</sup> (<b>57</b> versus <b>58</b> or <b>67</b> versus <b>66</b>) or R<sup>11</sup> (<b>68</b> versus <b>66</b>), reduces potency (HBV DNA) significantly. Variation of the <i>N</i>-phenyl <i>m</i>-alkyl, as in compounds <b>62</b> (Et), <b>64</b> (iPr), and <b>65</b> (cPr), reduced potency (HBV DNA) versus the methyl analogue <b>61</b>. Replacing the <i>m</i>-methyl (R<sup>8</sup>) in <b>54</b> by <i>m</i>-omethyl (<b>60</b>) reduced potency (HBV DNA), while variation to <i>m</i>-cyano (<b>59</b>) resulted in decreased potency, metabolic stability was further improved.</div><div class="NLM_p">Among several suitable candidates (compounds <b>54</b>, <b>58</b>, <b>61</b>, <b>63</b>, and <b>66</b>) that were further profiled in vitro, <b>54</b> (JNJ-632) was selected based on whether it is a suitable in vitro profile for further in vivo characterization. In the high-content multiparameter cytotoxicity (HepG2), JNJ-632 showed EC<sub>20</sub>s in the 10â30 Î¼M range (considered weakly cytotoxic). Notably, in contrast, <b>63</b> was considered cytotoxic, with an EC<sub>20</sub> ranging down to 1 Î¼M).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a></div><div class="NLM_p">While JNJ-632 was clean in a kinase panel (1 Î¼M, <i>n</i> = 240), a receptor, ion channel, and transporter assay profiling panel (<i>n</i> = 80) resulted in one hit at 10 Î¼M (5-HT2B (71%)). The compound did not show agonist activity of 5-HT2B but was an antagonist of 5-HT2B with IC<sub>50</sub> of 5.6 Î¼M. Activity on the serotonin receptor 2B was observed across several analogues in this series, with <b>12</b> and <b>63</b> as more potent examples (IC<sub>50</sub> 5HT2B: 0.09 and 0.23 Î¼M, respectively, versus 4.0 Î¼M for JNJ-632). JNJ-632 did not significantly bind to NaCH, CaCH, or hERG with IC<sub>50</sub>> 10 Î¼M, and an automated hERG patch clamp system indicated that <b>54</b> showed 31% of IK<sub>r</sub> inhibition at 3 Î¼M (versus 14% of IK<sub>r</sub> inhibition by the solvent). Moreover, JNJ-632 exhibits low CYP inhibition with IC<sub>50</sub> > 10 Î¼M against six major CYP enzymes (CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4). <b>54</b> was found to be positive in GSH (glutathione) trapping assay (oxidative defluorination followed by GSH addition) in human liver microsomes. No cleavage of the <i>N</i>-phenylamide was observed in primary hepatocytes in contrast to related analogues like compound <b>66</b> (data not shown). Finally, JNJ-632 tested negative in Ames II and the in vitro micronucleus test.</div><div class="NLM_p">The permeability of JNJ-632 was measured in the LLC-PK1-MDR1 cell line in A to B direction in absence and presence of the P-gp inhibitor GF-120,918. The apparent permeability value <i>P</i><sub>app</sub> (AâB) (âGF) was 7.3 Ã 10<sup>â6</sup> cm/s, and the apparent permeability value <i>P</i><sub>app</sub> (AâB) (+GF) was 16.2 Ã 10<sup>â6</sup> cm/s. The ratio <i>P</i><sub>app</sub> (AâB) (+GF)/<i>P</i><sub>app</sub> (AâB) (âGF) indicated that the compound was a weak P-gp substrate. The unbound fraction of JNJ-632 was determined to be 12.6% and 8.1% in mouse and human plasma, respectively. Notably, when determining plasma protein binding for certain compounds, not for JNJ-632, a low recovery was noticed specifically in the case of mouse plasma, not in human plasma, possibly indicating instability in the former medium. Finally, JNJ-632 gave 51% turnover after 15 min incubation in mouse liver microsomes and 26% turnover after 15 min incubation in human liver microsomes.</div><div class="NLM_p">The single dose PK profile of JNJ-632 was evaluated in C57BL/6 mice following intravenous (iv) and oral (po) administration. JNJ-632 had a moderate plasma clearance of 34 mL/min/kg and a moderate volume of distribution of 1.3 L/kg. The oral bioavailability was 40% following oral administration of 10 mg/kg and 66% following oral administration of 50 mg/kg. To circumvent the first pass metabolism, compound was also dosed subcutaneously at 50 mg/kg in C57BL/6 mice and this resulted in a concentration in plasma after 24 h of dosing of 102 ng/mL and concentration in liver after 24 h of dosing of 1297 ng/g (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Finally, the PK of <b>54</b> was assessed in uninfected humanized mice (Phoenix Bio) following subcutaneous administration of 50 and 200 mg/kg as a methocel suspension. Compound JNJ-632 was dosed for 8 days and PK was evaluated on days 1 and 8. Repeated subcutaneous dosing of a suspension resulted in higher exposure at day 8 versus day 1 (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. PK Parameters of C57BL/6 Mice for <b>54</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="center" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="Â±">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="Â±">AUC <sub>0âlast</sub> (ngÂ·h/mL)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2.5 (iv)</td><td class="colsep0 rowsep0" align="char" char="Â±">34Â Â±Â 9.2</td><td class="colsep0 rowsep0" align="char" char="Â±">1.3Â Â±Â 0.20</td><td class="colsep0 rowsep0" align="char" char="Â±">0.42Â Â±Â 0.06</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">1240Â Â±Â 303</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10 (po)</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">1.1Â Â±Â 0.67</td><td class="colsep0 rowsep0" align="char" char="Â±">1940Â Â±Â 296</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="char" char="Â±">1990Â Â±Â 159</td><td class="colsep0 rowsep0" align="char" char="Â±">40Â Â±Â 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50Â (po)</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">2.4Â Â±Â 2.3</td><td class="colsep0 rowsep0" align="char" char="Â±">9440Â Â±Â 1420</td><td class="colsep0 rowsep0" align="center">0.7Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">16400Â Â±Â 2350</td><td class="colsep0 rowsep0" align="char" char="Â±">66Â Â±Â 9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50Â (sc)</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">5.3Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">3367Â Â±Â 342</td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="char" char="Â±">16877Â Â±Â 2959</td><td class="colsep0 rowsep0" align="char" char="Â±">68Â Â±Â 12</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Exposure of JNJ-632 in Uninfected Humanized Mice after Subcutaneous Administration of 50 and 200 mg/kg</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="Â±" /></col><col align="center" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">QD dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">dosing day</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="Â±">AUC<sub>0â24</sub> (ngÂ·h/mL)</th><th class="colsep0 rowsep0" align="center" char="Â±">AUC<sub>0ââ</sub> (ngÂ·h/mL)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>C</i><sub>plasma</sub>,<sub>24h</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="Â±"><i>C</i><sub>liver</sub>,<sub>24h</sub> (ng/g)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">day 1</td><td class="colsep0 rowsep0" align="char" char="Â±">2190Â Â±Â 246</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char="Â±">4750<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a>Â Â±Â 326</td><td class="colsep0 rowsep0" align="char" char="Â±">4780Â Â±Â 313</td><td class="colsep0 rowsep0" align="char" char="Â±">1.1Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">day 8</td><td class="colsep0 rowsep0" align="char" char="Â±">4380Â Â±Â 1280</td><td class="colsep0 rowsep0" align="center">0.8Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="char" char="Â±">19200Â Â±Â 2180</td><td class="colsep0 rowsep0" align="char" char="Â±">20700Â Â±Â 2850</td><td class="colsep0 rowsep0" align="char" char="Â±">6.2Â Â±Â 1.1</td><td class="colsep0 rowsep0" align="char" char="Â±">167Â Â±Â 70.2</td><td class="colsep0 rowsep0" align="char" char="Â±">570Â Â±Â 168</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">day 1</td><td class="colsep0 rowsep0" align="char" char="Â±">2110Â Â±Â 941</td><td class="colsep0 rowsep0" align="center">0.8Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="char" char="Â±">12000Â Â±Â 1060</td><td class="colsep0 rowsep0" align="char" char="Â±">12700Â Â±Â 561</td><td class="colsep0 rowsep0" align="char" char="Â±">5.6Â Â±Â 1.7</td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td><td class="colsep0 rowsep0" align="char" char="Â±">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">day 8</td><td class="colsep0 rowsep0" align="char" char="Â±">7700Â Â±Â 2490</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char="Â±">86900Â Â±Â 6520</td><td class="colsep0 rowsep0" align="char" char="Â±">119000Â Â±Â 4910</td><td class="colsep0 rowsep0" align="char" char="Â±">12.1Â Â±Â 3.2</td><td class="colsep0 rowsep0" align="char" char="Â±">1820Â Â±Â 179</td><td class="colsep0 rowsep0" align="char" char="Â±">4880Â Â±Â 1060</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">AUC<sub>(0â8h)</sub> was used instead of AUC<sub>(0â24h)</sub></p></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Antiviral Activity of JNJ-632 in HBV-Infected Chimeric Mice</h3><div class="NLM_p">The anti-HBV activity of JNJ-632 was tested in HBV infected primary human hepatocytes (PHHs) derived from naive chimeric mice. qPCR analysis of the HBV DNA in the cell culture supernatant showed anti-HBV activity with an EC<sub>50</sub> of 200 nM for genotype D, which is similar to the EC<sub>50</sub> obtained in HepG2.2.15 cells (genotype D).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The anti-HBV activity of JNJ-632 was tested in an in vivo proof of mechanism study in genotype D HBV-infected chimeric mice with humanized liver. HBV-infected chimeric mice were used extensively for HBV research in the past due to authentic HBV infection of human hepatocytes and persistent formation of cccDNA in vivo.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> All mice used in this study had a human hepatocyte replacement index of 70% or more as assessed by the level of human albumin in the serum (data not shown).</div><div class="NLM_p">JNJ-632 was dosed subcutaneously once a day over 28 days at a dose of 200 mg/kg, whereas saline and ETV was dosed once a day orally and served as negative and positive control, respectively. None of the compounds reduced human albumin levels in the serum over time (data not shown), indicating that the treatment did not have cytotoxic effects on the human hepatocytes in the liver of the mice. A mean â2.77 log reduction of HBV DNA in the serum was observed for JNJ-632, demonstrating that the compound inhibited HBV replication in vivo (<named-content content-type="anchor" rid="fig2" type="simple"></named-content><a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). No reduction of HBe- and HBsAg levels was observed during this 28 day study (data not shown).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked binding mode of JNJ-632.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antiviral activity in HBV genotype D infected chimeric mice. Mean HBV DNA change in serum after daily treatment with saline, ETV, and JNJ-632 for 28 days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Mean HBV DNA Change of ETV and JNJ-632 versus the Saline Control in HBV Genotype D Infected Chimeric Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">mean HBV DNA change (SD)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">saline</td><td class="colsep0 rowsep0" align="center">â0.29Â (0.14)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ETV 0.03 mg/kgÂ QD,Â po</td><td class="colsep0 rowsep0" align="center">â3.03Â (0.19)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNJ-632 200 mg/kgÂ QD,Â sc</td><td class="colsep0 rowsep0" align="center">â2.77Â (0.10)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">from baseline at day 29.</p></div></div></div><div class="NLM_p last">HBV genotype D infected chimeric mice with a human hepatocyte replacement index of 70% or more were treated once a day for 28 days with saline (oral), 0.03 mg/kg ETV (oral), and 200 mg/kg JNJ-632 (subcutan; sc). Values in the table represent the mean HBV DNA change from baseline at day 29 and the standard deviation (SD) from 4 (ETV) and 5 (saline and JNJ-632) mice per group, respectively.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Docking of JNJ-632</h3><div class="NLM_p last">JNJ-632 was docked to adopt a binding mode as depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. The methyl-fluor-phenyl group binds in a hydrophobic pocket surrounded by residues Pro25, Asp29, Leu30, Thr33, Trp102, Ile105, Ser106, Val124, Arg127, and Thr128. The amide group makes hydrogen bonds with Trp102 and Thr128, while the sulfonamide group picks up a hydrogen bond with Leu140 and a water mediated hydrogen bond with Ser121. The tetrahydrofuryl group resides in a solvent-accessible area. It is possible that this part of the inhibitor helps in stabilizing the arginine-rich domain of the C-terminus, which is not part of the crystal structure.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div class="NLM_p">New 3-sulfamoyl-<i>N</i>-phenylbenzamide compounds were prepared according to the general <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> starting from either 3-(chlorosulfonyl)benzoic acid derivatives (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A) or 3-(chlorosulfonyl)benzoyl chloride (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> As depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A, starting from 3-(chlorosulfonyl)benzoic acid <b>69a</b>, for compounds <b>7</b>, <b>10</b>, <b>29</b>â<b>34</b>, <b>41</b>â<b>44</b>, <b>49</b>, <b>50</b>, <b>55</b>â<b>57</b>, <b>59</b>â<b>61</b>, and <b>63</b> and from 5-(chlorosulfonyl)-2-fluorobenzoic acid <b>69b</b> for compounds <b>14</b> and <b>15</b>, the chlorosulfone was condensed with the corresponding amine in the presence of a base, followed by amide formation under influence of HATU, or by activation of the carboxylic acid to the corresponding acid chloride followed by amide formation. Alternatively, for the synthesis of compounds <b>6</b>, <b>35</b>â<b>40</b>, <b>45</b>â<b>48</b>, <b>51</b>â<b>54</b>, <b>58</b>, and <b>66</b>â<b>68</b> applying the well described difference in reactivity of carboxy acid chlorides and sulfonyl chlorides,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> 3-(chlorosulfonyl)benzoyl chloride is first reacted with an aniline <b>72</b>, resulting in the formation of an amide, followed by the reaction of another amine <b>70</b>, resulting in the formation of the sulfonamide. Synthesis of compounds <b>8</b>, <b>9</b>, <b>11</b>â<b>13</b>, <b>17</b>â<b>27</b>, <b>62</b>, <b>64</b>, and <b>65</b> is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis New <i>N</i>-Phenyl-3-sulfamoyl-benzamide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>69a</b>, <b>70</b>, CH<sub>2</sub>Cl<sub>2</sub>, NEt<sub>3</sub>, room temperature, overnight or <b>69a</b>, <b>70</b>, NaOH, THF, 20â25 Â°C, 2â3 h; <b>71a</b>â<b>d</b>, 33â93% yield; <b>71b</b>, EtOAc, iPrNH<sub>2</sub>, 25 Â°C, 3 h, 79% yield; <b>71e</b>, <b>69b</b>, cyclohexamine, room temperature, EtOAc, 10 min, 86% yield. (ii) HATU, CH<sub>2</sub>Cl<sub>2,</sub> DIPEA, 0 Â°C to room temperature, 2 h to overnight, 9â66% yield or 13â39% yield over two steps from <b>69a</b> (<b>7</b>, <b>10</b>, <b>42</b>, <b>44</b>), <b>14</b>, and <b>15</b>: <b>71e</b>, <b>72</b>, HATU, CH<sub>2</sub>Cl<sub>2</sub>, DIPEA or NEt<sub>3</sub>, 2â3 h, 28â52% yield; <b>55</b>, <b>56</b>, <b>59</b> and <b>60</b>: <b>71a</b>, <b>72</b>, DMF/CH<sub>2</sub>Cl<sub>2</sub>, (COCl)<sub>2</sub>, 2 h, 0 to 20 Â°C, 2 h then NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 20 Â°C, 2 h, 14â61% yield; <b>57</b>: <b>71a</b>, 3,4-difluoro-2-methyl aniline, DIPEA, Pybrop, DMF, 18 Â°C, 23% yield. (iiia) <b>72</b>, CH<sub>2</sub>Cl<sub>2,</sub> NEt<sub>3</sub>, 0 Â°C then 20 Â°C, 1 h or toluene, reflux, 30 min. (iiib) <b>70</b>, NEt<sub>3</sub> 0 Â°C then 20 Â°C, 1 h; 10â50% yield over two steps, or (<b>54</b>) <b>70</b>, toluene/CH<sub>2</sub>Cl<sub>2</sub>, DIPEA, 4 h room temperature, 39% two steps.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, the authors described a hit-to-lead optimization, resulting in the discovery of JNJ-632 (<b>54</b>), a <i>N</i>-phenyl-3-sulfamoyl-benzamide derivative and HBV capsid assembly modulator that can inhibit HBV in vitro (HepG2.117, HepG2.2.15, and HBV infected primary human hepatocytes) and in vivo (HBV infected humanized mice). Further optimization toward JNJ-6379, a capsid assembly modulator currently in phase 2 clinical trials,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> will be published in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p">Reagents and solvents were purchased from commercial sources and used without purification. Purity of commercial, tested compounds was assessed by at least one LC-MS method and that of all synthesized and tested compounds by two independent LC-MS methods. Compounds exhibited greater than 95% purity, except for compound <b>26</b>, which was tested at 94â95% purity. Purities and LC methods are listed in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p">NMR spectra were recorded on Bruker DPX-400, Bruker Avance I-400, Bruker Avance III-400, and Bruker Avance IIIâH- 600 spectrometers, operating at the frequencies specified. High resolution mass spectrometry was performed on a Waters Acquity I Class UPLC-DAD and Xevo G2-S QTOF. The samples were run on a Waters BEH C18 (1.7 Î¼m, 2.1 mm Ã 50 mm, at 50 Â°C) column using reversed-phase chromatography with a gradient from 95% A to 5% A in 4.6 min, held for 0.4 min (A, 95% 6.5 mM CH<sub>3</sub>COONH<sub>4</sub>/5% CH<sub>3</sub>CN; B, CH<sub>3</sub>CN).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 3-(Cyclopentylsulfamoyl)-<i>N</i>-(4-fluorophenyl)benzamide (<b>6</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 21%. Method B; <i>R</i><sub>t</sub> 4.27 min; <i>m</i>/<i>z</i> 363.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 363.1184 (calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>S: 362.1100). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.50â10.62 (m, 1H), 8.36 (t, <i>J</i> = 1.70 Hz, 1H), 8.19 (ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 8.00 (ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 7.74â7.82 (m, 4H), 7.19â7.25 (m, 2H), 3.41â3.48 (m, 1H), 1.49â1.64 (m, 4H), 1.33â1.43 (m, 1H), 1.24â1.32 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.2, 158.5, 142.1, 135.6, 135.2, 131.1, 129.5, 129.3, 125.9, 122.4, 115.3, 54.5, 32.4, 22.8.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-(Cyclohexylsulfamoyl)-<i>N</i>-(4-fluorophenyl)benzamide (<b>7</b>)</h4><div class="NLM_p last">To a solution of 3-(chlorosulfonyl)benzoic acid (1 g, 4.53 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) at 5 Â°C, cyclohexanamine (0.899 g, 9.06 mmol) and triethylamine (1.38 g, 13.60 mmol) were successively added dropwise. The solution was stirred at room temperature overnight. The mixture was washed with 1 N HCl (50 mL). The organic phase was dried over MgSO<sub>4</sub> and concentrated, resulting in 3-(<i>N</i>-cyclohexylsulfamoyl)benzoic acid as a white solid (1.2 g, 93%), which was used in the next step without purification. To a solution of 3-(<i>N</i>-cyclohexylsulfamoyl)benzoic acid (1.2 g, 4.24 mmol) in DMF (15 mL) at 5 Â°C, 4-fluoroaniline (0.52 g, 4.66 mmol) and DIPEA (1.64 g, 12.71 mmol) were successively added. The mixture was stirred for 20 min, and then HATU (1.93 g, 5.08 mmol) was added. The solution was stirred at room temperature overnight. To the reaction mixture, aqueous NaHCO<sub>3</sub> (50 mL) was added followed by EtOAc (50 mL). The organic layer was washed with HCl (5%; 50 mL) and brine. The organic layer was dried with MgSO<sub>4</sub> and concentrated, resulting in a residue. The obtained residue was purified by a silica gel chromatography column (petroleum ether:EtOAc = 2:1) resulting in compound <b>7</b> as a white solid (850 mg, 25% yield over two steps). Method B; <i>R</i><sub>t</sub> 4.50 min; <i>m</i>/<i>z</i> 377.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 377.1339 (calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>3</sub>S: 376.1257). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.55 (s, 1H), 8.36â8.39 (m, 1H), 8.16â8.22 (m, <i>J</i> = 8.10 Hz, 1H), 7.99â8.05 (m, <i>J</i> = 8.10 Hz, 1H), 7.74â7.83 (m, 4H), 7.19â7.25 (m, 2H), 2.94â3.04 (m, 1H), 1.51â1.63 (m, 4H), 1.40â1.51 (m, 1H), 1.00â1.23 (m, 5H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.2, 158.4, 142.8, 135.5, 135.2, 131.0, 129.4, 129.0, 125.6, 122.4, 115.2, 52.1, 33.2, 24.8, 24.3</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-[Cyclopentyl(methyl)sulfamoyl]-<i>N</i>-(4-fluorophenyl)benzamide (<b>10</b>)</h4><div class="NLM_p last">To a solution of 3-(chlorosulfonyl)benzoic acid (1.10 g, 4.97 mmol) in THF (60 mL), sodium hydroxide was added (aq, 2 mL, 5N) while cooled in an ice bath, followed by adding <i>N</i>-methylcyclopentanamine (0.50 g, 4.97 mmol). After stirring at 25 Â°C for 3 h, the reaction mixture was diluted with H<sub>2</sub>O (50 mL) and extracted with EtOAc (50 mL). The aqueous layer was adjusted to pH = 3 by HCl (2N) and extracted with EtOAc (3 Ã 50 mL). The combined organic layer was washed with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated in vacuo, resulting in 3-(<i>N</i>-cyclopentyl-<i>N</i>-methylsulfamoyl)benzoic acid (0.8 g). To a solution of 3-(<i>N</i>-cyclopentyl-<i>N</i>-methylsulfamoyl)benzoic acid (0.80 g, 2.82 mmol), 4-fluoroaniline (0.31 g, 2.82 mmol), and HATU (1.61 g, 4.24 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), cooled in an ice bath, DIPEA (1.09 g, 8.47 mmol) was added under N<sub>2</sub> atmosphere. The resulting mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and washed with saturated aqueous NaHCO<sub>3</sub> (15 mL) and brine (10 mL) and dried over anhydrous MgSO<sub>4</sub>, and the solvent was removed in vacuo. The obtained residue was purified by preparative high performance liquid chromatography over RP-18 (eluent: CH<sub>3</sub>CN in H<sub>2</sub>O from 30% to 80%, v/v; 0.05% TFA as addition). The pure fractions were collected, and the volatiles were removed in vacuo. The aqueous layer was adjusted to Ph = 7 with Amberlite IRA-900 ion-exchange resin (OH form), filtered, and lyophilized to dryness resulting in compound <b>10</b> (0.73 g, 39% two steps). Method B; <i>R</i><sub>t</sub> 4.43 min; <i>m</i>/<i>z</i> 377.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 377.1337 (calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>3</sub>S: 376.1257). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.55 (s, 1H), 8.31â8.35 (m, 1H), 8.22â8.27 (m, <i>J</i> = 7.70 Hz, 1H), 7.97â8.02 (m, <i>J</i> = 8.10 Hz, 1H), 7.74â7.82 (m, 3H), 7.18â7.25 (m, 2H), 4.29 (quin, <i>J</i> = 7.97 Hz, 1H), 2.68 (s, 3H), 1.26â1.54 (m, 8H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 163.9, 158.5, 139.1, 135.6, 135.1, 131.7, 129.8, 129.7, 125.9, 122.5, 115.2, 57.8, 28.5, 27.3, 23.6</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 5-(Cyclohexylsulfamoyl)-2-fluoro-<i>N</i>-(4-fluorophenyl)benzamide (<b>14</b>)</h4><div class="NLM_p last">5-(<i>N</i>-Cyclohexylsulfamoyl)-2-fluorobenzoic acid (2.0 g, 6.637 mmol), 4-fluoroaniline (0.740 g, 6.660 mmol), and HATU (3.78 g, 9.941 mmol) were dissolved in dichloromethane (40 mL) at 20 Â°C. Triethylamine (1.34 g, 13.3 mmol) was added to the reaction mixture. The reaction mixture was stirred for 2 h at 20 Â°C. The mixture was washed with saturated aqueous K<sub>2</sub>CO<sub>3</sub> (20 mL) and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under vacuum. The crude product was purified by preparative high performance liquid chromatography (column, Phenomenex Synergi C18 250 mm Ã 50 mm, 10 Î¼m; mobile phase, CH<sub>3</sub>CN in water (TFA 0.1%) from 20% to 65%; flow rate, 60 mL/min). The pure fractions were collected and washed with aqueous Na<sub>2</sub>CO<sub>3</sub> and extracted with DCM (40 mL). The organic layer was concentrated in vacuum to give compound <b>14</b> (1080 mg, 52%). Method C; <i>R</i><sub>t</sub> 4.21 min; <i>m</i>/<i>z</i> 395.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 395.1244 (calcd for C<sub>19</sub>H<sub>20</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S: 394.1163). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.68 (1 H, br s), 8.08 (1 H, dd, <i>J</i> = 6.0, 2.5 Hz), 8.01 (1 H, ddd, <i>J</i> = 8.5, 4.5, 2.5 Hz), 7.83 (1 H, br s), 7.70â7.77 (2 H, m), 7.60 (1 H, app. t, <i>J</i> = 9.0 Hz), 7.18â7.27 (2H, m), 2.90â3.07 (1 H, m), 1.53â1.67 (4 H, m), 1.40â1.53 (1 H, m), 0.96â1.25 (5 H, m). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 161.2, 160.5, 158.5, 138.9, 134.9, 130.7, 128.4, 125.3, 121.7, 117.4, 115.4, 52.1, 33.2, 24.8, 24.3.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 5-(Cyclohexylsulfamoyl)-2-fluoro-<i>N</i>-phenyl-benzamide (<b>15</b>)</h4><div class="NLM_p last">To an ice-cooled mixture of 5-(<i>N</i>-cyclohexylsulfamoyl)-2-fluorobenzoic acid (602 mg, 2 mmol, 1.0 equiv), aniline (223 mg, 2.4 mmol, 1.2 equiv), and HATU (1.14 g, 3.06 mmol, 1.5 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was added DIPEA (0.774 g, 6 mmol, 3.0 equiv) under N<sub>2</sub> atmosphere. The resulting mixture was stirred at room temperature for 3 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and washed with saturated aq NaHCO<sub>3</sub> solution (10 mL) and brine (10 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The organic layer was concentrated under vacuum. The crude product was purified by preparative high performance liquid chromatography preparative high-performance liquid chromatography (column, C18; eluent, CH<sub>3</sub>CN/H<sub>2</sub>O from 35/65 to 60/40; 0.1% CF<sub>3</sub>COOH). The desired fraction was collected and basified by saturated NaHCO<sub>3</sub> (aq). The mixture was concentrated and extracted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL Ã 3). The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under vacuum. The product was dried under vacuum to result in compound <b>15</b> (210 mg, 28%). Method C; <i>R</i><sub>t</sub> 4.17 min; <i>m</i>/<i>z</i> 377.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 377.1334 (calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>3</sub>S: 376.1257). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.59 (s, 1H), 8.06â8.11 (m, 1H), 7.97â8.05 (m, 1H), 7.81 (br s, 1H), 7.68â7.76 (m, 2H), 7.59 (t, <i>J</i> = 9.15 Hz, 1H), 7.38 (t, <i>J</i> = 7.53 Hz, 2H), 7.09â7.19 (m, 1H), 2.99 (br s, 1H), 1.60 (br d, <i>J</i> = 7.73 Hz, 4H), 1.46 (br d, <i>J</i> = 11.80 Hz, 1H), 0.96â1.28 (m, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 161.3, 160.4, 138.8, 138.5, 130.6, 128.8, 128.4, 125.5, 124.1, 119.8, 117.4, 52.1, 33.2, 24.8, 24.3;</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-(Cyclopentylsulfamoyl)-<i>N</i>-(3-fluorophenyl)benzamide (<b>29</b>)</h4><div class="NLM_p last">Yield 66% from 3-(<i>N</i>-cyclopentylsulfamoyl)benzoic acid according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A as described for compound <b>32</b>. Method B; <i>R</i><sub>t</sub> 5.45 min; <i>m</i>/<i>z</i> 363.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 363.1178 (calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>S: 362.1100). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 1.23â1.43 (m, 4 H) 1.47â1.64 (m, 4 H) 3.38â3.51 (m, 1 H) 6.97 (td, <i>J</i> = 8.3, 2.5 Hz, 1 H) 7.41 (td, <i>J</i> = 8.3, 7.0 Hz, 1 H) 7.54â7.59 (m, 1 H) 7.71â7.85 (m, 3 H) 8.02 (ddd, <i>J</i> = 7.8, 1.5, 1.0 Hz, 1 H) 8.19 (ddd, <i>J</i> = 7.8, 1.5, 1.0 Hz, 1 H) 8.35 (t, <i>J</i> = 1.5 Hz, 1 H) 10.68 (br s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.5, 162.0, 142.1, 140.6, 135.4, 131.2, 130.3, 129.5 (2 Ã C), 125.9, 116.2, 110.4, 107.2, 54.5, 32.4, 22.8</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-(Cyclopentylsulfamoyl)-<i>N</i>-(3,4-difluorophenyl)benzamide (<b>30</b>)</h4><div class="NLM_p last">Yield 47% from 3-(<i>N</i>-cyclopentylsulfamoyl)benzoic acid according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A as described for compound <b>32</b>. Method B; <i>R</i><sub>t</sub> 4.34 min; <i>m</i>/<i>z</i> 381.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 381.1085 (calcd for C<sub>18</sub>H<sub>18</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S: 380.1006). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 1.20â1.44 (m, 4 H), 1.44â1.68 (m, 4 H), 3.44 (sxt, <i>J</i> = 6.8 Hz, 1 H), 7.45 (dt, <i>J</i> = 10.6, 9.0 Hz, 1 H), 7.51â7.60 (m, 1 H), 7.77 (t, <i>J</i> = 7.8 Hz, 1 H), 7.80 (d, <i>J</i> = 7.2 Hz, 1 H), 7.93 (ddd, <i>J</i> = 13.2, 7.5, 2.5 Hz, 1 H), 8.02 (d, <i>J</i> = 7.8 Hz, 1 H), 8.19 (d, <i>J</i> = 7.7 Hz, 1 H), 8.35 (t, <i>J</i> = 1.7 Hz, 1 H), 10.70 (s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.4, 148.8, 145.7, 142.1, 135.8, 135.2, 131.1, 129.5 (2 Ã C), 125.8, 117.3, 116.8, 109.5, 54.5, 32.4, 22.8</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 3-(Cyclopentylsulfamoyl)-<i>N</i>-(3,5-difluorophenyl)benzamide (<b>31</b>)</h4><div class="NLM_p last">Yield 9% from 3-(<i>N</i>-cyclopentylsulfamoyl)benzoic acid according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A as described for compound <b>32</b>. Method B; <i>R</i><sub>t</sub> 4.43 min; <i>m</i>/<i>z</i> 381.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 381.1087 (calcd for C<sub>18</sub>H<sub>18</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S: 380.1006). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.86 (br s, 1H), 8.37â8.40 (m, 1H), 8.19â8.24 (m, <i>J</i> = 7.70 Hz, 1H), 8.00â8.06 (m, <i>J</i> = 8.50 Hz, 1H), 7.71â7.88 (m, 2H), 7.54â7.62 (m, 2H), 6.99 (tt, <i>J</i> = 2.42, 9.28 Hz, 1H), 3.38â3.50 (m, 1H), 1.48â1.65 (m, 4H), 1.23â1.43 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.7, 162.3, 142.2, 141.4, 135.0, 131.3, 129.7, 129.5, 125.9, 103.2, 99.0, 54.5, 32.4, 22.8</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 3-(Cyclopentylsulfamoyl)-<i>N</i>-(4-fluoro-3-methyl-phenyl)benzamide (<b>32</b>)</h4><div class="NLM_p last">Representative procedure route <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>a: To an iced-cooled mixture of cyclopentanamine (1.93 g, 22.66 mmol) and a solution of NaOH (1.81 g, 45.32 mmol) in H<sub>2</sub>O (25 mL) and THF (25 mL) was added 3-(chloro-sulfonyl)benzoic acid (5.0 g, 22.66 mmol) in portions. The reaction mixture was stirred at 20 Â°C for 2 h. The resulting mixture was diluted with H<sub>2</sub>O (20 mL) and extracted with ethyl acetate (30 mL). The aqueous layer was separated and adjusted pH = 2 by 4 N HCl and extracted with dichloromethane (3 Ã 30 mL). The combined organic layers were washed with brine (15 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to afford 3-(<i>N</i>-cyclopentylsulfamoyl)benzoic acid (<b>71d</b>, 4.5 g, 73%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.30â8.34 (m, 1H), 8.10â8.20 (m, 1H), 8.00â8.05 (m, 1H), 7.80 (d, <i>J</i> = 7.2 Hz, 1H), 7.65â7.75 (m, 1H), 1.40â1.60 (m, 4H), 1.30â1.38 (m, 2H), 1.20â1.28 (m, 2H), one CH signal under residual water peak. To an ice-cooled mixture of 3-(<i>N</i>-cyclopentylsulfamoyl)benzoic acid (250 mg, 0.928 mmol), 4-fluoro-3-methylaniline (116.2 mg, 0.928 mmol), and HATU (388.2 mg, 1.021 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL), DIPEA (359.8 mg, 2.784 mmol) was added under a N<sub>2</sub> atmosphere. The resulting mixture was stirred at 20 Â°C for 16 h. The solvent was removed in vacuo. The mixture was washed with saturated aqueous critic acid (10 mL) and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo. The residue was purified by column chromatography over silica gel (gradient eluent: petroleum ether/ethyl acetate from 100/0 to 10/90). The pure fractions were collected and the solvent was removed in vacuo. The residue was further purified by preparative high performance liquid chromatography over RP-18 (eluent: CH<sub>3</sub>CN in H<sub>2</sub>O from 45% to 75%, v/v; 0.01% HCl as addition). The pure fractions were collected and the volatiles were removed in vacuo. The aqueous layer was adjusted to pH = 7 with Amberlite IRA-900 ion-exchange resin (OH form), filtrated, and lyophilized to dryness to afford compound <b>32</b> (170.0 mg, 49%). Method B; <i>R</i><sub>t</sub> 4.31 min; <i>m</i>/<i>z</i> 377.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 377.1338 (calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>3</sub>S: 376.1257). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.47 (1 H, br s), 8.33â8.35 (1 H, m), 8.17 (1 H, dm, <i>J</i> = 8.0), 7.98 (1 H, dm, <i>J</i> = 8.0), 7.78 (1 H, d, <i>J</i> = 7.0 Hz), 7.74 (1 H, t, <i>J</i> = 8.0 Hz), 7.62â7.68 (1 H, m), 7.53â7.61 (1 H, m), 7.13 (1 H, t, <i>J</i> = 9.0 Hz), 3.37â3.48 (1 H, m), 2.23 (3 H, d, <i>J</i> = 1.8 Hz), 1.44â1.69 (4 H, m), 1.12â1.45 (4 H, m). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 157.1, 142.1, 135.6, 134.8, 131.1, 129.4, 129.3, 125.8, 124.1, 123.7, 119.9, 114.8, 54.5, 32.4, 22.8, 14.4</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-(Cyclopentylsulfamoyl)-<i>N</i>-(3-fluoro-5-methyl-phenyl)benzamide (<b>33</b>)</h4><div class="NLM_p last">Yield 49% from 3-(<i>N</i>-cyclopentylsulfamoyl)benzoic acid according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A as described for compound <b>32</b>. Method B; <i>R</i><sub>t</sub> 4.41 min; <i>m</i>/<i>z</i> 377.2 (M + H)<sup>+</sup>. Exact mass: 376.1. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 377.1340 (calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>3</sub>S: 376.1257). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.60 (1 H, bs), 8.36 (1 H, t, <i>J</i> = 1.5 Hz), 8.19 (1 H, dm, <i>J</i> = 7.5 Hz), 8.02 (1 H, dm, <i>J</i> = 7.5 Hz), 7.81 (1 H, d, <i>J</i> = 7.5 Hz), 7.78 (1 H, t, <i>J</i> = 7.5 Hz), 7.55 (1 H, dm, <i>J</i> = 11.0 Hz), 7.38â7.46 (1 H, m), 6.82 (1 H, dm, <i>J</i> = 9.5 Hz), 3.41â3.54 (1 H, m), 2.34 (3 H, s), 1.45â1.70 (4 H, m), 1.19â1.45 (4 H, m). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.4, 161.9, 142.1, 140.2, 140.2, 135.4, 131.2, 129.5, 129.4, 125.8, 116.6, 111.0, 104.4, 54.5, 32.4, 22.8, 21.1</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-(Cyclopentylsulfamoyl)-<i>N</i>-(3-fluoro-4-methyl-phenyl)benzamide (<b>34</b>)</h4><div class="NLM_p last">Yield 63% from 3-(<i>N</i>-cyclopentylsulfamoyl)benzoic acid according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A as described for compound <b>32</b>. The residue was purified by column chromatography over silica gel (gradient eluent: petroleum ether/ethyl acetate from 100/0 to 40/60). Method B; <i>R</i><sub>t</sub> 4.41 min; <i>m</i>/<i>z</i> 377.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 377.1339 (calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>3</sub>S: 376.1257). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.58 (br s, 1H), 8.35 (t, <i>J</i> = 1.60 Hz, 1H), 8.19 (td, <i>J</i> = 1.32, 7.70 Hz, 1H), 8.01 (d, <i>J</i> = 7.70 Hz, 1H), 7.73â7.82 (m, 2H), 7.68 (dd, <i>J</i> = 2.03, 12.21 Hz, 1H), 7.46 (dd, <i>J</i> = 2.03, 8.14 Hz, 1H), 7.26 (t, <i>J</i> = 8.54 Hz, 1H), 3.45 (br s, 1H), 2.21 (d, <i>J</i> = 1.63 Hz, 3H), 1.45â1.64 (m, 4H), 1.25â1.43 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.3, 160.1, 142.1, 138.2, 135.5, 131.3, 131.1, 129.4, 129.4, 125.9, 119.3, 116.0, 107.1, 54.5, 32.4, 22.8, 13.7</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(4-Fluorophenyl)-3-(4-methylpiperazin-1-yl)sulfonyl-benzamide (<b>36</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 31%. Method A; <i>R</i><sub>t</sub> 4.14 min; <i>m</i>/<i>z</i> 378.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 378.1304 (calcd for C<sub>18</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>3</sub>S: 377.1209). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.57 (s, 1H), 8.28â8.34 (m, 1H), 8.23â8.27 (m, 1H), 7.92â7.98 (m, 1H), 7.75â7.86 (m, 3H), 7.17â7.26 (m, 2H), 2.88â3.06 (m, 4H), 2.36â2.48 (m, 4H), 2.18 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 163.9, 158.5, 135.8, 135.4, 135.0, 132.2, 130.3, 129.7, 126.4, 122.5, 115.2, 53.3, 45.5, 45.0</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-(4-Acetylpiperazin-1-yl)sulfonyl-<i>N</i>-(4-fluorophenyl)benzamide (<b>37</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 13 %. Method A; <i>R</i><sub>t</sub> 4.82 min; <i>m</i>/<i>z</i> 406.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 406.1239 (calcd for C1<sub>9</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>4</sub>S: 405.1159). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.56 (s, 1H), 8.28â8.33 (m, 1H), 8.25â8.28 (m, 1H), 7.92â7.98 (m, 1H), 7.74â7.86 (m, 3H), 7.17â7.28 (m, 2H), 3.47â3.57 (m, 4H), 2.94â3.01 (m, 2H), 2.85â2.94 (m, 2H), 1.93 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.3, 163.8, 158.5, 135.8, 135.3, 135.0, 132.3, 130.3, 129.8, 126.4, 122.5, 115.2, 46.0, 45.7, 44.9, 21.0</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-(4-Fluorophenyl)-3-morpholinosulfonyl-benzamide (<b>38</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 42%. Method A; <i>R</i><sub>t</sub> 5.07 min; <i>m</i>/<i>z</i> 365.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 365.0972 (calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>4</sub>S: 364.0893). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.57 (s, 1H), 8.28â8.34 (m, 1H), 8.23â8.28 (m, 1H), 7.93â7.97 (m, 1H), 7.84 (t, <i>J</i> = 7.73 Hz, 1H), 7.76â7.81 (m, 2H), 7.17â7.27 (m, 2H), 3.60â3.69 (m, 4H), 2.86â2.98 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 163.9, 158.5, 135.9, 135.1, 134.9, 132.4, 130.4, 129.8, 126.6, 122.5, 115.2, 65.2, 45.9</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(4-Fluorophenyl)-3-pyrrolidin-1-ylsulfonyl-benzamide (<b>39</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 35%. Method A; <i>R</i><sub>t</sub> 5.42 min; <i>m</i>/<i>z</i> 349.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 349.1025 (calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>3</sub>S: 348.0944). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.56 (s, 1H), 8.30â8.37 (m, 1H), 8.25â8.30 (m, 1H), 7.99â8.05 (m, 1H), 7.72â7.85 (m, 3H), 7.17â7.26 (m, <i>J</i> = 8.90, 8.90 Hz, 2H), 3.19 (s, 4H), 1.60â1.75 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 163.9, 158.5, 136.7, 135.6, 135.1, 132.0, 130.1, 129.8, 126.2, 122.6, 115.2, 47.9, 24.7</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-(Dimethylsulfamoyl)-<i>N</i>-(4-fluorophenyl)benzamide (<b>40</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 50%. Method A; <i>R</i><sub>t</sub> 5.09 min; <i>m</i>/<i>z</i> 323.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 323.0870 (calcd for C<sub>15</sub>H<sub>15</sub>FN<sub>2</sub>O<sub>3</sub>S: 322.0787). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.56 (s, 1H), 8.25â8.31 (m, 2H), 7.92â7.98 (m, 1H), 7.75â7.85 (m, 3H), 7.18â7.25 (m, 2H), 2.66 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 163.9, 158.5, 135.7, 135.3, 135.0, 132.0, 130.3, 129.7, 126.4, 122.6, 115.2, 37.5</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(4-Fluorophenyl)-3-(isopropylsulfamoyl)benzamide (<b>41</b>)</h4><div class="NLM_p last">Yield 49% from 3-(<i>N</i>-isopropylsulfamoyl)benzoic acid (<b>71b</b>), prepared similarly as described for compound <b>61</b>. Method A; <i>R</i><sub>t</sub> 5.01 min; <i>m</i>/<i>z</i> 337.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 337.1025 (calcd for C<sub>16</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>3</sub>S: 336.0944). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.54 (br s, 1H), 8.36 (t, <i>J</i> = 2.03 Hz, 1H), 8.17â8.21 (m, 1H), 7.98â8.03 (m, 1H), 7.76 (s, 4H), 7.21 (s, 2H), 3.23â3.32 (m, 1H), 0.96 (d, <i>J</i> = 6.51 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 158.4, 142.3, 135.5, 135.1, 131.1, 129.4, 129.1, 125.7, 122.4, 115.2, 45.3, 23.2</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(1-Ethylpropylsulfamoyl)-<i>N</i>-(4-fluorophenyl)benzamide (<b>42</b>)</h4><div class="NLM_p last">Yield 22% over two steps from 3-(chlorosulfonyl)benzoic acid similarly as described for compound <b>50</b>. Method B; <i>R</i><sub>t</sub> 4.24 min; <i>m</i>/<i>z</i> 365.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 365.1342 (calcd for C<sub>18</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>3</sub>S: 364.1257). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.6, 158.9, 143.3, 135.8, 135.6, 131.4, 129.8, 129.6, 126.1, 122.9, 115.7, 56.8, 27.3, 10.3. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.55 (s, 1H), 8.36 (t, <i>J</i> = 1.80 Hz, 1H), 8.18 (ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 8.00 (ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 7.76â7.83 (m, 2H), 7.74 (t, <i>J</i> = 7.80 Hz, 1H), 7.65 (d, <i>J</i> = 7.76 Hz, 1H), 7.19â7.24 (m, 2H), 2.95â3.03 (m, 1H), 1.30â1.39 (m, 2H), 1.19â1.27 (m, 2H), 0.65 (t, <i>J</i> = 7.43 Hz, 6H)</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(4-Fluorophenyl)-3-[[(1<i>S</i>)-1-methylpropyl]sulfamoyl]benzamide (<b>43</b>)</h4><div class="NLM_p last">Enantiomer of compound <b>44</b>. Prepared similar as described for compound <b>44</b> starting from (<i>S</i>)-butan-2-amine instead of (<i>R</i>)-butan-2-amine.Method B; <i>R</i><sub>t</sub> 4.03 min; <i>m</i>/<i>z</i> 351.2 (M + H)<sup>+</sup>. Exact mass: 350.1 ([Î±]<sub>20</sub><sup>D</sup> = (<i>c</i> 0.2, MeOH). [Î±]<sub>20</sub><sup>D</sup> = +9.49 (<i>c</i> 0.611 w/v %, DMF). Column: Chiralpak AD-3 150 mm Ã 4.6 mm I.D., 3 Î¼m. Mobile phase: methanol (0.05% diethylamine) in CO<sub>2</sub> from 5% to 40%. Flow rate: 2.5 mL/min; <i>R</i><sub>t</sub> 7.73 min; [Î±]<sub>20</sub><sup>D</sup> 589 + 9.49Â° (<i>c</i> 0.61 w/v %, MeOH). ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 351.1184 (calcd for C<sub>17</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>S: 350.1100).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(4-Fluorophenyl)-3-[[(1<i>R</i>)-1-methylpropyl]sulfamoyl]benzamide (<b>44</b>)</h4><div class="NLM_p last">To an iced-cooled mixture of (<i>R</i>)-butan-2-amine (0.500 g, 6.837 mmol) and NaOH (0.547 g, 13.67 mmol) in H<sub>2</sub>O (15 mL) and THF (15 mL), 3-(chlorosulfonyl)benzoic acid was added (1.508 g, 6.84 mmol) in portions. The reaction mixture was stirred at 20 Â°C for 2 h. The resulting mixture was diluted with H<sub>2</sub>O (15 mL) and extracted with ethyl acetate (15 mL). The aqueous layer was separated and pH was adjusted to 3 by 1 N HCl and extracted with ethyl acetate (3 Ã 10 mL). The combined organic layers were washed with brine (10 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure, resulting in (<i>R</i>)-3-(<i>N</i>-<i>sec</i>-butylsulfamoyl)benzoic acid (0.73 g, 35%). To an ice-cooled mixture of (<i>R</i>)-3-(<i>N</i>-<i>sec</i>-butylsulfamoyl)benzoic acid (730 mg), 4-fluoroaniline (347 mg, 3.121 mmol), and HATU (1.294 g, 3.404 mmol) in DMF (10 mL), DIPEA (1.48 mL, 8.51 mmol) was added under N<sub>2</sub> atmosphere. The resulting mixture was stirred at 20 Â°C for 2 h. The solvent was removed in vacuo. The mixture was washed with saturated aqueous critic acid (10 mL) and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo. The residue was purified by column chromatography over silica gel (gradient eluent: petroleum ether/ethyl acetate from 100/0 to 55/45). The pure fractions were collected and the solvent was removed in vacuo. The residue was purified by SFC separation (Chiralcel OJ, 20 Î¼m; Supercritical CO<sub>2</sub>, MeOH (0.2% diethylamine)). The pure fractions were collected and the solvent was removed in vacuo, resulting in compound <b>44</b> (300 mg, 13% over two steps). Method A; <i>R</i><sub>t</sub> 5.25 min; <i>m</i>/<i>z</i> 351.2 (M + H)<sup>+</sup>. Exact mass: 350.1. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 351.1183 (calcd for C<sub>17</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>S: 350.1100) [Î±]<sub>20</sub><sup>D</sup> = â9.9 (<i>c</i> 0.435 w/v %, DMF). Column: Chiralpak AD-3 150 mm Ã 4.6 mm I.D., 3 Î¼m. Mobile phase: methanol (0.05% diethylamine) in CO<sub>2</sub> from 5% to 40%. Flow rate: 2.5 mL/min; <i>R</i><sub>t</sub> 7.58 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 0.70 (t, <i>J</i> = 7.4 Hz, 3 H), 0.88 (d, <i>J</i> = 6.5 Hz, 3 H), 1.30 (quin, <i>J</i> = 7.2 Hz, 2 H), 3.01â3.18 (m, 1 H), 7.21 (t, <i>J</i> = 8.8 Hz, 2 H), 7.67 (br d, <i>J</i> = 5.5 Hz, 1 H), 7.75 (t, <i>J</i> = 7.8 Hz, 1 H), 7.78 (dd, <i>J</i> = 8.8, 5.1 Hz, 2 H), 8.00 (d, <i>J</i> = 7.8 Hz, 1 H), 8.19 (d, <i>J</i> = 7.8 Hz, 1 H), 8.36 (s, 1 H), 10.55 (s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 158.5, 142.5, 135.4, 135.1, 131.0, 129.4, 129.2, 125.7, 122.4, 115.2, 50.8, 29.5, 20.6, 10.0</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-(<i>tert</i>-Butylsulfamoyl)-<i>N</i>-(4-fluorophenyl)benzamide (<b>45</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 10%. Method B; <i>R</i><sub>t</sub> 4.24 min; <i>m</i>/<i>z</i> 351.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 351.1181 (calcd for C<sub>17</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>S: 350.1100). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.55 (s, 1H), 8.38 (t, <i>J</i> = 1.70 Hz, 1H), 8.17 (ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 8.03 (ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 7.77â7.81 (m, 2H), 7.74 (t, <i>J</i> = 7.80 Hz, 1H), 7.70 (br s, 1H), 7.18â7.25 (m, 2H), 1.10 (s, 9H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.2, 158.5, 144.8, 135.5, 135.2, 130.8, 129.3, 129.2, 125.6, 122.4, 115.3, 53.5, 29.8</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(Cyclobutylsulfamoyl)-<i>N</i>-(4-fluorophenyl)benzamide (<b>46</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 43%. Method A; <i>R</i><sub>t</sub> 5.32 min; <i>m</i>/<i>z</i> 349.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 349.1025 (calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>3</sub>S: 348.0944). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.54 (s, 1H), 8.34 (t, <i>J</i> = 1.70 Hz, 1H), 8.20 (ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 8.09 (br d, <i>J</i> = 8.00 Hz, 1H), 7.98 (ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 7.69â7.83 (m, 3H), 7.14â7.27 (m, 2H), 3.67 (sxt, <i>J</i> = 8.22 Hz, 1H), 1.83â1.97 (m, 2H), 1.66â1.80 (m, 2H), 1.38â1.55 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 158.5, 142.1, 135.5, 135.2, 131.2, 129.4, 129.2, 125.8, 122.4, 115.2, 47.5, 30.5, 14.5</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(4-Fluorophenyl)-3-(oxetan-3-ylsulfamoyl)benzamide (<b>47</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b as described for compound <b>53</b>. Yield 29%. Method A; <i>R</i><sub>t</sub> 4.64 min; <i>m</i>/<i>z</i> 351.1 (M + H)<sup>+</sup> ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 351.0818 (calcd for C<sub>16</sub>H<sub>15</sub>FN<sub>2</sub>O<sub>4</sub>S: 350.0737) <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.56 (s, 1H), 8.70 (br s, 1H), 8.33 (t, <i>J</i> = 1.60 Hz, 1H), 8.22 (ddd, <i>J</i> = 1.00, 1.70, 7.90 Hz, 1H), 7.98 (ddd, <i>J</i> = 1.00, 1.70, 7.90 Hz, 1H), 7.74â7.82 (m, 3H), 7.19â7.25 (m, 2H), 4.38â4.55 (m, 3H), 4.24â4.30 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.0, 158.5, 141.2, 135.7, 135.1, 131.6, 129.7, 129.1, 125.6, 122.5, 115.3, 77.0, 47.0</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(4-Fluorophenyl)-3-[(3-methyloxetan-3-yl)sulfamoyl]benzamide (<b>48</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b as described for compound <b>53</b>. Yield 39%. Method A; <i>R</i><sub>t</sub> 4.87 min; <i>m</i>/<i>z</i> 365.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 365.0972 (calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>4</sub>S: 364.0893). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.56 (s, 1H), 8.50 (br s, 1H), 8.36â8.40 (m, 1H), 8.19â8.25 (m, <i>J</i> = 7.70 Hz, 1H), 8.03 (d, <i>J</i> = 7.80 Hz, 1H), 7.74â7.83 (m, 3H), 7.22 (t, <i>J</i> = 8.38 Hz, 2H), 4.56 (d, <i>J</i> = 6.06 Hz, 2H), 4.14 (d, <i>J</i> = 6.46 Hz, 2H), 1.42 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.0, 158.5, 143.5, 135.7, 135.1, 131.3, 129.6, 128.9, 125.4, 122.4, 115.2, 81.2, 54.7, 24.2</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(4-Fluorophenyl)-3-[[(3<i>R</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>49</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-tetrahydrofuran-3-amine (0.87 g, 9.97 mmol) in THF (20 mL), aqueous sodium hydroxide was added (4 mL, 5 N) in an ice bath followed by 3-(chlorosulfonyl)benzoic acid (2.2 g, 9.97 mmol). After stirring at 25 Â°C for 3 h, the reaction mixture was diluted with H<sub>2</sub>O (20 mL) and extracted with EtOAc (20 mL). The aqueous layer was adjusted to pH = 3 by aq HCl (2 N), and then the resulting mixture was extracted with EtOAc (3 Ã 20 mL). The combined organic layers were washed with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated in vacuo, resulting in compound (<i>R</i>)-3-(<i>N</i>-(tetrahydrofuran-3-yl)sulfamoyl)benzoic acid (900 mg, 33%). To a solution of compound (<i>R</i>)-3-(<i>N</i>-(tetrahydrofuran-3-yl)sulfamoyl)benzoic acid (0.80 g, 2.95 mmol), 4-fluoroaniline (0.39g, 3.54 mmol), and HATU (3.36 g, 8.85 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) cooled in an ice bath under N<sub>2</sub> atmosphere, DIPEA (0.57g, 0.44 mmol) was added. The resulting mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and washed with saturated aqueous NaHCO<sub>3</sub> (15 mL) and brine (10 mL). After drying over anhydrous MgSO<sub>4</sub>, the solvent was removed in vacuo. The obtained residue was purified by preparative high performance liquid chromatography over RP-18 (eluent: CH<sub>3</sub>CN in H<sub>2</sub>O from 40% to 80%, v/v; 0.05% TFA as addition). The pure fractions were collected, and the volatiles were removed in vacuo. The aqueous layer was adjusted to PH = 7 with Amberlite IRA-900 ion-exchange resin (OH form), filtrated, and lyophilized. The obtained residue was further purified by prep. SFC (Column, Chiralpak AD-3 150 mm Ã 4.6 mm I.D., 3 Î¼m; mobile phase, 40% of methanol (0.05% diethylamine) in CO<sub>2</sub>. Flow rate: 2.5 mL/min), resulting in compound <b>49</b> (370 mg, 34%) Method A; <i>R</i><sub>t</sub> 4.6 min; <i>m</i>/<i>z</i> 365.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 365.0970 (calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>4</sub>S: 364.0893). [Î±]<sub>20</sub><sup>D</sup> = â13.60 (<i>c</i> = 0.11, MeOH). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.57 (1 H, br s), 8.34â8.40 (1 H, m), 8.18â8.27 (1 H, m), 8.09 (1 H, br s), 7.99â8.06 (1 H, m), 7.74â7.84 (3 H, m), 7.13â7.33 (2 H, m), 3.64â3.83 (2 H, m), 3.50â3.64 (2 H, m), 3.35â3.39 (1 H, m), 1.80â1.99 (1 H, m), 1.51â1.68 (1 H, m). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 158.5, 141.4, 135.7, 135.2, 131.5, 129.7, 129.4, 125.9, 122.5, 115.3, 72.0, 66.1, 53.2, 32.1</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(4-Fluorophenyl)-3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>50</b>)</h4><div class="NLM_p last">To an iced-cooled mixture of (<i>S</i>)-tetrahydrofuran-3-amine hydrochloride (0.500 g, 4.41 mmol) and NaOH (0.485 g, 12.138 mmol) in H<sub>2</sub>O (5 mL) and THF (5 mL), 3-(chlorosulfonyl)benzoic acid (0.893 g, 4.406 mmol) was added in several portions. Then, the reaction mixture was stirred at 20 Â°C for 2 h. The resulting mixture was diluted with H<sub>2</sub>O (10 mL) and extracted with ethyl acetate (10 mL). The pH value of aqueous layer was adjusted to 3 by adding 1 N HCl, and then the mixture was extracted with ethyl acetate (3 Ã 10 mL). The combined organic layer was washed by brine (10 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure, resulting in (<i>S</i>)-3-(<i>N</i>-(tetrahydrofuran-3-yl)sulfamoyl)benzoic acid (<b>71a</b>, 0.60 g, 45%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.36 (s, 1H), 8.19 (d, <i>J</i> = 8.0 Hz, 1H), 8.12 (d, <i>J</i> = 6.8 Hz, 1H), 8.06 (d, <i>J</i> = 7.6 Hz, 1H), 7.70â7.80 (m, 1H), 3.65â3.75 (m, 2H), 3.50â3.64 (m, 3H), 1.80â1.95 (m, 1H), 1.50â1.65 (m, 1H). To an ice-cooled mixture of (<i>S</i>)-3-(<i>N</i>-(tetrahydrofuran-3-yl)sulfamoyl)benzoic acid (600 mg, 2.212 mmol), 4-fluoroaniline (270 mg, 2.433 mmol), and HATU (1.01 g, 2.654 mmol) in DMF (5 mL), DIPEA (1.15 mL, 6.636 mmol) was added under N<sub>2</sub> atmosphere. The resulting mixture was stirred at 20 Â°C for 2 h. The solvent was removed in vacuo. The mixture was washed with saturated aqueous critic acid (10 mL) and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo. The residue was purified by column chromatography over silica gel (gradient eluent: petroleum ether/ethyl acetate from 100/0 to 10/90). The pure fractions were collected and the solvent was removed in vacuo. The residue was further purified by preparative high performance liquid chromatography over RP-18 (eluent: CH<sub>3</sub>CN in H<sub>2</sub>O from 40% to 80%, v/v; 0.06% NH<sub>4</sub>HCO<sub>3</sub> as addition). The pure fractions were collected and the volatiles were removed in vacuo. The aqueous layer was lyophilized to dryness resulting in compound <b>50</b> (0.48 g, 59%). Method A; <i>R</i><sub>t</sub> 4.6 min; <i>m</i>/<i>z</i> 365.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> (calcd for 365.0972 C<sub>17</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>4</sub>S: 364.0893); [Î±]<sub>20</sub><sup>D</sup> = +15.56 (<i>c</i> 0.10, MeOH). <sup>1</sup>H NMR (400 MHz, 80 Â°C, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.35 (1 H, br s), 8.32â8.48 (1 H, m), 8.15â8.32 (1 H, m), 8.03 (1 H, br s), 7.83â7.94 (1 H, m), 7.68â7.83 (3 H, m), 7.06â7.31 (2 H, m), 3.70â3.87 (2 H, m), 3.51â3.70 (2 H, m), 3.32â3.48 (1 H, m), 1.85â2.04 (1 H, m), 1.59â1.78 (1 H, m). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 158.5, 141.4, 135.7, 135.1, 131.4, 129.6, 129.4, 125.9, 122.5, 115.3, 72.0, 66.1, 53.1, 32.1</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-[(1-Acetyl-4-piperidyl)sulfamoyl]-<i>N</i>-(4-fluorophenyl)benzamide (<b>51</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 10% . Method A; <i>R</i><sub>t</sub> 4.75 min; <i>m</i>/<i>z</i> 420.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 420.1402 (calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>4</sub>S: 419.1315). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.55 (s, 1H), 8.36â8.42 (m, 1H), 8.18â8.25 (m, 1H), 8.01â8.07 (m, 1H), 7.95 (br s, 1H), 7.72â7.85 (m, 3H), 7.16â7.28 (m, 2H), 3.98â4.12 (m, 1H), 3.58â3.70 (m, 1H), 3.21â3.30 (m, 1H), 2.95â3.07 (m, 1H), 2.60â2.74 (m, 1H), 1.93 (s, 3H), 1.50â1.64 (m, 2H), 1.11â1.36 (m, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 167.9, 164.1, 158.5, 142.4, 135.6, 135.1, 131.2, 129.5, 129.1, 125.6, 122.4, 115.2, 50.0, 44.0, 32.8, 32.0, 21.1</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(4-Fluorophenyl)-3-[(1-methyl-4-piperidyl)sulfamoyl]benzamide (<b>52</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 18%. Method A; <i>R</i><sub>t</sub> 4.05 min; <i>m</i>/<i>z</i> 392.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 392.1440 (calcd for C<sub>19</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>3</sub>S: 391.1366). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.55 (s, 1H), 8.38 (s, 1H), 8.15â8.24 (m, 1H), 7.98â8.06 (m, 1H), 7.67â7.89 (m, 4H), 7.11â7.29 (m, 2H), 2.87â3.05 (m, 1H), 2.54â2.69 (m, 2H), 2.10 (s, 3H), 1.77â1.96 (m, 2H), 1.46â1.60 (m, 2H), 1.29â1.46 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 158.5, 142.5, 135.6, 135.1, 131.1, 129.5, 129.1, 125.6, 122.4, 115.2, 53.6, 50.0, 45.5, 32.1</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(4-Fluorophenyl)-3-(tetrahydropyran-4-ylsulfamoyl)benzamide (<b>53</b>)</h4><div class="NLM_p last">Representative procedure route <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b: 3-(chlorosulfonyl)benzoyl chloride (207 mg, 1 mmol) was dissolved in dichloromethane (3 mL) and 4-fluoroaniline (111 mg, 1.0 mmol) and triethylamine (112 mg, 1.0 mmol) in dichloromethane (2 mL) were added to the mixture at 0 Â°C. The mixture was next stirred at 20 Â°C for 1 h. To this reaction mixture containing 3-(4-fluorophenylcarbamoyl)benzene-1-sulfonyl chloride at 0 Â°C, a solution of triethylamine (121 mg, 1.2 mmol) and 4-aminotetrahydropyran (88 mg, 0.861 mmol) in dichloromethane (3 mL) was added. The mixture was stirred at 20 Â°C for 1 h. The solvent was removed in vacuo. The residue was purified by high performance liquid chromatography (Column: Phenomenex Synergi C18 150 mm Ã 20 mm Ã 5 Î¼m; A, H<sub>2</sub>O + 0.1%TFA; B, MeCN). The product fractions were collected, and the organic solvent was evaporated. The fraction was neutralized by saturated NaHCO<sub>3</sub>. The mixture was extracted with dichloromethane. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated, resulting in compound <b>53</b> (85.4 mg, 23% yield) Method A; <i>R</i><sub>t</sub> 4.88 min; <i>m</i>/<i>z</i> 379.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 379.1125 (calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>4</sub>S: 378.1050). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) Î´ 8.38 (t, <i>J</i> = 1.51 Hz, 1H), 8.11â8.17 (m, <i>J</i> = 7.80 Hz, 1H), 8.06 (d, <i>J</i> = 8.00 Hz, 1H), 7.99â8.04 (m, 1H), 7.68 (t, <i>J</i> = 7.78 Hz, 1H), 7.58â7.65 (m, 2H), 7.11 (d, <i>J</i> = 8.53 Hz, 2H), 4.82 (d, <i>J</i> = 7.28 Hz, 1H), 3.83â3.93 (m, 2H), 3.30â3.47 (m, 3H), 1.70â1.84 (m, 2H), 1.41â1.55 (m, 2H)</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(4-Fluoro-3-methyl-phenyl)-3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>54</b>)</h4><div class="NLM_p last">3-(Chlorosulfonyl)benzoyl chloride (1200 mg, 5.0 mmol) was dissolved in dichloromethane (15 mL). A solution of 4-fluoro-3-methylaniline (625 mg, 5.0 mmol) and triethylamine (606 mg, 6.0 mmol) in dichloromethane (15 mL) was added to the mixture at 0 Â°C. The mixture was stirred at 25 Â°C for 1 h. The reaction mixture was used to the next step without further purification. To the above reaction mixture a solution of triethylamine (606 mg, 6.0 mmol) and (<i>S</i>)-tetrahydrofuran-3-amine (460.0 mg, 5.3 mmol) in dichloromethane (15 mL) was added at 0 Â°C. The mixture was stirred at 25 Â°C for 1 h. The solvent was removed in vacuo. The residue was purified by reversed phase high performance liquid chromatography (eluent: CH<sub>3</sub>CN in water (0.1% TFA) from 25 to 55, v/v). The pure fractions were collected, and the organic solvent was evaporated. The aqueous layer was neutralized with saturated aqueous NaHCO<sub>3</sub> to pH = 7â8. The mixture was extracted with dichloromethane (3 Ã 15 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo, resulting in compound <b>54</b> (620 mg, 33%). Method A; <i>R</i><sub>t</sub> 4.88 min; <i>m</i>/<i>z</i> 379.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 379.1130 (calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>4</sub>S: 378.1050). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 1.56â1.65 (m, 1 H), 1.85â1.94 (m, 1 H), 2.22â2.28 (m, 3 H), 3.33â3.39 (m, 1 H), 3.52â3.65 (m, 2 H), 3.65â3.73 (m, 1 H), 3.73â3.79 (m, 1 H), 7.14 (t, <i>J</i> = 9.2 Hz, 1 H), 7.56â7.62 (m, 1 H), 7.67 (dd, <i>J</i> = 7.0, 2.3 Hz, 1 H), 7.78 (t, <i>J</i> = 7.8 Hz, 1 H), 8.02 (d, <i>J</i> = 7.8 Hz, 1 H), 8.10 (d, <i>J</i> = 4.5 Hz, 1 H), 8.21 (d, <i>J</i> = 7.8 Hz, 1 H), 8.37 (s, 1 H), 10.49 (s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.0, 157.1, 141.4, 135.7, 134.7, 131.3, 129.5, 129.3, 125.8, 124.1, 123.7, 119.9, 114.8, 71.9, 66.1, 53.1, 32.1, 14.3. Alternative synthesis of compound <b>54</b>: A mixture of 3-(chlorosulfonyl)benzoyl chloride (4.61 g, 19.28 mmol) in toluene (45 mL) was refluxed under a gentle flow of nitrogen. 4-Fluoro-3-methylaniline (2.19 g, 17.53 mmol) in toluene (15 mL) was added dropwise to the refluxing solution. After addition, the mixture was refluxed for another 30 min. The mixture was next cooled to room temperature, and a mixture of (<i>S</i>)-3-aminotetrahydrofuran tosylate (5 g, 19.28 mmol) and diisopropylethylamine (15 mL) in toluene (15 mL) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise. After addition, the mixture was stirred for 4 h at room temperature. The resulting mixture was washed with HCl (2 Ã 100 mL, 1 M aq), water (2 Ã 100 mL), and NaHCO<sub>3</sub> (2 Ã 100 mL, satd aq). The organic layer was dried on MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The obtained residue was purified using silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>âMeOH 100:0 to 95:5), yielding 3-(4-fluoro-3-methylphenylcarbamoyl)benzene-1-sulfonyl chloride (1.07 g; method J; <i>R</i><sub>t</sub> 1.11 min; <i>m</i>/<i>z</i> 326.0 (M â H)<sup>â</sup>; exact mass 327.0) during CH<sub>2</sub>Cl<sub>2</sub> elution, followed by compound <b>54</b> (2.85 g, 39%) as a white solid after removal of the solvent (dried in a vacuum oven at 55 Â°C for 20 h) ([Î±]<sub>20</sub><sup>D</sup> = â5.21 (<i>c</i> 0.67 w/v %, MeOH). Method J; <i>R</i><sub>t</sub> 0.88 min; <i>m</i>/<i>z</i> 379.1 (M + H)<sup>+</sup>. Exact mass: 378.1. The compound was crystallized from CH<sub>2</sub>Cl<sub>2</sub>: DSC (From 30 to 300 Â°C at 10 Â°C/min): 149 Â°C. [Î±]<sub>20</sub><sup>D</sup> = +3.21 (<i>c</i> 0.65 w/v %, DMF).</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(2,4-Difluoro-3-methyl-phenyl)-3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>55</b>)</h4><div class="NLM_p last">Yield 14%, prepared similarly as described for compound <b>60</b>. Method A; <i>R</i><sub>t</sub> 5.17 min; <i>m</i>/<i>z</i>: 397.3 (M + H)<sup>+</sup> ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 397.1031 (calcd for C<sub>18</sub>H<sub>18</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S: 396.0955). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.40 (br s, 1H), 8.35â8.42 (m, 1H), 8.20â8.27 (m, 1H), 8.05â8.16 (m, 1H), 8.00â8.05 (m, 1H), 7.78 (t, <i>J</i> = 7.76 Hz, 1H), 7.38â7.47 (m, 1H), 7.06â7.14 (m, 1H), 3.72â3.79 (m, 1H), 3.66â3.72 (m, 1H), 3.60â3.66 (m, 1H), 3.54â3.60 (m, 1H), 3.33â3.39 (m, 1H), 2.20 (s, 3H), 1.85â1.98 (m, 1H), 1.53â1.67 (m, 1H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.3, 158.4, 154.7, 141.5, 134.7, 131.5, 129.8, 129.6, 126.0, 125.1, 121.6, 113.1, 110.5, 72.0, 66.1, 53.1, 32.1, 7.2</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(2,4-Difluoro-5-methyl-phenyl)-3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>56</b>)</h4><div class="NLM_p last">Yield 61%, prepared similarly as described for compound <b>60</b>. Method A; <i>R</i><sub>t</sub> 5.18 min; <i>m</i>/<i>z</i> 397.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 397.1034 (calcd for C<sub>18</sub>H<sub>18</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S: 396.0955). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 1.54â1.69 (m, 1 H) 1.82â1.98 (m, 1 H) 2.24 (s, 3 H) 3.35â3.40 (m, 1 H) 3.52â3.66 (m, 2 H) 3.66â3.83 (m, 2 H) 7.32 (t, <i>J</i> = 10.0 Hz, 1 H) 7.49 (t, <i>J</i> = 8.5 Hz, 1 H) 7.79 (t, <i>J</i> = 7.8 Hz, 1 H) 8.04 (d, <i>J</i> = 8.0 Hz, 1 H) 8.07â8.18 (m, 1 H) 8.23 (d, <i>J</i> = 7.8 Hz, 1 H) 8.39 (s, 1 H) 10.40 (br s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.2, 158.0, 154.2, 141.5, 134.7, 131.5, 129.7, 129.6, 129.5, 125.9, 121.2, 120.1, 103.9, 72.0, 66.1, 53.1, 32.1, 13.5.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(3,4-Difluoro-2-methyl-phenyl)-3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>57</b>)</h4><div class="NLM_p last">To a stirred solution of 3,4-difluoro-2-methyl-aniline (369 mg, 2.6 mmol), 3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzoic acid (700 mg, 2.58 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (1.35 mL, 7.74 mmol) in DMF (10 mL), Pybrop (132705-51-2, 1.82 g, 3.9 mmol) was added at 0 Â°C. The resulting mixture was stirred overnight at 18 Â°C. The mixture was concentrated in vacuo, ethyl acetate (15 mL) was added, and the organic layer was washed with 1 N HCl (15 mL) and saturated aqueous NaHCO<sub>3</sub> (15 mL). After drying over Na<sub>2</sub>SO<sub>4</sub> and concentration in vacuo, the crude residue was purified by reversed phase preparative high-performance liquid chromatography (eluent: CH<sub>3</sub>CN in H<sub>2</sub>O (0.05% NH<sub>3</sub>Â·H<sub>2</sub>O) from 37% to 37%, v/v). The pure fractions were collected, and the volatiles were removed in vacuo. The aqueous layer was lyophilized to dryness, resulting in compound <b>57</b> (238 mg, 23%). Method D; <i>R</i><sub>t</sub> 5.01 min; <i>m</i>/<i>z</i> 396.9 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 397.1037 (calcd for <i>C</i><sub>18</sub><i>H</i><sub>18</sub><i>F</i><sub>2</sub><i>N</i><sub>2</sub><i>O</i><sub>4</sub><i>S</i>: 396.0955). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.37 (br s, 1H), 8.38â8.43 (m, 1H), 8.22â8.28 (m, <i>J</i> = 7.70 Hz, 1H), 8.10 (br s, 1H), 8.01â8.07 (m, <i>J</i> = 7.70 Hz, 1H), 7.79 (t, <i>J</i> = 7.67 Hz, 1H), 7.26â7.35 (m, 1H), 7.16â7.24 (m, 1H), 3.67â3.80 (m, 2H), 3.56â3.67 (m, 2H), 3.35â3.39 (m, 1H), 2.18 (d, <i>J</i> = 2.02 Hz, 3H), 1.87â1.96 (m, 1H), 1.59â1.67 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.4, 148.0, 148.1, 141.5, 135.0, 133.2, 131.4, 129.7, 129.5, 126.0, 124.1, 122.9, 113.9, 72.0, 66.1, 53.1, 32.1, 10.3.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(3,4-Difluorophenyl)-3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>58</b>)</h4><div class="NLM_p last">3-(Chlorosulfonyl)benzoyl chloride (1200 mg, 5.0 mmol) was dissolved in dichloromethane (15 mL). A solution of 3,4-difluoroaniline (650 mg, 5.0 mmol) and triethylamine (606 mg, 6.0 mmol) in dichloromethane (15 mL) was added to the mixture at 0 Â°C. The mixture was stirred at 25 Â°C for 1 h. To the obtained reaction mixture, a solution of triethylamine (606 mg, 6.0 mmol) and (S)-tetrahydrofuran-3-amine (460.0 mg, 5.3 mmol) in dichloromethane (15 mL) was added at 0 Â°C. The mixture was stirred at 25 Â°C for 1 h. The solvent was removed in vacuo. The obtained residue was purified by high performance liquid chromatography over RP-18 (eluent: CH<sub>3</sub>CN in water (0.1%TFA) from 30 to 60, v/v). The pure fractions were collected, and the organic solvent was evaporated. The aqueous layer was neutralized with saturated aqueous NaHCO<sub>3</sub> to pH = 7â8. The mixture was extracted with dichloromethane (3 Ã 15 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo, resulting in compound <b>58</b> (710 mg, 37%). Method A; <i>R</i><sub>t</sub> 4.16 min; <i>m</i>/<i>z</i> 383.0 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 383.0875 (calcd for C<sub>17</sub>H<sub>16</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S: 382.0799). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 1.54â1.63 (m, 1 H), 1.83â1.93 (m, 1 H), 3.32â3.38 (m, 1 H), 3.52â3.63 (m, 2 H), 3.63â3.77 (m, 2 H), 7.45 (dt, <i>J</i> = 10.5, 9.0 Hz, 1 H), 7.51â7.57 (m, 1 H), 7.78 (t, <i>J</i> = 7.8 Hz, 1 H), 7.92 (ddd, <i>J</i> = 13.3, 7.5, 2.5 Hz, 1 H), 8.02 (d, <i>J</i> = 7.8 Hz, 1 H), 8.09 (d, <i>J</i> = 6.5 Hz, 1 H), 8.20 (d, <i>J</i> = 7.8 Hz, 1 H), 8.35 (s, 1 H), 10.70 (s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.4, 148.8, 145.7, 141.4, 135.8, 135.4, 131.5, 129.7, 129.6, 125.9, 117.4, 116.9, 109.6, 72.0, 66.1, 53.1, 32.1. SFC: column, Chiralcel OJ-H 250 mm Ã 4.6 mm I.D., 5 Î¼m. Flow: 2.35 mL/min. Mobile phase: methanol (0.05% diethylamine) in CO<sub>2</sub> from 5% to 40%; <i>R</i><sub>t</sub> 5.61 min; [Î±]<sub>20</sub><sup>D</sup> = +3.21 (<i>c</i> 0.624 w/v %, DMF).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(3-Cyano-4-fluoro-phenyl)-3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>59</b>)</h4><div class="NLM_p last">Yield 25%, prepared similarly as described for compound <b>60</b>. Method A; <i>R</i><sub>t</sub> 5.10 min; <i>m</i>/<i>z</i> 390.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 390.0923 (calcd for C<sub>18</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>4</sub>S: 389.0846). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.44 (br s, 1H), 8.40 (t, <i>J</i> = 1.70 Hz, 1H), 8.28 (dd, <i>J</i> = 2.60, 5.90 Hz, 1H), 8.24 (ddd, <i>J</i> = 1.00, 1.70, 7.90 Hz, 1H), 8.08 (ddd, <i>J</i> = 2.60, 4.90, 9.19 Hz, 1H), 8.04 (br ddd, <i>J</i> = 1.00, 1.70, 7.80 Hz, 1H), 7.79 (t, <i>J</i> = 7.80 Hz, 1H), 7.56 (t, <i>J</i> = 9.20 Hz, 1H), 3.66â3.81 (m, 2H), 3.53â3.65 (m, 2H), 3.32â3.39 (m, 1H), 1.84â1.96 (m, 1H), 1.56â1.66 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.5, 158.5, 141.6, 136.2, 135.2, 131.4, 129.6, 129.6, 128.0, 125.9, 124.6, 116.9, 113.9, 99.8, 72.0, 66.1, 53.1, 32.1.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(4-Fluoro-3-methoxy-phenyl)-3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzamide (<b>60</b>)</h4><div class="NLM_p last">3-[[(3<i>S</i>)-Tetrahydrofuran-3-yl]sulfamoyl]benzoic acid (400 mg, 1.47 mmol) was dissolved in DMF (0.5 mL) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL). (COCl)<sub>2</sub> (223 mg, 1.76 mmol) was added at 0 Â°C. The mixture was stirred at 20 Â°C for 2 h. The solvent was removed in vacuo, and the obtained residue was coevaporated with toluene (2 Ã 10 mL), resulting in crude 3-[[(3<i>S</i>)-tetrahydrofuran-3-yl]sulfamoyl]benzoyl chloride (400 mg). The crude product was used in the next step without purification. 3-[[(3<i>S</i>)-Tetrahydrofuran-3-yl]sulfamoyl]benzoyl chloride (200 mg) was dissolved in dichloromethane (5 mL). 4-Fluoro-3-methoxy-aniline (78 mg, 0.552 mmol) and triethylamine (167 mg, 165 mmol) were added at 0 Â°C. The mixture was stirred at 20 Â°C for 2 h, washed with H<sub>2</sub>O (5 mL), and the water layer extracted with dichloromethane (3 Ã 10 mL). The combined organic layers were concentrated in vacuo. The obtained residue was purified by reversed phase high performance liquid chromatography (mobile phase: CH<sub>3</sub>CN in water (0.1% TFA) from 30% to 60%). The pure fractions were collected and neutralized with solid NaHCO<sub>3</sub>. The organic solvent was removed in vacuo. The obtained precipitate was filtered, washed with H<sub>2</sub>O (5 mL), and dried under high vacuum. The residue was suspended in water (5 mL) lyophilized to dryness, resulting in compound <b>60</b> (140 mg, 24% yield). Method A; <i>R</i><sub>t</sub> 4.98 min; <i>m</i>/<i>z</i> 395.2 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 395.1077 (calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>5</sub>S: 394.0999). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.52 (br s, 1H), 8.34â8.42 (m, 1H), 8.18â8.26 (m, <i>J</i> = 7.70 Hz, 1H), 8.08 (br s, 1H), 7.99â8.05 (m, <i>J</i> = 7.70 Hz, 1H), 7.79 (t, <i>J</i> = 7.87 Hz, 1H), 7.65 (dd, <i>J</i> = 1.82, 7.87 Hz, 1H), 7.31â7.42 (m, 1H), 7.21 (dd, <i>J</i> = 8.88, 10.90 Hz, 1H), 3.85 (s, 3H), 3.66â3.78 (m, 2H), 3.55â3.66 (m, 2H), 3.34â3.39 (m, 1H), 1.85â1.96 (m, 1H), 1.57â1.66 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 146.8, 147.9, 141.4, 135.7, 135.5, 131.4, 129.6, 129.3, 125.8, 115.6, 112.5, 106.6, 71.9, 66.1, 55.8, 53.1, 32.1</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(4-Fluoro-3-methyl-phenyl)-3-(isopropylsulfamoyl)benzamide (<b>61</b>)</h4><div class="NLM_p last">To an iced-cooled solution of 3-(chlorosulfonyl)benzoic acid (50.0 g, 226.6 mmol) in ethyl acetate (1000 mL) was added isopropylamine (67.0 g, 1.13 mol) in one portion. The reaction mixture was stirred at 25 Â°C for 3 h. The resulting mixture was diluted with 1 N HCl (500 mL) and extracted with ethyl acetate (2 Ã 500 mL). The combined organic layers were washed with brine (400 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure, resulting 3-(<i>N</i>-isopropylsulfamoyl)benzoic acid (<b>71b</b>, 46 g, 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.33 (s, 1H), 8.14 (d, <i>J</i> = 7.6 Hz, 1H), 7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.65â7.80 (m, 2H), 3.20â3.30 (m, 1H), 0.92 (d, <i>J</i> = 6.4 Hz, 6H). To an ice-cooled mixture of 3-(<i>N</i>-isopropylsulfamoyl)benzoic acid (7.0 g, 28.77 mmol), 4-fluoro-3-methylaniline (3.6 g, 28.77 mmol), and DIPEA (18.6 g, 143.91 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (70 mL), HATU (12.0 g, 31.56 mmol) was added under N<sub>2</sub> atmosphere. The resulting mixture was stirred at 20Â° for 16 h. The solvent was removed in vacuo. The mixture was washed with saturated aqueous critic acid (30 mL) and brine (20 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo. The residue was purified by preparative high performance liquid chromatography on SYNERGI 250 mm Ã 50 mm, 10 Î¼m (eluent: CH<sub>3</sub>CN in H<sub>2</sub>O (0.05% TFA) from 35% to 65%, v/v). The pure fractions were collected and adjusted to pH = 7 with Amberlite IRA-900(OH) anionic exchange resin. The resin was filtered off. The filtrate was lyophilized to dryness, resulting in compound <b>61</b> (7.5 g, 74% yield). Method B; <i>R</i><sub>t</sub> 3.44 min; <i>m</i>/<i>z</i> 351.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 351.1185 (calcd for C<sub>17</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>S: 350.1100). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.49 (1 H, br s), 8.36 (1 H, t, <i>J</i> = 1.5 Hz), 8.19 (1 H, ddd, <i>J</i> = 7.8, 1.5, 1.0 Hz), 8.01 (1 H, ddd, <i>J</i> = 7.8, 1.5, 1.0 Hz), 7.76 (1 H, t, <i>J</i> = 7.8 Hz), 7.68 (1 H, dd, <i>J</i> = 7.0, 3.0 Hz), 7.75 (1 H, bs), 7.59 (1 H, ddd, <i>J</i> = 9.0, 4.5, 3.0 Hz), 7.15 (1 H, t, <i>J</i> = 9.0 Hz), 3.14â3.33 (1 H, m), 2.25 (3 H, d, <i>J</i> = 1.5 Hz), 0.96 (6 H, d, <i>J</i> = 6.5 Hz). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 157.1, 142.4, 135.6, 134.8, 131.0, 129.4, 129.1, 125.7, 124.1, 123.7, 119.9, 114.8, 45.3, 23.2, 14.3</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(3,4-Difluorophenyl)-3-(isopropylsulfamoyl)benzamide (<b>63</b>)</h4><div class="NLM_p last">Yield 65% from 3-(<i>N</i>-isopropylsulfamoyl)benzoic acid (<b>71b</b>), similarly as described for compound <b>61</b>. Method E; <i>R</i><sub>t</sub> 5.31 min; <i>m</i>/<i>z</i> 355.1 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 355.0933 (calcd for C<sub>16</sub>H<sub>16</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S: 354.0850). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.71 (s, 1 H), 8.36 (t, <i>J</i> = 1.5 Hz, 1 H), 8.19 (d, <i>J</i> = 7.8 Hz, 1 H), 7.98â8.08 (m, 1 H), 7.94 (ddd, <i>J</i> = 13.2, 7.5, 2.4 Hz, 1 H), 7.71â7.83 (m, 2 H), 7.53â7.59 (m, 1 H), 7.42â7.51 (m, 1 H), 3.21â3.29 (m, 1 H), 0.96 (d, <i>J</i> = 6.5 Hz, 6 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.4, 148.8, 145.7, 142.4, 135.8, 135.2, 131.1, 129.5, 129.4, 125.7, 117.4, 116.9, 109.5, 45.3, 23.2</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(4-Fluoro-3-methyl-phenyl)-3-[(3-methyloxetan-3-yl)sulfamoyl]benzamide (<b>66</b>)</h4><div class="NLM_p last">To 3-(4-fluoro-3-methylphenylcarbamoyl)benzene-1-sulfonyl chloride (500 mg, 1.53 mmol) in toluene (10 mL) at room temperature, a solution of diisopropylethylamine (0.657 mL, 141.6 mmol) and 3-methyl-3-oxetanamine hydrochloride (207 mg, 1.68 mmol) in toluene (5 mL) and dichloromethane (10 mL) was added dropwise. After 2 h, the reaction mixture was washed with 1 M hydrochloric acid (2 Ã 10 mL, saturated NaHCO<sub>3</sub> (2 Ã 10 mL), and brine (2 Ã 10 mL). The organic layer was dried on MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure until only toluene remained. The formed white precipitate was filtered and recrystallized out of diisopropylether and acetonitrile. The crystals were dried in a vacuum oven at 55 Â°C for 20 h, yielding compound <b>66</b> (361 mg, 63%) as a white solid. Method J; <i>R</i><sub>t</sub> 0.89 min; <i>m</i>/<i>z</i> 379.0 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 379.1129 (calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>4</sub>S: 378.1050). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 1.41 (s, 3 H), 2.25 (d, <i>J</i> = 1.5 Hz, 3 H), 4.14 (d, <i>J</i> = 6.3 Hz, 2 H), 4.56 (d, <i>J</i> = 6.3 Hz, 2 H), 7.14 (t, <i>J</i> = 9.0 Hz, 1 H), 7.52â7.64 (m, 1 H), 7.68 (dd, <i>J</i> = 7.0, 2.2 Hz, 1 H), 7.77 (t, <i>J</i> = 8.0 Hz, 1 H), 7.99â8.06 (m, 1 H), 8.20 (d, <i>J</i> = 8.0 Hz, 1 H), 8.37 (t, <i>J</i> = 1.5 Hz, 1 H), 8.50 (br s., 1 H), 10.48 (s, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 163.9, 157.1, 143.5, 135.7, 134.7, 131.2, 129.6, 128.9, 125.4, 124.1, 123.7, 119.9, 114.8, 81.2, 54.7, 24.2, 14.3</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(4-Fluoro-2,3-dimethyl-phenyl)-3-[(3-methyloxetan-3-yl)sulfamoyl]benzamide (<b>67</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B as described for compound <b>53</b>. Yield 27%. Method A; <i>R</i><sub>t</sub> 4.98 min; <i>m</i>/<i>z</i> 393.3 (M + H)<sup>+</sup>. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 393.1287 (calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>4</sub>S: 392.1206). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.22 (br s, 1H), 8.49 (br s, 1H), 8.40 (s, 1H), 8.25 (br d, <i>J</i> = 8.07 Hz, 1H), 8.02 (d, <i>J</i> = 8.07 Hz, 1H), 7.77 (t, <i>J</i> = 7.87 Hz, 1H), 7.16 (dd, <i>J</i> = 5.65, 8.48 Hz, 1H), 7.04 (t, <i>J</i> = 8.88 Hz, 1H), 4.57 (d, <i>J</i> = 6.06 Hz, 2H), 4.15 (d, <i>J</i> = 6.06 Hz, 2H), 2.20 (d, <i>J</i> = 1.61 Hz, 3H), 2.14 (s, 3H), 1.43 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.2, 158.7, 143.5, 135.7, 135.3, 131.9, 131.2, 129.6, 128.9, 125.8, 125.5, 123.4, 112.1, 81.2, 54.7, 24.2, 14.6, 11.2</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(4-Fluoro-2,5-dimethyl-phenyl)-3-[(3-methyloxetan-3-yl)sulfamoyl]benzamide (<b>68</b>)</h4><div class="NLM_p last">Synthesis according to the representative procedure of <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b as described for compound <b>53</b>. Yield 34%. Method A; <i>R</i><sub>t</sub> 5.27 min; <i>m</i>/<i>z</i> 393.3 (M + H)<sup>+</sup>. Exact mass: 392.1. ESI-HRMS (TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> 393.1290 (calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>4</sub>S: 392.1206). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.14 (br s, 1H), 8.53 (br s, 1H), 8.39 (s, 1H), 8.23 (d, <i>J</i> = 7.26 Hz, 1H), 7.99â8.05 (m, <i>J</i> = 7.30 Hz, 1H), 7.76 (t, <i>J</i> = 7.81 Hz, 1H), 7.23 (d, <i>J</i> = 7.48 Hz, 1H), 7.08 (d, <i>J</i> = 10.34 Hz, 1H), 4.57 (d, <i>J</i> = 6.16 Hz, 2H), 4.15 (d, <i>J</i> = 6.60 Hz, 2H), 2.21 (s, 3H), 2.19 (s, 3H), 1.43 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.1, 158.6, 143.5, 135.3, 133.8, 131.8, 131.1, 129.7, 129.6, 128.8, 125.4, 121.4, 116.2, 81.2, 54.7, 24.2, 17.4, 13.7</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00654" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85313" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85313" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00654" class="ext-link">10.1021/acs.jmedchem.8b00654</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures for the synthesis of compound <b>8</b>, <b>9</b>, <b>11</b>â<b>13</b>, <b>17</b>â<b>27</b>, <b>62</b>, <b>64</b>, and <b>65</b>; LC-MS methods, list of retention times, and purities of tested compounds; details on JNJ-632 modeling; experimental details on the anti HBV cellular assay; experimental details on the size exclusion chromatography; experimental details on the biochemical fluorescence quenching; fluorescence quenching curve for representative compounds; experimental details on determination of metabolic stability in liver microsomes, kinetic solubility, and pharmacokinetic assessment; experimental details on the determination of the anti-HBV activity of JNJ-632 in chimeric mice (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">List of molecular formula strings and associated biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_001.csv">jm8b00654_si_001.csv (4.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf">jm8b00654_si_002.pdf (1.46 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00654" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koen Vandyck</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0923-8301" title="Orcid link">http://orcid.org/0000-0002-0923-8301</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#69021f08070d100a0229001d1a47030703470a0604"><span class="__cf_email__" data-cfemail="8fe4f9eee1ebf6ece4cfe6fbfca1e5e1e5a1ece0e2">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geert Rombouts</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bart Stoops</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abdellah Tahri</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Vos</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wim Verschueren</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yiming Wu</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong
Road, China (Shanghai) Pilot Free Trade Zone; Shanghai 200131, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jingmei Yang</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong
Road, China (Shanghai) Pilot Free Trade Zone; Shanghai 200131, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fuliang Hou</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong
Road, China (Shanghai) Pilot Free Trade Zone; Shanghai 200131, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing Huang</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong
Road, China (Shanghai) Pilot Free Trade Zone; Shanghai 200131, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Vergauwen</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascale Dehertogh</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Martin Berke</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre Raboisson</span> - <span class="hlFld-Affiliation affiliation">Janssen
Pharmaceutica NV, Janssen Pharmaceutical
Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Michel Carpentier, Alberto Fontana, and Alex De Groot for analysis. We also thank Kenny Simmen for his support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">HBV</td><td class="NLM_def"><p class="first last">hepatitis B virus</p></td></tr><tr><td class="NLM_term">(PEG)-IFNÎ±</td><td class="NLM_def"><p class="first last">(pegylated) interferon-alpha</p></td></tr><tr><td class="NLM_term">CAM</td><td class="NLM_def"><p class="first last">capsid assembly modulator</p></td></tr><tr><td class="NLM_term">SBA</td><td class="NLM_def"><p class="first last">sulfamoylbenzamide</p></td></tr><tr><td class="NLM_term">SOC</td><td class="NLM_def"><p class="first last">sulfamoyl carboxamide</p></td></tr><tr><td class="NLM_term">PHH</td><td class="NLM_def"><p class="first last">primary human hepatocytes</p></td></tr><tr><td class="NLM_term">HLM/MLM</td><td class="NLM_def"><p class="first last">human/mouse liver microsome stability</p></td></tr><tr><td class="NLM_term">SEC</td><td class="NLM_def"><p class="first last">size exclusion chromatography</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">pgRNA</td><td class="NLM_def"><p class="first last">pregenomic RNA</p></td></tr><tr><td class="NLM_term">rcDNA</td><td class="NLM_def"><p class="first last">relaxed circular DNA</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">quaque die or once a day</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 21 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ott, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groeger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiersma, S. T.</span></span> <span> </span><span class="NLM_article-title">Global Epidemiology of Hepatitis B Virus Infection: New Estimates of Age-Specific HBsAg Seroprevalence and Endemicity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2212</span>â <span class="NLM_lpage">2219</span>, <span class="refDoi">Â DOI: 10.1016/j.vaccine.2011.12.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.vaccine.2011.12.116" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=2212-2219&author=J.+J.+Ottauthor=G.+A.+Stevensauthor=J.+Groegerauthor=S.+T.+Wiersma&title=Global+Epidemiology+of+Hepatitis+B+Virus+Infection%3A+New+Estimates+of+Age-Specific+HBsAg+Seroprevalence+and+Endemicity&doi=10.1016%2Fj.vaccine.2011.12.116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2011.12.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2011.12.116%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DJ.%2BJ.%26aulast%3DStevens%26aufirst%3DG.%2BA.%26aulast%3DGroeger%26aufirst%3DJ.%26aulast%3DWiersma%26aufirst%3DS.%2BT.%26atitle%3DGlobal%2520Epidemiology%2520of%2520Hepatitis%2520B%2520Virus%2520Infection%253A%2520New%2520Estimates%2520of%2520Age-Specific%2520HBsAg%2520Seroprevalence%2520and%2520Endemicity%26jtitle%3DVaccine%26date%3D2012%26volume%3D30%26spage%3D2212%26epage%3D2219%26doi%3D10.1016%2Fj.vaccine.2011.12.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berke, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehertogh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergauwen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mostmans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandyck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauwels, F.</span></span> <span> </span><span class="NLM_article-title">Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e00560-17</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00560-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1128%2FAAC.00560-17" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e00560-17&author=J.+M.+Berkeauthor=P.+Dehertoghauthor=K.+Vergauwenauthor=E.+Van+Dammeauthor=W.+Mostmansauthor=K.+Vandyckauthor=F.+Pauwels&title=Capsid+Assembly+Modulators+Have+a+Dual+Mechanism+of+Action+in+Primary+Human+Hepatocytes+Infected+with+Hepatitis+B+Virus&doi=10.1128%2FAAC.00560-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2FAAC.00560-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00560-17%26sid%3Dliteratum%253Aachs%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26aulast%3DDehertogh%26aufirst%3DP.%26aulast%3DVergauwen%26aufirst%3DK.%26aulast%3DVan%2BDamme%26aufirst%3DE.%26aulast%3DMostmans%26aufirst%3DW.%26aulast%3DVandyck%26aufirst%3DK.%26aulast%3DPauwels%26aufirst%3DF.%26atitle%3DCapsid%2520Assembly%2520Modulators%2520Have%2520a%2520Dual%2520Mechanism%2520of%2520Action%2520in%2520Primary%2520Human%2520Hepatocytes%2520Infected%2520with%2520Hepatitis%2520B%2520Virus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De00560-17%26doi%3D10.1128%2FAAC.00560-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span> </span><span class="NLM_article-title">An Efficacy, Safety, and Pharmacokinetics
Study of JNJ-56136379 in
Participants With Chronic Hepatitis B Virus Infection</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National
Intitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda</span>, December 5, 2017; <a href="https://ClinicalTrials.gov/show/NCT03361956" class="extLink">https://ClinicalTrials.gov/show/NCT03361956</a> (accessed June 4, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Efficacy%2C+Safety%2C+and+Pharmacokinetics%0AStudy+of+JNJ-56136379+in%0AParticipants+With+Chronic+Hepatitis+B+Virus+Infection.+ClinicalTrials.gov%3B+U.S.+National%0AIntitutes+of+Health%3A+Bethesda%2C+December+5%2C+2017%3B+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT03361956+%28accessed+June+4%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAn%2520Efficacy%252C%2520Safety%252C%2520and%2520Pharmacokinetics%250AStudy%2520of%2520JNJ-56136379%2520in%250AParticipants%2520With%2520Chronic%2520Hepatitis%2520B%2520Virus%2520Infection%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AIntitutes%2520of%2520Health" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berke, J. M.</span>; <span class="NLM_string-name">Dehertogh, P.</span>; <span class="NLM_string-name">Vergauwen, K.</span>; <span class="NLM_string-name">Van Damme, E.</span>; <span class="NLM_string-name">Raboisson, P.</span>; <span class="NLM_string-name">Pauwels, F.</span>; <span class="NLM_string-name">Vandyck, K.</span></span> <span> </span><span class="NLM_article-title">In Capsid Assembly Modulator JNJ-56136379 Prevents de Novo Infection of Primary Human Hepatocytes with Hepatitis B Virus</span>,  <i>AASLD The Liver Meeting, Boston, 2016</i>: <span class="NLM_publisher-loc">Boston</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+M.+Berke&author=P.+Dehertogh&author=K.+Vergauwen&author=E.+Van+Damme&author=P.+Raboisson&author=F.+Pauwels&author=K.+Vandyck&title=In+Capsid+Assembly+Modulator+JNJ-56136379+Prevents+de+Novo+Infection+of+Primary+Human+Hepatocytes+with+Hepatitis+B+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26atitle%3DIn%2520Capsid%2520Assembly%2520Modulator%2520JNJ-56136379%2520Prevents%2520de%2520Novo%2520Infection%2520of%2520Primary%2520Human%2520Hepatocytes%2520with%2520Hepatitis%2520B%2520Virus%26jtitle%3DAASLD%2520The%2520Liver%2520Meeting%252C%2520Boston%252C%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perni, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladner, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaifert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, R. W.</span></span> <span> </span><span class="NLM_article-title">Phenylpropenamide Derivatives as Inhibitors of Hepatitis B Virus Replication</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2687</span>â <span class="NLM_lpage">2690</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(00)00544-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2FS0960-894X%2800%2900544-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=11128652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlantbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2687-2690&author=R.+B.+Perniauthor=S.+C.+Conwayauthor=S.+K.+Ladnerauthor=K.+Zaifertauthor=M.+J.+Ottoauthor=R.+W.+King&title=Phenylpropenamide+Derivatives+as+Inhibitors+of+Hepatitis+B+Virus+Replication&doi=10.1016%2FS0960-894X%2800%2900544-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication</span></div><div class="casAuthors">Perni, R. B.; Conway, S. C.; Ladner, S. K.; Zaifert, K.; Otto, M. J.; King, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2687-2690</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A non-nucleoside class of compds. that inhibits the replication of hepatitis B virus (HBV) in cell culture has been discovered.  A series of substituted analogs of phenylpropenamide has been prepd. and evaluated in the HepAD38 cellular assay.  Structure-activity relationships of this series are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcZcKEPcrqkbVg90H21EOLACvtfcHk0lhyxbkExbVCjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlantbw%253D&md5=4c3ee48f05dc8bee0724ba928d89f8a1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900544-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900544-8%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DConway%26aufirst%3DS.%2BC.%26aulast%3DLadner%26aufirst%3DS.%2BK.%26aulast%3DZaifert%26aufirst%3DK.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26atitle%3DPhenylpropenamide%2520Derivatives%2520as%2520Inhibitors%2520of%2520Hepatitis%2520B%2520Virus%2520Replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2687%26epage%3D2690%26doi%3D10.1016%2FS0960-894X%2800%2900544-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feld, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colledge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sozzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlejohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locarnini, S. A.</span></span> <span> </span><span class="NLM_article-title">The Phenylpropenamide Derivative AT-130 Blocks HBV Replication at the Level of Viral RNA Packaging</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">168</span>â <span class="NLM_lpage">177</span>, <span class="refDoi">Â DOI: 10.1016/j.antiviral.2007.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.antiviral.2007.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=17709147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOgtb3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=168-177&author=J.+J.+Feldauthor=D.+Colledgeauthor=V.+Sozziauthor=R.+Edwardsauthor=M.+Littlejohnauthor=S.+A.+Locarnini&title=The+Phenylpropenamide+Derivative+AT-130+Blocks+HBV+Replication+at+the+Level+of+Viral+RNA+Packaging&doi=10.1016%2Fj.antiviral.2007.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging</span></div><div class="casAuthors">Feld, J. J.; Colledge, D.; Sozzi, V.; Edwards, R.; Littlejohn, M.; Locarnini, S. A.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-177</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nucleos(t)ide analog antiviral therapy for chronic hepatitis B has proven to be effective in the short term but the frequent development of resistance limits its clin. utility.  Agents targeting other stages of viral replication are needed in order to develop improved combination therapies.  The phenylpropenamide derivs. AT-61 and AT-130 have been shown to inhibit HBV replication in vitro, but the mechanism of action of these compds. remains undefined.  The aim of this study was to det. the mechanism of action of AT-130, a nonnucleoside inhibitor of HBV in several in vitro models of replication.  These studies found that AT-130 inhibited HBV DNA replication in hepatoma cells but had no effect on viral DNA polymerase activity or core protein translation.  Total HBV RNA prodn. was also unaffected in the presence of the drug while the amt. of encapsidated RNA was significantly reduced, thereby inhibiting subsequent viral reverse transcription.  These studies have established that the inhibition of HBV genome replication by a nonnucleoside analog acting at the level of viral encapsidation and packaging is a potentially useful strategy for future therapeutic drug development in the management of chronic hepatitis B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGXzYFUdjuOrVg90H21EOLACvtfcHk0lhyxbkExbVCjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOgtb3K&md5=d8989ca5da33e96859f3de9f87f38872</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2007.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2007.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DFeld%26aufirst%3DJ.%2BJ.%26aulast%3DColledge%26aufirst%3DD.%26aulast%3DSozzi%26aufirst%3DV.%26aulast%3DEdwards%26aufirst%3DR.%26aulast%3DLittlejohn%26aufirst%3DM.%26aulast%3DLocarnini%26aufirst%3DS.%2BA.%26atitle%3DThe%2520Phenylpropenamide%2520Derivative%2520AT-130%2520Blocks%2520HBV%2520Replication%2520at%2520the%2520Level%2520of%2520Viral%2520RNA%2520Packaging%26jtitle%3DAntiviral%2520Res.%26date%3D2007%26volume%3D76%26spage%3D168%26epage%3D177%26doi%3D10.1016%2Fj.antiviral.2007.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deres, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paessens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niewohner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleiss, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltefuss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koletzki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masantschek, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckermann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlemmer, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haebich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubsamen-Waigmann, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>299</i></span>,  <span class="NLM_fpage">893</span>â <span class="NLM_lpage">896</span>, <span class="refDoi">Â DOI: 10.1126/science.1077215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1126%2Fscience.1077215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=12574631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2003&pages=893-896&author=K.+Deresauthor=C.+H.+Schroderauthor=A.+Paessensauthor=S.+Goldmannauthor=H.+J.+Hackerauthor=O.+Weberauthor=T.+Kramerauthor=U.+Niewohnerauthor=U.+Pleissauthor=J.+Stoltefussauthor=E.+Graefauthor=D.+Koletzkiauthor=R.+N.+Masantschekauthor=A.+Reimannauthor=R.+Jaegerauthor=R.+Grossauthor=B.+Beckermannauthor=K.+H.+Schlemmerauthor=D.+Haebichauthor=H.+Rubsamen-Waigmann&title=Inhibition+of+Hepatitis+B+Virus+Replication+by+Drug-Induced+Depletion+of+Nucleocapsids&doi=10.1126%2Fscience.1077215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids</span></div><div class="casAuthors">Deres, Karl; Schroeder, Claus H.; Paessens, Arnold; Goldmann, Siegfried; Hacker, Hans Joerg; Weber, Olaf; Kraemer, Thomas; Niewoehner, Ulrich; Pleiss, Ulrich; Stoltefuss, Juergen; Graef, Erwin; Koletzki, Diana; Masantschek, Ralf N. A.; Reimann, Anja; Jaeger, Rainer; Gro, Rainer; Beckermann, Bernhard; Schlemmer, Karl-Heinz; Haebich, Dieter; Ruebsamen-Waigmann, Helga</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">5608</span>),
    <span class="NLM_cas:pages">893-896</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection is a major cause of liver disease.  Only interferon-Î± and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy.  However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors.  Potent new antiviral compds. suitable for monotherapy or combination therapy are highly desired.  We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity.  These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAlJUFASSEhLVg90H21EOLACvtfcHk0lhyxbkExbVCjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D&md5=a5e74b45d335f74ba17ec9fe4d31e24b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1077215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1077215%26sid%3Dliteratum%253Aachs%26aulast%3DDeres%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DC.%2BH.%26aulast%3DPaessens%26aufirst%3DA.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DHacker%26aufirst%3DH.%2BJ.%26aulast%3DWeber%26aufirst%3DO.%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DNiewohner%26aufirst%3DU.%26aulast%3DPleiss%26aufirst%3DU.%26aulast%3DStoltefuss%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DE.%26aulast%3DKoletzki%26aufirst%3DD.%26aulast%3DMasantschek%26aufirst%3DR.%2BN.%26aulast%3DReimann%26aufirst%3DA.%26aulast%3DJaeger%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DR.%26aulast%3DBeckermann%26aufirst%3DB.%26aulast%3DSchlemmer%26aufirst%3DK.%2BH.%26aulast%3DHaebich%26aufirst%3DD.%26aulast%3DRubsamen-Waigmann%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520Hepatitis%2520B%2520Virus%2520Replication%2520by%2520Drug-Induced%2520Depletion%2520of%2520Nucleocapsids%26jtitle%3DScience%26date%3D2003%26volume%3D299%26spage%3D893%26epage%3D896%26doi%3D10.1126%2Fscience.1077215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Last, S. J.</span>; <span class="NLM_string-name">Raboisson, P. J.-M. B.</span>; <span class="NLM_string-name">Rombouts, G.</span>; <span class="NLM_string-name">Vandyck, K.</span>; <span class="NLM_string-name">Verschueren, W. G.</span></span> <span> </span><span class="NLM_article-title">Sulfamoyl-Arylamides and the Use Thereof as Medicaments for the Treatment of Hepatitis B</span>. <span class="NLM_patent">WO2014033176</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+J.+Last&author=P.+J.-M.+B.+Raboisson&author=G.+Rombouts&author=K.+Vandyck&author=W.+G.+Verschueren&title=Sulfamoyl-Arylamides+and+the+Use+Thereof+as+Medicaments+for+the+Treatment+of+Hepatitis+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLast%26aufirst%3DS.%2BJ.%26atitle%3DSulfamoyl-Arylamides%2520and%2520the%2520Use%2520Thereof%2520as%2520Medicaments%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520B%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.-T.</span>; <span class="NLM_string-name">Xu, X.</span>; <span class="NLM_string-name">Block Timothy, M.</span></span> <span> </span><span class="NLM_article-title">Sulfamoylbenzamide Derivatives as Antiviral Agents Against HBV Infection</span>. <span class="NLM_patent">WO 2013/006394 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.-T.+Guo&author=X.+Xu&author=M.+Block+Timothy&title=Sulfamoylbenzamide+Derivatives+as+Antiviral+Agents+Against+HBV+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.-T.%26atitle%3DSulfamoylbenzamide%2520Derivatives%2520as%2520Antiviral%2520Agents%2520Against%2520HBV%2520Infection%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartman George, D.</span>; <span class="NLM_string-name">Flores Osvaldo, A.</span></span> <span> </span><span class="NLM_article-title">Hepatitis B Antiviral Agents</span>. <span class="NLM_patent">WO 2013/096744 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+Hartman+George&author=A.+Flores+Osvaldo&title=Hepatitis+B+Antiviral+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%2BGeorge%26aufirst%3DD.%26atitle%3DHepatitis%2520B%2520Antiviral%2520Agents%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campagna, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuconati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. T.</span></span> <span> </span><span class="NLM_article-title">Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">6931</span>â <span class="NLM_lpage">6942</span>, <span class="refDoi">Â DOI: 10.1128/JVI.00582-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1128%2FJVI.00582-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=23576513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=6931-6942&author=M.+R.+Campagnaauthor=F.+Liuauthor=R.+Maoauthor=C.+Millsauthor=D.+Caiauthor=F.+Guoauthor=X.+Zhaoauthor=H.+Yeauthor=A.+Cuconatiauthor=H.+Guoauthor=J.+Changauthor=X.+Xuauthor=T.+M.+Blockauthor=J.+T.+Guo&title=Sulfamoylbenzamide+Derivatives+Inhibit+the+Assembly+of+Hepatitis+B+Virus+Nucleocapsids&doi=10.1128%2FJVI.00582-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span></div><div class="casAuthors">Campagna, Matthew R.; Liu, Fei; Mao, Richeng; Mills, Courtney; Cai, Dawei; Guo, Fang; Zhao, Xuesen; Ye, Hong; Cuconati, Andrea; Guo, Haitao; Chang, Jinhong; Xu, Xiaodong; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6931-6942</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection, a serious public health problem leading to cirrhosis and hepatocellular carcinoma, is currently treated with either pegylated alpha interferon (pegIFN-Î±) or one of the five nucleos(t)ide analog viral DNA polymerase inhibitors.  However, neither pegIFN-Î± nor nucleos(t)ide analogs are capable of reliably curing the viral infection.  In order to develop novel antiviral drugs against HBV, we established a cell-based screening assay by using an immortalized mouse hepatocyte-derived stable cell line supporting a high level of HBV replication in a tetracycline-inducible manner.  Screening of a library consisting of 26,900 small mols. led to the discovery of a series of sulfamoylbenzamide (SBA) derivs. that significantly reduced the amt. of cytoplasmic HBV DNA.  Structure-activity relationship studies have thus far identified a group of fluorine-substituted SBAs with submicromolar antiviral activity against HBV in human hepatoma cells.  Mechanistic analyses reveal that the compds. dose dependently inhibit the formation of pregenomic RNA (pgRNA)-contg. nucleocapsids of HBV but not other animal hepadnaviruses, such as woodchuck hepatitis virus (WHV) and duck hepatitis B virus (DHBV).  Moreover, heterologous genetic complementation studies of capsid protein, DNA polymerase, and pgRNA between HBV and WHV suggest that HBV capsid protein confers sensitivity to the SBAs.  In summary, SBAs represent a novel chem. entity with superior activity and a unique antiviral mechanism and are thus warranted for further development as novel antiviral therapeutics for the treatment of chronic hepatitis B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNUsTkQKVBQbVg90H21EOLACvtfcHk0lhOSdyar8A7hw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D&md5=80cd9d05d889ecf1bd2f6c28f7946bcf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FJVI.00582-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00582-13%26sid%3Dliteratum%253Aachs%26aulast%3DCampagna%26aufirst%3DM.%2BR.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.%2BT.%26atitle%3DSulfamoylbenzamide%2520Derivatives%2520Inhibit%2520the%2520Assembly%2520of%2520Hepatitis%2520B%2520Virus%2520Nucleocapsids%26jtitle%3DJ.%2520Virol%26date%3D2013%26volume%3D87%26spage%3D6931%26epage%3D6942%26doi%3D10.1128%2FJVI.00582-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klumpp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allweiss, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ¼tgehetmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandri, M.</span></span> <span> </span><span class="NLM_article-title">Efficacy of NVR 3â778, Alone and in Combination with Pegylated Interferon, vs Entecavir In uPA/SCID Mice with Humanized Livers and HBV Infection</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">652</span>â <span class="NLM_lpage">662</span>, <span class="refDoi">Â DOI: 10.1053/j.gastro.2017.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1053%2Fj.gastro.2017.10.017" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=652-662&author=K.+Klumppauthor=T.+Shimadaauthor=L.+Allweissauthor=T.+Volzauthor=M.+L%C3%BCtgehetmannauthor=G.+Hartmanauthor=O.+A.+Floresauthor=A.+M.+Lamauthor=M.+Dandri&title=Efficacy+of+NVR+3%E2%80%93778%2C+Alone+and+in+Combination+with+Pegylated+Interferon%2C+vs+Entecavir+In+uPA%2FSCID+Mice+with+Humanized+Livers+and+HBV+Infection&doi=10.1053%2Fj.gastro.2017.10.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2017.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2017.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DT.%26aulast%3DAllweiss%26aufirst%3DL.%26aulast%3DVolz%26aufirst%3DT.%26aulast%3DL%25C3%25BCtgehetmann%26aufirst%3DM.%26aulast%3DHartman%26aufirst%3DG.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DDandri%26aufirst%3DM.%26atitle%3DEfficacy%2520of%2520NVR%25203%25E2%2580%2593778%252C%2520Alone%2520and%2520in%2520Combination%2520with%2520Pegylated%2520Interferon%252C%2520vs%2520Entecavir%2520In%2520uPA%252FSCID%2520Mice%2520with%2520Humanized%2520Livers%2520and%2520HBV%2520Infection%26jtitle%3DGastroenterology%26date%3D2018%26volume%3D154%26spage%3D652%26epage%3D662%26doi%3D10.1053%2Fj.gastro.2017.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozturk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassit, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amblard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinazi, R. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Sulfamoylbenzamide Derivatives as HBV Capsid Assembly Effector</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">407</span>â <span class="NLM_lpage">421</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2017.06.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.ejmech.2017.06.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=28688280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFChurvI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=407-421&author=O.+Sariauthor=S.+Boucleauthor=B.+D.+Coxauthor=T.+Ozturkauthor=O.+O.+Russellauthor=L.+Bassitauthor=F.+Amblardauthor=R.+F.+Schinazi&title=Synthesis+of+Sulfamoylbenzamide+Derivatives+as+HBV+Capsid+Assembly+Effector&doi=10.1016%2Fj.ejmech.2017.06.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effectors</span></div><div class="casAuthors">Sari, Ozkan; Boucle, Sebastien; Cox, Bryan D.; Ozturk, Tugba; Russell, Olivia Ollinger; Bassit, Leda; Amblard, Franck; Schinazi, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">407-421</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis of novel series of sulfamoylbenzamides, e.g. I [R1 = F, R2 = H; R1R2 = (CH2)2, (CH2)3; X = R3R4NSO2, R5SO2NH; R3 = cyclopentyl, cyclopentyloxy, MeSO2, PhCHMe, etc., R4 = H; R3R4 = CH2CF2CH2CH2, C(O)(CH2)3, etc.; R5 = cyclopropyl, cyclopentyl, cyclohexyl] as HBV capsid assembly effector is reported.  The structure was divided into five parts which were independently modified as part of the lead optimization.  All the synthesized compds. were evaluated for their anti-HBV activity and toxicity in human hepatocytes, lymphocytes and other cells.  Addnl., their effect on HBV cccDNA formation in an HBeAg reporter cell-based assay was assessed.  Among the 27 compds. reported, several analogs exhibited submicromolar activities and significant redn. of HBeAg secretion.  Selected compds. were studied under neg.-stain electron microscopy for their ability to disrupt the HBV capsid formation.  Structures were modeled into a binding site recently identified in the HBV capsid protein for similar mols. to rationalize the structure-activity relationships for this family of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUa_fzgDe9WrVg90H21EOLACvtfcHk0lhOSdyar8A7hw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFChurvI&md5=cc0de429427455fac4cebd76c51119ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.062%26sid%3Dliteratum%253Aachs%26aulast%3DSari%26aufirst%3DO.%26aulast%3DBoucle%26aufirst%3DS.%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DOzturk%26aufirst%3DT.%26aulast%3DRussell%26aufirst%3DO.%2BO.%26aulast%3DBassit%26aufirst%3DL.%26aulast%3DAmblard%26aufirst%3DF.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DSynthesis%2520of%2520Sulfamoylbenzamide%2520Derivatives%2520as%2520HBV%2520Capsid%2520Assembly%2520Effector%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D407%26epage%3D421%26doi%3D10.1016%2Fj.ejmech.2017.06.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataiah, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotnick, A.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Effectors of Hepatitis B Virus Capsid Assembly Give Insight into Virus Life Cycle</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">10262</span>â <span class="NLM_lpage">10270</span>, <span class="refDoi">Â DOI: 10.1128/JVI.01360-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1128%2FJVI.01360-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=18684823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=10262-10270&author=C.+Bourneauthor=S.+Leeauthor=B.+Venkataiahauthor=A.+Leeauthor=B.+Korbaauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Small-Molecule+Effectors+of+Hepatitis+B+Virus+Capsid+Assembly+Give+Insight+into+Virus+Life+Cycle&doi=10.1128%2FJVI.01360-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span></div><div class="casAuthors">Bourne, Christina; Lee, Sejin; Venkataiah, Bollu; Lee, Angela; Korba, Brent; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10262-10270</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The relationship between the phys. chem. and biol. of self-assembly is poorly understood, but it will be crit. to quant. understand infection and for the design of antivirals that target virus genesis.  Here the authors take advantage of heteroaryldihydropyrimidines (HAPs), which affect hepatitis B virus (HBV) assembly, to gain insight and correlate in vitro assembly with HBV replication in culture.  Based on a low-resoln. crystal structure of a capsid-HAP complex, a closely related series of HAPs were designed and synthesized.  These differentially strengthen the assocn. between neighboring capsid proteins, alter the kinetics of assembly, and give rise to aberrant structures incompatible with a functional capsid.  The chem. nature of the HAP variants correlated well with the structure of the HAP binding pocket.  The thermodn. and kinetics of in vitro assembly had strong and predictable effects on product morphol.  However, only the kinetics of in vitro assembly had a strong correlation with inhibition of HBV replication in HepG2.2.15 cells; there was at best a weak correlation between assembly thermodn. and replication.  The correlation between assembly kinetics and virus suppression implies a competition between successful assembly and misassembly, small mol. induced or otherwise.  This is a predictive and testable model for the mechanism of action of assembly effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodMfnjIqX51LVg90H21EOLACvtfcHk0ljtchKPey0VkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE&md5=78266773fa27c6f87b4c871c47cd2fe6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FJVI.01360-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01360-08%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DVenkataiah%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DKorba%26aufirst%3DB.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DSmall-Molecule%2520Effectors%2520of%2520Hepatitis%2520B%2520Virus%2520Capsid%2520Assembly%2520Give%2520Insight%2520into%2520Virus%2520Life%2520Cycle%26jtitle%3DJ.%2520Virol%26date%3D2008%26volume%3D82%26spage%3D10262%26epage%3D10270%26doi%3D10.1128%2FJVI.01360-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stray, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopek, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotnick, A.</span></span> <span> </span><span class="NLM_article-title">An <i>In Vitro</i> Fluorescence Screen to Identify Antivirals that Disrupt Hepatitis B Virus Capsid Assembly</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">358</span>â <span class="NLM_lpage">362</span>, <span class="refDoi">Â DOI: 10.1038/nbt1187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1038%2Fnbt1187" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=358-362&author=S.+J.+Strayauthor=J.+M.+Johnsonauthor=B.+G.+Kopekauthor=A.+Zlotnick&title=An+In+Vitro+Fluorescence+Screen+to+Identify+Antivirals+that+Disrupt+Hepatitis+B+Virus+Capsid+Assembly&doi=10.1038%2Fnbt1187"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnbt1187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1187%26sid%3Dliteratum%253Aachs%26aulast%3DStray%26aufirst%3DS.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BM.%26aulast%3DKopek%26aufirst%3DB.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DAn%2520In%2520Vitro%2520Fluorescence%2520Screen%2520to%2520Identify%2520Antivirals%2520that%2520Disrupt%2520Hepatitis%2520B%2520Virus%2520Capsid%2520Assembly%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D358%26epage%3D362%26doi%3D10.1038%2Fnbt1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towne, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrior, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, D. J.</span></span> <span> </span><span class="NLM_article-title">Application of a High-Content Multiparameter Cytotoxicity Assay to Prioritize Compounds Based on Toxicity Potential in Humans</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">527</span>â <span class="NLM_lpage">537</span>, <span class="refDoi">Â DOI: 10.1177/1087057108318428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1177%2F1087057108318428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=18566484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt1eiurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=527-537&author=V.+C.+Abrahamauthor=D.+L.+Towneauthor=J.+F.+Waringauthor=U.+Warriorauthor=D.+J.+Burns&title=Application+of+a+High-Content+Multiparameter+Cytotoxicity+Assay+to+Prioritize+Compounds+Based+on+Toxicity+Potential+in+Humans&doi=10.1177%2F1087057108318428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans</span></div><div class="casAuthors">Abraham, Vivek C.; Towne, Danli L.; Waring, Jeffrey F.; Warrior, Usha; Burns, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">527-537</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Prioritization of compds. based on human hepatotoxicity potential is currently a key unmet need in drug discovery, as it can become a major problem for several lead compds. in later stages of the drug discovery pipeline.  The authors report the validation and implementation of a high-content multiparametric cytotoxicity assay based on simultaneous measurement of 8 key cell health indicators assocd. with nuclear morphol., plasma membrane integrity, mitochondrial function, and cell proliferation.  Compds. are prioritized by (a) computing an in vitro safety margin using the min. cytotoxic concn. (IC20) across all 8 indicators and cell-based efficacy data and (b) using the minimal cytotoxic concn. alone to take into account concn. of drug in tissues.  Feasibility data using selected compds., including quinolone antibiotics, thiazolidinediones, and statins, suggest the viability of this approach.  To increase overall throughput of compd. prioritization, the authors have identified the higher throughput, plate reader-based CyQUANT assay that is similar to the high-content screening (HCS) assay in sensitivity of measuring inhibition of cell proliferation.  It is expected that the phenotypic output from the multiparametric HCS assay in combination with other highly sensitive approaches, such as microarray-based expression anal. of toxic signatures, will contribute to a better understanding and predictivity of human hepatotoxicity potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmmpX3J1LQGLVg90H21EOLACvtfcHk0ljtchKPey0VkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt1eiurg%253D&md5=3dd6e876f6e82650178a35932513a5fb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F1087057108318428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057108318428%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DV.%2BC.%26aulast%3DTowne%26aufirst%3DD.%2BL.%26aulast%3DWaring%26aufirst%3DJ.%2BF.%26aulast%3DWarrior%26aufirst%3DU.%26aulast%3DBurns%26aufirst%3DD.%2BJ.%26atitle%3DApplication%2520of%2520a%2520High-Content%2520Multiparameter%2520Cytotoxicity%2520Assay%2520to%2520Prioritize%2520Compounds%2520Based%2520on%2520Toxicity%2520Potential%2520in%2520Humans%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2008%26volume%3D13%26spage%3D527%26epage%3D537%26doi%3D10.1177%2F1087057108318428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">OâBrien, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard-Cofield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krejsa, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeline, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hougham, C.</span></span> <span> </span><span class="NLM_article-title">High Concordance of Drug-Induced Human Hepatotoxicity with In Vitro Cytotoxicity Measured in a Novel Cell-Based Model Using High Content Screening</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">580</span>â <span class="NLM_lpage">604</span>, <span class="refDoi">Â DOI: 10.1007/s00204-006-0091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1007%2Fs00204-006-0091-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=16598496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVynurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=580-604&author=P.+J.+O%E2%80%99Brienauthor=W.+Irwinauthor=D.+Diazauthor=E.+Howard-Cofieldauthor=C.+M.+Krejsaauthor=M.+R.+Slaughterauthor=B.+Gaoauthor=N.+Kaludercicauthor=A.+Angelineauthor=P.+Bernardiauthor=P.+Brainauthor=C.+Hougham&title=High+Concordance+of+Drug-Induced+Human+Hepatotoxicity+with+In+Vitro+Cytotoxicity+Measured+in+a+Novel+Cell-Based+Model+Using+High+Content+Screening&doi=10.1007%2Fs00204-006-0091-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening</span></div><div class="casAuthors">O'Brien, P. J.; Irwin, W.; Diaz, D.; Howard-Cofield, E.; Krejsa, C. M.; Slaughter, M. R.; Gao, B.; Kaludercic, N.; Angeline, A.; Bernardi, P.; Brain, P.; Hougham, C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">580-604</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To develop and validate a practical, in vitro, cell-based model to assess human hepatotoxicity potential of drugs, we used the new technol. of high content screening (HCS) and a novel combination of crit. model features, including (1) use of live, human hepatocytes with drug metab. capability, (2) preincubation of cells for 3 days with drugs at a range of concns. up to at least 30 times the efficacious concn. or 100 Î¼M, (3) measurement of multiple parameters that were (4) morphol. and biochem., (5) indicative of prelethal cytotoxic effects, (6) representative of different mechanisms of toxicity, (7) at the single cell level and (8) amenable to rapid throughput.  HCS is based on automated epifluorescence microscopy and image anal. of cells in a microtiter plate format.  The assay was applied to HepG2 human hepatocytes cultured in 96-well plates and loaded with four fluorescent dyes for: calcium (Fluo-4 AM), mitochondrial membrane potential (TMRM), DNA content (Hoechst 33342) to det. nuclear area and cell no. and plasma membrane permeability (TOTO-3).  Assay results were compared with those from 7 conventional, in vitro cytotoxicity assays that were applied to 611 compds. and shown to have low sensitivity (<25%), although high specificity (â¼90%) for detection of toxic drugs.  For 243 drugs with varying degrees of toxicity, the HCS, sublethal, cytotoxicity assay had a sensitivity of 93% and specificity of 98%.  Drugs testing pos. that did not cause hepatotoxicity produced other serious, human organ toxicities.  For 201 pos. assay results, 86% drugs affected cell no., 70% affected nuclear area and mitochondrial membrane potential and 45% affected membrane permeability and 41% intracellular calcium concn.  Cell no. was the first parameter affected for 56% of these drugs, nuclear area for 34% and mitochondrial membrane potential for 29% and membrane permeability for 7% and intracellular calcium for 10%.  Hormesis occurred for 48% of all drugs with pos. response, for 26% of mitochondrial and 34% nuclear area changes and 12% of cell no. changes.  Pattern of change was dependent on the class of drug and mechanism of toxicity.  The ratio of concns. for in vitro cytotoxicity to maximal efficaciousness in humans was not different across groups (12Â±22).  Human toxicity potential was detected with 80% sensitivity and 90% specificity at a concn. of 30Ã the maximal efficacious concn. or 100 Î¼M when efficaciousness was not considered.  We conclude that human hepatotoxicity is highly concordant with in vitro cytotoxicity in this novel model and as detected by HCS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroZK_xw9EaJrVg90H21EOLACvtfcHk0ligZm1Xy50ZFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVynurc%253D&md5=84df3243f11d3309cf86a2f3f6160533</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs00204-006-0091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-006-0091-3%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%2BJ.%26aulast%3DIrwin%26aufirst%3DW.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DHoward-Cofield%26aufirst%3DE.%26aulast%3DKrejsa%26aufirst%3DC.%2BM.%26aulast%3DSlaughter%26aufirst%3DM.%2BR.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DAngeline%26aufirst%3DA.%26aulast%3DBernardi%26aufirst%3DP.%26aulast%3DBrain%26aufirst%3DP.%26aulast%3DHougham%26aufirst%3DC.%26atitle%3DHigh%2520Concordance%2520of%2520Drug-Induced%2520Human%2520Hepatotoxicity%2520with%2520In%2520Vitro%2520Cytotoxicity%2520Measured%2520in%2520a%2520Novel%2520Cell-Based%2520Model%2520Using%2520High%2520Content%2520Screening%26jtitle%3DArch.%2520Toxicol.%26date%3D2006%26volume%3D80%26spage%3D580%26epage%3D604%26doi%3D10.1007%2Fs00204-006-0091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dandri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, J.</span></span> <span> </span><span class="NLM_article-title">Chimeric Mouse Model of Hepatitis B Virus Infection</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">493</span>â <span class="NLM_lpage">495</span>, <span class="refDoi">Â DOI: 10.1016/j.jhep.2011.05.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.jhep.2011.05.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=21801701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A280%3ADC%252BC387ltFSlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=493-495&author=M.+Dandriauthor=J.+Petersen&title=Chimeric+Mouse+Model+of+Hepatitis+B+Virus+Infection&doi=10.1016%2Fj.jhep.2011.05.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Chimeric mouse model of hepatitis B virus infection</span></div><div class="casAuthors">Dandri Maura; Petersen Jorg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">493-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSj20RUU6aR15PlX7E30qdzfW6udTcc2eb7SVa9K8kBorntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387ltFSlsQ%253D%253D&md5=db3ca4789af611c30bc7b7c88dcb1d21</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2011.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2011.05.037%26sid%3Dliteratum%253Aachs%26aulast%3DDandri%26aufirst%3DM.%26aulast%3DPetersen%26aufirst%3DJ.%26atitle%3DChimeric%2520Mouse%2520Model%2520of%2520Hepatitis%2520B%2520Virus%2520Infection%26jtitle%3DJ.%2520Hepatol.%26date%3D2012%26volume%3D56%26spage%3D493%26epage%3D495%26doi%3D10.1016%2Fj.jhep.2011.05.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rath, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinoda, W.</span></span> <span> </span><span class="NLM_article-title">Identification of Factors Promoting HBV Capsid Self-Assembly by Assembly-Promoting Antivirals</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">328</span>â <span class="NLM_lpage">337</span>, <span class="refDoi">Â DOI: 10.1021/acs.jcim.7b00471</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.7b00471" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslShug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2018&pages=328-337&author=S.+L.+Rathauthor=H.+Liuauthor=S.+Okazakiauthor=W.+Shinoda&title=Identification+of+Factors+Promoting+HBV+Capsid+Self-Assembly+by+Assembly-Promoting+Antivirals&doi=10.1021%2Facs.jcim.7b00471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Factors Promoting HBV Capsid Self-Assembly by Assembly-Promoting Antivirals</span></div><div class="casAuthors">Rath, Soumya Lipsa; Liu, Huihui; Okazaki, Susumu; Shinoda, Wataru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-337</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Around 270 million individuals currently live with hepatitis B virus (HBV) infection.  Heteroaryldihydropyrimidines (HAPs) are a family of antivirals that target the HBV capsid protein and induce aberrant self-assembly.  The capsids formed resemble the native capsid structure but are unable to propagate the virus progeny because of a lack of RNA/DNA.  Under normal conditions, self-assembly is initiated by the viral genome.  The mode of action of HAPs, however, remains largely unknown.  In this work, using mol. dynamics simulations, we attempted to understand the action of HAP by comparing the dynamics of capsid proteins with and without HAPs.  We found that the inhibitor is more stable in higher oligomers.  It retains its stability in the hexamer throughout 1 Î¼s of simulation.  Our results also show that the inhibitor might help in stabilizing the C-terminus, the HBc 149-183 arginine-rich domain of the capsid protein.  The C-termini of dimers interact with each other, assisted by the HAP inhibitor.  During capsid assembly, the termini are supposed to directly interact with the viral genome, thereby suggesting that the viral genome might work in a similar way to stabilize the capsid protein.  Our results may help in understanding the underlying mol. mechanism of HBV capsid self-assembly, which should be crucial for exploring new drug targets and structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojAFTMtxGuMbVg90H21EOLACvtfcHk0ligZm1Xy50ZFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslShug%253D%253D&md5=c3e2991026b1bbdecfa73c8ad0027f44</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.7b00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.7b00471%26sid%3Dliteratum%253Aachs%26aulast%3DRath%26aufirst%3DS.%2BL.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DOkazaki%26aufirst%3DS.%26aulast%3DShinoda%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520Factors%2520Promoting%2520HBV%2520Capsid%2520Self-Assembly%2520by%2520Assembly-Promoting%2520Antivirals%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2018%26volume%3D58%26spage%3D328%26epage%3D337%26doi%3D10.1021%2Facs.jcim.7b00471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salminen, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissberger, A.</span></span> <span> </span><span class="NLM_article-title">The Reaction of 3-Chlorosulfonylbenzoyl Chloride with Amines</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">4131</span>â <span class="NLM_lpage">4133</span>, <span class="refDoi">Â DOI: 10.1021/ja01153a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01153a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1951&pages=4131-4133&author=C.+R.+Barrauthor=I.+F.+Salminenauthor=A.+Weissberger&title=The+Reaction+of+3-Chlorosulfonylbenzoyl+Chloride+with+Amines&doi=10.1021%2Fja01153a023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja01153a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01153a023%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DC.%2BR.%26aulast%3DSalminen%26aufirst%3DI.%2BF.%26aulast%3DWeissberger%26aufirst%3DA.%26atitle%3DThe%2520Reaction%2520of%25203-Chlorosulfonylbenzoyl%2520Chloride%2520with%2520Amines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1951%26volume%3D73%26spage%3D4131%26epage%3D4133%26doi%3D10.1021%2Fja01153a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.-C.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Synthesis of Aryl Carboxamido Sulfonic Acid Derivatives</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2640</span>â <span class="NLM_lpage">2646</span>, <span class="refDoi">Â DOI: 10.1016/j.tet.2013.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.tet.2013.01.028" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=2640-2646&author=Y.-L.+Yangauthor=B.+Rajagopalauthor=C.-F.+Liangauthor=C.-C.+Chenauthor=H.-P.+Laiauthor=C.-H.+Chouauthor=Y.-P.+Leeauthor=Y.-L.+Yangauthor=J.-W.+Zengauthor=C.-L.+Ouauthor=P.-C.+Lin&title=Chemoselective+Synthesis+of+Aryl+Carboxamido+Sulfonic+Acid+Derivatives&doi=10.1016%2Fj.tet.2013.01.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2013.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2013.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.-L.%26aulast%3DRajagopal%26aufirst%3DB.%26aulast%3DLiang%26aufirst%3DC.-F.%26aulast%3DChen%26aufirst%3DC.-C.%26aulast%3DLai%26aufirst%3DH.-P.%26aulast%3DChou%26aufirst%3DC.-H.%26aulast%3DLee%26aufirst%3DY.-P.%26aulast%3DYang%26aufirst%3DY.-L.%26aulast%3DZeng%26aufirst%3DJ.-W.%26aulast%3DOu%26aufirst%3DC.-L.%26aulast%3DLin%26aufirst%3DP.-C.%26atitle%3DChemoselective%2520Synthesis%2520of%2520Aryl%2520Carboxamido%2520Sulfonic%2520Acid%2520Derivatives%26jtitle%3DTetrahedron%26date%3D2013%26volume%3D69%26spage%3D2640%26epage%3D2646%26doi%3D10.1016%2Fj.tet.2013.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">WooChan Kim, Jung-Ah Kang, Minji Park, Pyeong-Hwa Jeong, Yoon Jun Kim, Yuri Cho, Sung-Gyoo Park, <span class="NLM_string-name hlFld-ContribAuthor">Yong-Chul Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5500-5518. <a href="https://doi.org/10.1021/acs.jmedchem.0c01938" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01938%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPyrimidine-Based%252BCapsid%252BAssembly%252BModulators%252Bas%252BPotent%252BAnti-HBV%252BAgents%26aulast%3DKim%26aufirst%3DWooChan%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09112020%26date%3D23042021%26volume%3D64%26issue%3D9%26spage%3D5500%26epage%3D5518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christian M. Heckmann, Beatriz Dominguez, <span class="NLM_string-name hlFld-ContribAuthor">Francesca Paradisi</span>. </span><span class="cited-content_cbyCitation_article-title">Enantio-Complementary Continuous-Flow Synthesis of 2-Aminobutane Using Covalently Immobilized Transaminases. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2021,</strong> <em>9 </em>
                                    (11)
                                     , 4122-4129. <a href="https://doi.org/10.1021/acssuschemeng.0c09075" title="DOI URL">https://doi.org/10.1021/acssuschemeng.0c09075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.0c09075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.0c09075%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DEnantio-Complementary%252BContinuous-Flow%252BSynthesis%252Bof%252B2-Aminobutane%252BUsing%252BCovalently%252BImmobilized%252BTransaminases%26aulast%3DHeckmann%26aufirst%3DChristian%2BM.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D14122020%26date%3D08022021%26date%3D05032021%26volume%3D9%26issue%3D11%26spage%3D4122%26epage%3D4129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wuhong Chen, Feifei Liu, Qiliang Zhao, Xinna Ma, Dong Lu, Heng Li, Yanping Zeng, Xiankun Tong, Limin Zeng, Jia Liu, Li Yang, Jianping Zuo, <span class="NLM_string-name hlFld-ContribAuthor">Youhong Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8134-8145. <a href="https://doi.org/10.1021/acs.jmedchem.0c00346" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00346%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPhthalazinone%252BDerivatives%252Bas%252BNovel%252BHepatitis%252BB%252BVirus%252BCapsid%252BInhibitors%26aulast%3DChen%26aufirst%3DWuhong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26022020%26date%3D21072020%26volume%3D63%26issue%3D15%26spage%3D8134%26epage%3D8145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chunting Wang, Yameng Pei, Lin Wang, Shuo Li, Chao Jiang, Xu Tan, Yi Dong, Ye Xiang, Yao Ma, <span class="NLM_string-name hlFld-ContribAuthor">Gang Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (1H-Pyrazolo[3,4-c]pyridin-5-yl)sulfonamide Analogues as Hepatitis B Virus Capsid Assembly Modulators by Conformation Constraint. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6066-6089. <a href="https://doi.org/10.1021/acs.jmedchem.0c00292" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00292%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525281H-Pyrazolo%25255B3%25252C4-c%25255Dpyridin-5-yl%252529sulfonamide%252BAnalogues%252Bas%252BHepatitis%252BB%252BVirus%252BCapsid%252BAssembly%252BModulators%252Bby%252BConformation%252BConstraint%26aulast%3DWang%26aufirst%3DChunting%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19022020%26date%3D03062020%26date%3D18052020%26volume%3D63%26issue%3D11%26spage%3D6066%26epage%3D6089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Li Yang, Feifei Liu, Xiankun Tong, Daniel Hoffmann, Jianping Zuo, <span class="NLM_string-name hlFld-ContribAuthor">Mengji Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (5)
                                     , 713-724. <a href="https://doi.org/10.1021/acsinfecdis.8b00337" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00337%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DTreatment%252Bof%252BChronic%252BHepatitis%252BB%252BVirus%252BInfection%252BUsing%252BSmall%252BMolecule%252BModulators%252Bof%252BNucleocapsid%252BAssembly%25253A%252BRecent%252BAdvances%252Band%252BPerspectives%26aulast%3DYang%26aufirst%3DLi%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D29112018%26date%3D29032019%26date%3D21032019%26volume%3D5%26issue%3D5%26spage%3D713%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah  Sauviller</span>, <span class="hlFld-ContribAuthor ">Karen  Vergauwen</span>, <span class="hlFld-ContribAuthor ">Steffen  Jaensch</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Gustin</span>, <span class="hlFld-ContribAuthor ">Danielle  Peeters</span>, <span class="hlFld-ContribAuthor ">Peter  Vermeulen</span>, <span class="hlFld-ContribAuthor ">Dirk  Wuyts</span>, <span class="hlFld-ContribAuthor ">Koen  Vandyck</span>, <span class="hlFld-ContribAuthor ">Frederik  Pauwels</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virological Methods</span><span> <strong>2021,</strong> <em>293 </em>, 114150. <a href="https://doi.org/10.1016/j.jviromet.2021.114150" title="DOI URL">https://doi.org/10.1016/j.jviromet.2021.114150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jviromet.2021.114150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jviromet.2021.114150%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virological%2520Methods%26atitle%3DDevelopment%252Bof%252Ba%252Bcellular%252Bhigh-content%25252C%252Bimmunofluorescent%252BHBV%252Bcore%252Bassay%252Bto%252Bidentify%252Bnovel%252Bcapsid%252Bassembly%252Bmodulators%252Bthat%252Binduce%252Bthe%252Bformation%252Bof%252Baberrant%252BHBV%252Bcore%252Bstructures%26aulast%3DSauviller%26aufirst%3DSarah%26date%3D2021%26volume%3D293%26spage%3D114150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karol R.  Francisco</span>, <span class="hlFld-ContribAuthor ">Carmine  Varricchio</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Paniak</span>, <span class="hlFld-ContribAuthor ">Marisa C.  Kozlowski</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Carlo  Ballatore</span>. </span><span class="cited-content_cbyCitation_article-title">Structure property relationships of N-acylsulfonamides and related bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113399. <a href="https://doi.org/10.1016/j.ejmech.2021.113399" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113399%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Bproperty%252Brelationships%252Bof%252BN-acylsulfonamides%252Band%252Brelated%252Bbioisosteres%26aulast%3DFrancisco%26aufirst%3DKarol%2BR.%26date%3D2021%26volume%3D218%26spage%3D113399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>, <span class="hlFld-ContribAuthor ">Weijie  Gu</span>, <span class="hlFld-ContribAuthor ">Erik  Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">AntiâDNA Virus Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-41. <a href="https://doi.org/10.1002/0471266949.bmc237.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc237.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc237.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc237.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAnti%2525E2%252580%252590DNA%252BVirus%252BAgents%26aulast%3DHerdewijn%26aufirst%3DPiet%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D41%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicky  Hwang</span>, <span class="hlFld-ContribAuthor ">Haiqun  Ban</span>, <span class="hlFld-ContribAuthor ">Junjun  Chen</span>, <span class="hlFld-ContribAuthor ">Julia  Ma</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Patrick  Lam</span>, <span class="hlFld-ContribAuthor ">John  Kulp</span>, <span class="hlFld-ContribAuthor ">Stephan  Menne</span>, <span class="hlFld-ContribAuthor ">Jinhong  Chang</span>, <span class="hlFld-ContribAuthor ">Ju-Tao  Guo</span>, <span class="hlFld-ContribAuthor ">Yanming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virus. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 459-472. <a href="https://doi.org/10.1007/s00044-020-02677-3" title="DOI URL">https://doi.org/10.1007/s00044-020-02677-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02677-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02677-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Bof%252B4-oxotetrahydropyrimidine-1%2525282H%252529-carboxamides%252Bderivatives%252Bas%252Bcapsid%252Bassembly%252Bmodulators%252Bof%252Bhepatitis%252BB%252Bvirus%26aulast%3DHwang%26aufirst%3DNicky%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D459%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Ma</span>, <span class="hlFld-ContribAuthor ">Wen-guang  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-ding  Liu</span>, <span class="hlFld-ContribAuthor ">Chang-cheng  Xi</span>, <span class="hlFld-ContribAuthor ">Fei  Xiong</span>, <span class="hlFld-ContribAuthor ">Shu-ping  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Docking and 3D-QSAR Studies on a Series of Benzenesulfonamide Derivatives as a Hepatitis B Virus Capsid Assembly Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2021,</strong> <em>39 </em>, 1-16. <a href="https://doi.org/10.1080/10406638.2020.1871038" title="DOI URL">https://doi.org/10.1080/10406638.2020.1871038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2020.1871038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2020.1871038%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DMolecular%252BDocking%252Band%252B3D-QSAR%252BStudies%252Bon%252Ba%252BSeries%252Bof%252BBenzenesulfonamide%252BDerivatives%252Bas%252Ba%252BHepatitis%252BB%252BVirus%252BCapsid%252BAssembly%252BInhibitor%26aulast%3DMa%26aufirst%3DChao%26date%3D2021%26date%3D2021%26volume%3D39%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujie  Ren</span>, <span class="hlFld-ContribAuthor ">Yue  Ma</span>, <span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">John E.  Tavis</span>, <span class="hlFld-ContribAuthor ">Luis  MenÃ©ndez-Arias</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112714. <a href="https://doi.org/10.1016/j.ejmech.2020.112714" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112714%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bbenzenesulfonamides-based%252Bhepatitis%252BB%252Bvirus%252Bcapsid%252Bmodulators%252Bvia%252Bcontemporary%252Bmedicinal%252Bchemistry%252Bstrategies%26aulast%3DRen%26aufirst%3DYujie%26date%3D2020%26volume%3D206%26spage%3D112714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haiyong  Jia</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Xianhong  Du</span>, <span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112495. <a href="https://doi.org/10.1016/j.ejmech.2020.112495" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112495%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bdiversity-oriented%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bheterocycle%252Bderivatives%252Bas%252Bnon-nucleoside%252BHBV%252Bcapsid%252Bprotein%252Binhibitors%26aulast%3DJia%26aufirst%3DHaiyong%26date%3D2020%26volume%3D202%26spage%3D112495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuocai  Wei</span>, <span class="hlFld-ContribAuthor ">Jie  Tan</span>, <span class="hlFld-ContribAuthor ">Xinhua  Cui</span>, <span class="hlFld-ContribAuthor ">Min  Zhou</span>, <span class="hlFld-ContribAuthor ">Yunhou  Huang</span>, <span class="hlFld-ContribAuthor ">Ning  Zang</span>, <span class="hlFld-ContribAuthor ">Zhaoni  Chen</span>, <span class="hlFld-ContribAuthor ">Wanxing  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3359. <a href="https://doi.org/10.3390/molecules25153359" title="DOI URL">https://doi.org/10.3390/molecules25153359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153359%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBioactive%252BEvaluation%252Bof%252BOxime%252BDerivatives%252Bof%252BDehydrocholic%252BAcid%252Bas%252BAnti-Hepatitis%252BB%252BVirus%252BAgents%26aulast%3DWei%26aufirst%3DZhuocai%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Lv</span>, <span class="hlFld-ContribAuthor ">Wenyan  Li</span>, <span class="hlFld-ContribAuthor ">Shuo  Wu</span>, <span class="hlFld-ContribAuthor ">Yunhe  Geng</span>, <span class="hlFld-ContribAuthor ">Apeng  Wang</span>, <span class="hlFld-ContribAuthor ">Lu  Yang</span>, <span class="hlFld-ContribAuthor ">Menghao  Huang</span>, <span class="hlFld-ContribAuthor ">Kushan  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Yuhuan  Li</span>, <span class="hlFld-ContribAuthor ">Mingliang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Amino acid prodrugs of NVR3-778: Design, synthesis and anti-HBV activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (9)
                                     , 127103. <a href="https://doi.org/10.1016/j.bmcl.2020.127103" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127103%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAmino%252Bacid%252Bprodrugs%252Bof%252BNVR3-778%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Banti-HBV%252Bactivity%26aulast%3DLv%26aufirst%3DKai%26date%3D2020%26volume%3D30%26issue%3D9%26spage%3D127103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lena  Allweiss</span>, <span class="hlFld-ContribAuthor ">Helene  Strick-Marchand</span>. </span><span class="cited-content_cbyCitation_article-title">In-vitro and in-vivo models for hepatitis B cure research. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in HIV and AIDS</span><span> <strong>2020,</strong> <em>15 </em>
                                    (3)
                                     , 173-179. <a href="https://doi.org/10.1097/COH.0000000000000616" title="DOI URL">https://doi.org/10.1097/COH.0000000000000616</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/COH.0000000000000616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCOH.0000000000000616%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520HIV%2520and%2520AIDS%26atitle%3DIn-vitro%252Band%252Bin-vivo%252Bmodels%252Bfor%252Bhepatitis%252BB%252Bcure%252Bresearch%26aulast%3DAllweiss%26aufirst%3DLena%26date%3D2020%26volume%3D15%26issue%3D3%26spage%3D173%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Karen  Vergauwen</span>, <span class="hlFld-ContribAuthor ">Wendy  Mostmans</span>, <span class="hlFld-ContribAuthor ">Koen  Vandyck</span>, <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>, <span class="hlFld-ContribAuthor ">Frederik  Pauwels</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (5)
                                     <a href="https://doi.org/10.1128/AAC.02439-19" title="DOI URL">https://doi.org/10.1128/AAC.02439-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02439-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02439-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DAntiviral%252BProperties%252Band%252BMechanism%252Bof%252BAction%252BStudies%252Bof%252Bthe%252BHepatitis%252BB%252BVirus%252BCapsid%252BAssembly%252BModulator%252BJNJ-56136379%26aulast%3DBerke%26aufirst%3DJan%2BMartin%26date%3D2020%26volume%3D64%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Sebastien  Boucle</span>, <span class="hlFld-ContribAuthor ">Leda  Bassit</span>, <span class="hlFld-ContribAuthor ">Bryan  Cox</span>, <span class="hlFld-ContribAuthor ">Ozkan  Sari</span>, <span class="hlFld-ContribAuthor ">Sijia  Tao</span>, <span class="hlFld-ContribAuthor ">Zhe  Chen</span>, <span class="hlFld-ContribAuthor ">Tugba  Ozturk</span>, <span class="hlFld-ContribAuthor ">Kiran  Verma</span>, <span class="hlFld-ContribAuthor ">Olivia  Russell</span>, <span class="hlFld-ContribAuthor ">Virgile  Rat</span>, <span class="hlFld-ContribAuthor ">Hugues  de Rocquigny</span>, <span class="hlFld-ContribAuthor ">Oriane  Fiquet</span>, <span class="hlFld-ContribAuthor ">Maud  Boussand</span>, <span class="hlFld-ContribAuthor ">James  Di Santo</span>, <span class="hlFld-ContribAuthor ">Helene  Strick-Marchand</span>, <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses
              In Vitro
              and in Humanized Mice. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (2)
                                     <a href="https://doi.org/10.1128/AAC.01701-19" title="DOI URL">https://doi.org/10.1128/AAC.01701-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01701-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01701-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DNovel%252BHepatitis%252BB%252BVirus%252BCapsid%252BAssembly%252BModulator%252BInduces%252BPotent%252BAntiviral%252BResponses%252BIn%252BVitro%252Band%252Bin%252BHumanized%252BMice%26aulast%3DAmblard%26aufirst%3DFranck%26date%3D2020%26volume%3D64%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Lv</span>, <span class="hlFld-ContribAuthor ">Shuo  Wu</span>, <span class="hlFld-ContribAuthor ">Wenyan  Li</span>, <span class="hlFld-ContribAuthor ">Yunhe  Geng</span>, <span class="hlFld-ContribAuthor ">Meng  Wu</span>, <span class="hlFld-ContribAuthor ">Jinming  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuhuan  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Gao</span>, <span class="hlFld-ContribAuthor ">Mingliang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anti-HBV activity of NVR3-778 derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103363. <a href="https://doi.org/10.1016/j.bioorg.2019.103363" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103363%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banti-HBV%252Bactivity%252Bof%252BNVR3-778%252Bderivatives%26aulast%3DLv%26aufirst%3DKai%26date%3D2020%26volume%3D94%26spage%3D103363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingying  Qiu</span>, <span class="hlFld-ContribAuthor ">Wang  Chen</span>, <span class="hlFld-ContribAuthor ">Yinpeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qingqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Lihua  Yang</span>, <span class="hlFld-ContribAuthor ">Jian  Gao</span>, <span class="hlFld-ContribAuthor ">Xiaoke  Gu</span>, <span class="hlFld-ContribAuthor ">Daoquan  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 41-49. <a href="https://doi.org/10.1016/j.ejmech.2019.05.014" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAssessment%252Bof%252Bquinazolinone%252Bderivatives%252Bas%252Bnovel%252Bnon-nucleoside%252Bhepatitis%252BB%252Bvirus%252Binhibitors%26aulast%3DQiu%26aufirst%3DJingying%26date%3D2019%26volume%3D176%26spage%3D41%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhavitavya  Nijampatnam</span>, <span class="hlFld-ContribAuthor ">Dennis C  Liotta</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the development of HBV capsid assembly modulators. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2019,</strong> <em>50 </em>, 73-79. <a href="https://doi.org/10.1016/j.cbpa.2019.02.009" title="DOI URL">https://doi.org/10.1016/j.cbpa.2019.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2019.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2019.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252BHBV%252Bcapsid%252Bassembly%252Bmodulators%26aulast%3DNijampatnam%26aufirst%3DBhavitavya%26date%3D2019%26volume%3D50%26spage%3D73%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ãmer Tahir  GÃ¼nkara</span>. </span><span class="cited-content_cbyCitation_article-title">Antikanser Aktivite GÃ¶sterebilecek Yeni HeterohalkalÄ± BileÅiklerin Sentezlenmesi Ve Karakterizasyonu. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Advances in Engineering and Pure Sciences</span><span> <strong>2019,</strong> <em> </em><a href="https://doi.org/10.7240/jeps.494603" title="DOI URL">https://doi.org/10.7240/jeps.494603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7240/jeps.494603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7240%2Fjeps.494603%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Advances%2520in%2520Engineering%2520and%2520Pure%2520Sciences%26atitle%3DAntikanser%252BAktivite%252BG%2525C3%2525B6sterebilecek%252BYeni%252BHeterohalkal%2525C4%2525B1%252BBile%2525C5%25259Fiklerin%252BSentezlenmesi%252BVe%252BKarakterizasyonu%26aulast%3DG%25C3%25BCnkara%26aufirst%3D%25C3%2596mer%2BTahir%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Two prototypical capsid assembly modulators Bay 41-4109 (CAM-II) and AT-130 (CAM-I).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked binding mode of JNJ-632.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antiviral activity in HBV genotype D infected chimeric mice. Mean HBV DNA change in serum after daily treatment with saline, ETV, and JNJ-632 for 28 days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/medium/jm-2018-006545_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis New <i>N</i>-Phenyl-3-sulfamoyl-benzamide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.8b00654/20180719/images/large/jm-2018-006545_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00654&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>69a</b>, <b>70</b>, CH<sub>2</sub>Cl<sub>2</sub>, NEt<sub>3</sub>, room temperature, overnight or <b>69a</b>, <b>70</b>, NaOH, THF, 20â25 Â°C, 2â3 h; <b>71a</b>â<b>d</b>, 33â93% yield; <b>71b</b>, EtOAc, iPrNH<sub>2</sub>, 25 Â°C, 3 h, 79% yield; <b>71e</b>, <b>69b</b>, cyclohexamine, room temperature, EtOAc, 10 min, 86% yield. (ii) HATU, CH<sub>2</sub>Cl<sub>2,</sub> DIPEA, 0 Â°C to room temperature, 2 h to overnight, 9â66% yield or 13â39% yield over two steps from <b>69a</b> (<b>7</b>, <b>10</b>, <b>42</b>, <b>44</b>), <b>14</b>, and <b>15</b>: <b>71e</b>, <b>72</b>, HATU, CH<sub>2</sub>Cl<sub>2</sub>, DIPEA or NEt<sub>3</sub>, 2â3 h, 28â52% yield; <b>55</b>, <b>56</b>, <b>59</b> and <b>60</b>: <b>71a</b>, <b>72</b>, DMF/CH<sub>2</sub>Cl<sub>2</sub>, (COCl)<sub>2</sub>, 2 h, 0 to 20 Â°C, 2 h then NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 to 20 Â°C, 2 h, 14â61% yield; <b>57</b>: <b>71a</b>, 3,4-difluoro-2-methyl aniline, DIPEA, Pybrop, DMF, 18 Â°C, 23% yield. (iiia) <b>72</b>, CH<sub>2</sub>Cl<sub>2,</sub> NEt<sub>3</sub>, 0 Â°C then 20 Â°C, 1 h or toluene, reflux, 30 min. (iiib) <b>70</b>, NEt<sub>3</sub> 0 Â°C then 20 Â°C, 1 h; 10â50% yield over two steps, or (<b>54</b>) <b>70</b>, toluene/CH<sub>2</sub>Cl<sub>2</sub>, DIPEA, 4 h room temperature, 39% two steps.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 21 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ott, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groeger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiersma, S. T.</span></span> <span> </span><span class="NLM_article-title">Global Epidemiology of Hepatitis B Virus Infection: New Estimates of Age-Specific HBsAg Seroprevalence and Endemicity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2212</span>â <span class="NLM_lpage">2219</span>, <span class="refDoi">Â DOI: 10.1016/j.vaccine.2011.12.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.vaccine.2011.12.116" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=2212-2219&author=J.+J.+Ottauthor=G.+A.+Stevensauthor=J.+Groegerauthor=S.+T.+Wiersma&title=Global+Epidemiology+of+Hepatitis+B+Virus+Infection%3A+New+Estimates+of+Age-Specific+HBsAg+Seroprevalence+and+Endemicity&doi=10.1016%2Fj.vaccine.2011.12.116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2011.12.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2011.12.116%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DJ.%2BJ.%26aulast%3DStevens%26aufirst%3DG.%2BA.%26aulast%3DGroeger%26aufirst%3DJ.%26aulast%3DWiersma%26aufirst%3DS.%2BT.%26atitle%3DGlobal%2520Epidemiology%2520of%2520Hepatitis%2520B%2520Virus%2520Infection%253A%2520New%2520Estimates%2520of%2520Age-Specific%2520HBsAg%2520Seroprevalence%2520and%2520Endemicity%26jtitle%3DVaccine%26date%3D2012%26volume%3D30%26spage%3D2212%26epage%3D2219%26doi%3D10.1016%2Fj.vaccine.2011.12.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berke, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehertogh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergauwen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mostmans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandyck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauwels, F.</span></span> <span> </span><span class="NLM_article-title">Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e00560-17</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00560-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1128%2FAAC.00560-17" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e00560-17&author=J.+M.+Berkeauthor=P.+Dehertoghauthor=K.+Vergauwenauthor=E.+Van+Dammeauthor=W.+Mostmansauthor=K.+Vandyckauthor=F.+Pauwels&title=Capsid+Assembly+Modulators+Have+a+Dual+Mechanism+of+Action+in+Primary+Human+Hepatocytes+Infected+with+Hepatitis+B+Virus&doi=10.1128%2FAAC.00560-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2FAAC.00560-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00560-17%26sid%3Dliteratum%253Aachs%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26aulast%3DDehertogh%26aufirst%3DP.%26aulast%3DVergauwen%26aufirst%3DK.%26aulast%3DVan%2BDamme%26aufirst%3DE.%26aulast%3DMostmans%26aufirst%3DW.%26aulast%3DVandyck%26aufirst%3DK.%26aulast%3DPauwels%26aufirst%3DF.%26atitle%3DCapsid%2520Assembly%2520Modulators%2520Have%2520a%2520Dual%2520Mechanism%2520of%2520Action%2520in%2520Primary%2520Human%2520Hepatocytes%2520Infected%2520with%2520Hepatitis%2520B%2520Virus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De00560-17%26doi%3D10.1128%2FAAC.00560-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span> </span><span class="NLM_article-title">An Efficacy, Safety, and Pharmacokinetics
Study of JNJ-56136379 in
Participants With Chronic Hepatitis B Virus Infection</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National
Intitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda</span>, December 5, 2017; <a href="https://ClinicalTrials.gov/show/NCT03361956" class="extLink">https://ClinicalTrials.gov/show/NCT03361956</a> (accessed June 4, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Efficacy%2C+Safety%2C+and+Pharmacokinetics%0AStudy+of+JNJ-56136379+in%0AParticipants+With+Chronic+Hepatitis+B+Virus+Infection.+ClinicalTrials.gov%3B+U.S.+National%0AIntitutes+of+Health%3A+Bethesda%2C+December+5%2C+2017%3B+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT03361956+%28accessed+June+4%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAn%2520Efficacy%252C%2520Safety%252C%2520and%2520Pharmacokinetics%250AStudy%2520of%2520JNJ-56136379%2520in%250AParticipants%2520With%2520Chronic%2520Hepatitis%2520B%2520Virus%2520Infection%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AIntitutes%2520of%2520Health" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berke, J. M.</span>; <span class="NLM_string-name">Dehertogh, P.</span>; <span class="NLM_string-name">Vergauwen, K.</span>; <span class="NLM_string-name">Van Damme, E.</span>; <span class="NLM_string-name">Raboisson, P.</span>; <span class="NLM_string-name">Pauwels, F.</span>; <span class="NLM_string-name">Vandyck, K.</span></span> <span> </span><span class="NLM_article-title">In Capsid Assembly Modulator JNJ-56136379 Prevents de Novo Infection of Primary Human Hepatocytes with Hepatitis B Virus</span>,  <i>AASLD The Liver Meeting, Boston, 2016</i>: <span class="NLM_publisher-loc">Boston</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+M.+Berke&author=P.+Dehertogh&author=K.+Vergauwen&author=E.+Van+Damme&author=P.+Raboisson&author=F.+Pauwels&author=K.+Vandyck&title=In+Capsid+Assembly+Modulator+JNJ-56136379+Prevents+de+Novo+Infection+of+Primary+Human+Hepatocytes+with+Hepatitis+B+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26atitle%3DIn%2520Capsid%2520Assembly%2520Modulator%2520JNJ-56136379%2520Prevents%2520de%2520Novo%2520Infection%2520of%2520Primary%2520Human%2520Hepatocytes%2520with%2520Hepatitis%2520B%2520Virus%26jtitle%3DAASLD%2520The%2520Liver%2520Meeting%252C%2520Boston%252C%25202016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perni, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladner, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaifert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, R. W.</span></span> <span> </span><span class="NLM_article-title">Phenylpropenamide Derivatives as Inhibitors of Hepatitis B Virus Replication</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2687</span>â <span class="NLM_lpage">2690</span>, <span class="refDoi">Â DOI: 10.1016/S0960-894X(00)00544-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2FS0960-894X%2800%2900544-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=11128652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlantbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2687-2690&author=R.+B.+Perniauthor=S.+C.+Conwayauthor=S.+K.+Ladnerauthor=K.+Zaifertauthor=M.+J.+Ottoauthor=R.+W.+King&title=Phenylpropenamide+Derivatives+as+Inhibitors+of+Hepatitis+B+Virus+Replication&doi=10.1016%2FS0960-894X%2800%2900544-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication</span></div><div class="casAuthors">Perni, R. B.; Conway, S. C.; Ladner, S. K.; Zaifert, K.; Otto, M. J.; King, R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2687-2690</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A non-nucleoside class of compds. that inhibits the replication of hepatitis B virus (HBV) in cell culture has been discovered.  A series of substituted analogs of phenylpropenamide has been prepd. and evaluated in the HepAD38 cellular assay.  Structure-activity relationships of this series are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcZcKEPcrqkbVg90H21EOLACvtfcHk0lhSxuRbA8IYtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlantbw%253D&md5=4c3ee48f05dc8bee0724ba928d89f8a1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900544-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900544-8%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DConway%26aufirst%3DS.%2BC.%26aulast%3DLadner%26aufirst%3DS.%2BK.%26aulast%3DZaifert%26aufirst%3DK.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DKing%26aufirst%3DR.%2BW.%26atitle%3DPhenylpropenamide%2520Derivatives%2520as%2520Inhibitors%2520of%2520Hepatitis%2520B%2520Virus%2520Replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2687%26epage%3D2690%26doi%3D10.1016%2FS0960-894X%2800%2900544-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feld, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colledge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sozzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlejohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locarnini, S. A.</span></span> <span> </span><span class="NLM_article-title">The Phenylpropenamide Derivative AT-130 Blocks HBV Replication at the Level of Viral RNA Packaging</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">168</span>â <span class="NLM_lpage">177</span>, <span class="refDoi">Â DOI: 10.1016/j.antiviral.2007.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.antiviral.2007.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=17709147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOgtb3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=168-177&author=J.+J.+Feldauthor=D.+Colledgeauthor=V.+Sozziauthor=R.+Edwardsauthor=M.+Littlejohnauthor=S.+A.+Locarnini&title=The+Phenylpropenamide+Derivative+AT-130+Blocks+HBV+Replication+at+the+Level+of+Viral+RNA+Packaging&doi=10.1016%2Fj.antiviral.2007.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging</span></div><div class="casAuthors">Feld, J. J.; Colledge, D.; Sozzi, V.; Edwards, R.; Littlejohn, M.; Locarnini, S. A.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-177</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nucleos(t)ide analog antiviral therapy for chronic hepatitis B has proven to be effective in the short term but the frequent development of resistance limits its clin. utility.  Agents targeting other stages of viral replication are needed in order to develop improved combination therapies.  The phenylpropenamide derivs. AT-61 and AT-130 have been shown to inhibit HBV replication in vitro, but the mechanism of action of these compds. remains undefined.  The aim of this study was to det. the mechanism of action of AT-130, a nonnucleoside inhibitor of HBV in several in vitro models of replication.  These studies found that AT-130 inhibited HBV DNA replication in hepatoma cells but had no effect on viral DNA polymerase activity or core protein translation.  Total HBV RNA prodn. was also unaffected in the presence of the drug while the amt. of encapsidated RNA was significantly reduced, thereby inhibiting subsequent viral reverse transcription.  These studies have established that the inhibition of HBV genome replication by a nonnucleoside analog acting at the level of viral encapsidation and packaging is a potentially useful strategy for future therapeutic drug development in the management of chronic hepatitis B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGXzYFUdjuOrVg90H21EOLACvtfcHk0lhSxuRbA8IYtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOgtb3K&md5=d8989ca5da33e96859f3de9f87f38872</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2007.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2007.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DFeld%26aufirst%3DJ.%2BJ.%26aulast%3DColledge%26aufirst%3DD.%26aulast%3DSozzi%26aufirst%3DV.%26aulast%3DEdwards%26aufirst%3DR.%26aulast%3DLittlejohn%26aufirst%3DM.%26aulast%3DLocarnini%26aufirst%3DS.%2BA.%26atitle%3DThe%2520Phenylpropenamide%2520Derivative%2520AT-130%2520Blocks%2520HBV%2520Replication%2520at%2520the%2520Level%2520of%2520Viral%2520RNA%2520Packaging%26jtitle%3DAntiviral%2520Res.%26date%3D2007%26volume%3D76%26spage%3D168%26epage%3D177%26doi%3D10.1016%2Fj.antiviral.2007.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deres, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paessens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niewohner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleiss, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltefuss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koletzki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masantschek, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckermann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlemmer, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haebich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubsamen-Waigmann, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>299</i></span>,  <span class="NLM_fpage">893</span>â <span class="NLM_lpage">896</span>, <span class="refDoi">Â DOI: 10.1126/science.1077215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1126%2Fscience.1077215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=12574631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2003&pages=893-896&author=K.+Deresauthor=C.+H.+Schroderauthor=A.+Paessensauthor=S.+Goldmannauthor=H.+J.+Hackerauthor=O.+Weberauthor=T.+Kramerauthor=U.+Niewohnerauthor=U.+Pleissauthor=J.+Stoltefussauthor=E.+Graefauthor=D.+Koletzkiauthor=R.+N.+Masantschekauthor=A.+Reimannauthor=R.+Jaegerauthor=R.+Grossauthor=B.+Beckermannauthor=K.+H.+Schlemmerauthor=D.+Haebichauthor=H.+Rubsamen-Waigmann&title=Inhibition+of+Hepatitis+B+Virus+Replication+by+Drug-Induced+Depletion+of+Nucleocapsids&doi=10.1126%2Fscience.1077215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids</span></div><div class="casAuthors">Deres, Karl; Schroeder, Claus H.; Paessens, Arnold; Goldmann, Siegfried; Hacker, Hans Joerg; Weber, Olaf; Kraemer, Thomas; Niewoehner, Ulrich; Pleiss, Ulrich; Stoltefuss, Juergen; Graef, Erwin; Koletzki, Diana; Masantschek, Ralf N. A.; Reimann, Anja; Jaeger, Rainer; Gro, Rainer; Beckermann, Bernhard; Schlemmer, Karl-Heinz; Haebich, Dieter; Ruebsamen-Waigmann, Helga</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">5608</span>),
    <span class="NLM_cas:pages">893-896</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection is a major cause of liver disease.  Only interferon-Î± and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy.  However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors.  Potent new antiviral compds. suitable for monotherapy or combination therapy are highly desired.  We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity.  These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAlJUFASSEhLVg90H21EOLACvtfcHk0lhSxuRbA8IYtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D&md5=a5e74b45d335f74ba17ec9fe4d31e24b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1077215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1077215%26sid%3Dliteratum%253Aachs%26aulast%3DDeres%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DC.%2BH.%26aulast%3DPaessens%26aufirst%3DA.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DHacker%26aufirst%3DH.%2BJ.%26aulast%3DWeber%26aufirst%3DO.%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DNiewohner%26aufirst%3DU.%26aulast%3DPleiss%26aufirst%3DU.%26aulast%3DStoltefuss%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DE.%26aulast%3DKoletzki%26aufirst%3DD.%26aulast%3DMasantschek%26aufirst%3DR.%2BN.%26aulast%3DReimann%26aufirst%3DA.%26aulast%3DJaeger%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DR.%26aulast%3DBeckermann%26aufirst%3DB.%26aulast%3DSchlemmer%26aufirst%3DK.%2BH.%26aulast%3DHaebich%26aufirst%3DD.%26aulast%3DRubsamen-Waigmann%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520Hepatitis%2520B%2520Virus%2520Replication%2520by%2520Drug-Induced%2520Depletion%2520of%2520Nucleocapsids%26jtitle%3DScience%26date%3D2003%26volume%3D299%26spage%3D893%26epage%3D896%26doi%3D10.1126%2Fscience.1077215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Last, S. J.</span>; <span class="NLM_string-name">Raboisson, P. J.-M. B.</span>; <span class="NLM_string-name">Rombouts, G.</span>; <span class="NLM_string-name">Vandyck, K.</span>; <span class="NLM_string-name">Verschueren, W. G.</span></span> <span> </span><span class="NLM_article-title">Sulfamoyl-Arylamides and the Use Thereof as Medicaments for the Treatment of Hepatitis B</span>. <span class="NLM_patent">WO2014033176</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+J.+Last&author=P.+J.-M.+B.+Raboisson&author=G.+Rombouts&author=K.+Vandyck&author=W.+G.+Verschueren&title=Sulfamoyl-Arylamides+and+the+Use+Thereof+as+Medicaments+for+the+Treatment+of+Hepatitis+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLast%26aufirst%3DS.%2BJ.%26atitle%3DSulfamoyl-Arylamides%2520and%2520the%2520Use%2520Thereof%2520as%2520Medicaments%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520B%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.-T.</span>; <span class="NLM_string-name">Xu, X.</span>; <span class="NLM_string-name">Block Timothy, M.</span></span> <span> </span><span class="NLM_article-title">Sulfamoylbenzamide Derivatives as Antiviral Agents Against HBV Infection</span>. <span class="NLM_patent">WO 2013/006394 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.-T.+Guo&author=X.+Xu&author=M.+Block+Timothy&title=Sulfamoylbenzamide+Derivatives+as+Antiviral+Agents+Against+HBV+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.-T.%26atitle%3DSulfamoylbenzamide%2520Derivatives%2520as%2520Antiviral%2520Agents%2520Against%2520HBV%2520Infection%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartman George, D.</span>; <span class="NLM_string-name">Flores Osvaldo, A.</span></span> <span> </span><span class="NLM_article-title">Hepatitis B Antiviral Agents</span>. <span class="NLM_patent">WO 2013/096744 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+Hartman+George&author=A.+Flores+Osvaldo&title=Hepatitis+B+Antiviral+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%2BGeorge%26aufirst%3DD.%26atitle%3DHepatitis%2520B%2520Antiviral%2520Agents%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campagna, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuconati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. T.</span></span> <span> </span><span class="NLM_article-title">Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">6931</span>â <span class="NLM_lpage">6942</span>, <span class="refDoi">Â DOI: 10.1128/JVI.00582-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1128%2FJVI.00582-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=23576513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=6931-6942&author=M.+R.+Campagnaauthor=F.+Liuauthor=R.+Maoauthor=C.+Millsauthor=D.+Caiauthor=F.+Guoauthor=X.+Zhaoauthor=H.+Yeauthor=A.+Cuconatiauthor=H.+Guoauthor=J.+Changauthor=X.+Xuauthor=T.+M.+Blockauthor=J.+T.+Guo&title=Sulfamoylbenzamide+Derivatives+Inhibit+the+Assembly+of+Hepatitis+B+Virus+Nucleocapsids&doi=10.1128%2FJVI.00582-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span></div><div class="casAuthors">Campagna, Matthew R.; Liu, Fei; Mao, Richeng; Mills, Courtney; Cai, Dawei; Guo, Fang; Zhao, Xuesen; Ye, Hong; Cuconati, Andrea; Guo, Haitao; Chang, Jinhong; Xu, Xiaodong; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6931-6942</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection, a serious public health problem leading to cirrhosis and hepatocellular carcinoma, is currently treated with either pegylated alpha interferon (pegIFN-Î±) or one of the five nucleos(t)ide analog viral DNA polymerase inhibitors.  However, neither pegIFN-Î± nor nucleos(t)ide analogs are capable of reliably curing the viral infection.  In order to develop novel antiviral drugs against HBV, we established a cell-based screening assay by using an immortalized mouse hepatocyte-derived stable cell line supporting a high level of HBV replication in a tetracycline-inducible manner.  Screening of a library consisting of 26,900 small mols. led to the discovery of a series of sulfamoylbenzamide (SBA) derivs. that significantly reduced the amt. of cytoplasmic HBV DNA.  Structure-activity relationship studies have thus far identified a group of fluorine-substituted SBAs with submicromolar antiviral activity against HBV in human hepatoma cells.  Mechanistic analyses reveal that the compds. dose dependently inhibit the formation of pregenomic RNA (pgRNA)-contg. nucleocapsids of HBV but not other animal hepadnaviruses, such as woodchuck hepatitis virus (WHV) and duck hepatitis B virus (DHBV).  Moreover, heterologous genetic complementation studies of capsid protein, DNA polymerase, and pgRNA between HBV and WHV suggest that HBV capsid protein confers sensitivity to the SBAs.  In summary, SBAs represent a novel chem. entity with superior activity and a unique antiviral mechanism and are thus warranted for further development as novel antiviral therapeutics for the treatment of chronic hepatitis B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNUsTkQKVBQbVg90H21EOLACvtfcHk0ljva1eQna2Blw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D&md5=80cd9d05d889ecf1bd2f6c28f7946bcf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FJVI.00582-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00582-13%26sid%3Dliteratum%253Aachs%26aulast%3DCampagna%26aufirst%3DM.%2BR.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.%2BT.%26atitle%3DSulfamoylbenzamide%2520Derivatives%2520Inhibit%2520the%2520Assembly%2520of%2520Hepatitis%2520B%2520Virus%2520Nucleocapsids%26jtitle%3DJ.%2520Virol%26date%3D2013%26volume%3D87%26spage%3D6931%26epage%3D6942%26doi%3D10.1128%2FJVI.00582-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klumpp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allweiss, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ¼tgehetmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandri, M.</span></span> <span> </span><span class="NLM_article-title">Efficacy of NVR 3â778, Alone and in Combination with Pegylated Interferon, vs Entecavir In uPA/SCID Mice with Humanized Livers and HBV Infection</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">652</span>â <span class="NLM_lpage">662</span>, <span class="refDoi">Â DOI: 10.1053/j.gastro.2017.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1053%2Fj.gastro.2017.10.017" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=652-662&author=K.+Klumppauthor=T.+Shimadaauthor=L.+Allweissauthor=T.+Volzauthor=M.+L%C3%BCtgehetmannauthor=G.+Hartmanauthor=O.+A.+Floresauthor=A.+M.+Lamauthor=M.+Dandri&title=Efficacy+of+NVR+3%E2%80%93778%2C+Alone+and+in+Combination+with+Pegylated+Interferon%2C+vs+Entecavir+In+uPA%2FSCID+Mice+with+Humanized+Livers+and+HBV+Infection&doi=10.1053%2Fj.gastro.2017.10.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2017.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2017.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DT.%26aulast%3DAllweiss%26aufirst%3DL.%26aulast%3DVolz%26aufirst%3DT.%26aulast%3DL%25C3%25BCtgehetmann%26aufirst%3DM.%26aulast%3DHartman%26aufirst%3DG.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DDandri%26aufirst%3DM.%26atitle%3DEfficacy%2520of%2520NVR%25203%25E2%2580%2593778%252C%2520Alone%2520and%2520in%2520Combination%2520with%2520Pegylated%2520Interferon%252C%2520vs%2520Entecavir%2520In%2520uPA%252FSCID%2520Mice%2520with%2520Humanized%2520Livers%2520and%2520HBV%2520Infection%26jtitle%3DGastroenterology%26date%3D2018%26volume%3D154%26spage%3D652%26epage%3D662%26doi%3D10.1053%2Fj.gastro.2017.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozturk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassit, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amblard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinazi, R. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Sulfamoylbenzamide Derivatives as HBV Capsid Assembly Effector</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">407</span>â <span class="NLM_lpage">421</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2017.06.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.ejmech.2017.06.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=28688280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFChurvI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=407-421&author=O.+Sariauthor=S.+Boucleauthor=B.+D.+Coxauthor=T.+Ozturkauthor=O.+O.+Russellauthor=L.+Bassitauthor=F.+Amblardauthor=R.+F.+Schinazi&title=Synthesis+of+Sulfamoylbenzamide+Derivatives+as+HBV+Capsid+Assembly+Effector&doi=10.1016%2Fj.ejmech.2017.06.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effectors</span></div><div class="casAuthors">Sari, Ozkan; Boucle, Sebastien; Cox, Bryan D.; Ozturk, Tugba; Russell, Olivia Ollinger; Bassit, Leda; Amblard, Franck; Schinazi, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">407-421</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis of novel series of sulfamoylbenzamides, e.g. I [R1 = F, R2 = H; R1R2 = (CH2)2, (CH2)3; X = R3R4NSO2, R5SO2NH; R3 = cyclopentyl, cyclopentyloxy, MeSO2, PhCHMe, etc., R4 = H; R3R4 = CH2CF2CH2CH2, C(O)(CH2)3, etc.; R5 = cyclopropyl, cyclopentyl, cyclohexyl] as HBV capsid assembly effector is reported.  The structure was divided into five parts which were independently modified as part of the lead optimization.  All the synthesized compds. were evaluated for their anti-HBV activity and toxicity in human hepatocytes, lymphocytes and other cells.  Addnl., their effect on HBV cccDNA formation in an HBeAg reporter cell-based assay was assessed.  Among the 27 compds. reported, several analogs exhibited submicromolar activities and significant redn. of HBeAg secretion.  Selected compds. were studied under neg.-stain electron microscopy for their ability to disrupt the HBV capsid formation.  Structures were modeled into a binding site recently identified in the HBV capsid protein for similar mols. to rationalize the structure-activity relationships for this family of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUa_fzgDe9WrVg90H21EOLACvtfcHk0ljva1eQna2Blw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFChurvI&md5=cc0de429427455fac4cebd76c51119ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.062%26sid%3Dliteratum%253Aachs%26aulast%3DSari%26aufirst%3DO.%26aulast%3DBoucle%26aufirst%3DS.%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DOzturk%26aufirst%3DT.%26aulast%3DRussell%26aufirst%3DO.%2BO.%26aulast%3DBassit%26aufirst%3DL.%26aulast%3DAmblard%26aufirst%3DF.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26atitle%3DSynthesis%2520of%2520Sulfamoylbenzamide%2520Derivatives%2520as%2520HBV%2520Capsid%2520Assembly%2520Effector%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D407%26epage%3D421%26doi%3D10.1016%2Fj.ejmech.2017.06.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataiah, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotnick, A.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Effectors of Hepatitis B Virus Capsid Assembly Give Insight into Virus Life Cycle</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">10262</span>â <span class="NLM_lpage">10270</span>, <span class="refDoi">Â DOI: 10.1128/JVI.01360-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1128%2FJVI.01360-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=18684823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=10262-10270&author=C.+Bourneauthor=S.+Leeauthor=B.+Venkataiahauthor=A.+Leeauthor=B.+Korbaauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Small-Molecule+Effectors+of+Hepatitis+B+Virus+Capsid+Assembly+Give+Insight+into+Virus+Life+Cycle&doi=10.1128%2FJVI.01360-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span></div><div class="casAuthors">Bourne, Christina; Lee, Sejin; Venkataiah, Bollu; Lee, Angela; Korba, Brent; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10262-10270</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The relationship between the phys. chem. and biol. of self-assembly is poorly understood, but it will be crit. to quant. understand infection and for the design of antivirals that target virus genesis.  Here the authors take advantage of heteroaryldihydropyrimidines (HAPs), which affect hepatitis B virus (HBV) assembly, to gain insight and correlate in vitro assembly with HBV replication in culture.  Based on a low-resoln. crystal structure of a capsid-HAP complex, a closely related series of HAPs were designed and synthesized.  These differentially strengthen the assocn. between neighboring capsid proteins, alter the kinetics of assembly, and give rise to aberrant structures incompatible with a functional capsid.  The chem. nature of the HAP variants correlated well with the structure of the HAP binding pocket.  The thermodn. and kinetics of in vitro assembly had strong and predictable effects on product morphol.  However, only the kinetics of in vitro assembly had a strong correlation with inhibition of HBV replication in HepG2.2.15 cells; there was at best a weak correlation between assembly thermodn. and replication.  The correlation between assembly kinetics and virus suppression implies a competition between successful assembly and misassembly, small mol. induced or otherwise.  This is a predictive and testable model for the mechanism of action of assembly effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodMfnjIqX51LVg90H21EOLACvtfcHk0ljiBn51jasoOQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE&md5=78266773fa27c6f87b4c871c47cd2fe6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FJVI.01360-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01360-08%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DVenkataiah%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DKorba%26aufirst%3DB.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DSmall-Molecule%2520Effectors%2520of%2520Hepatitis%2520B%2520Virus%2520Capsid%2520Assembly%2520Give%2520Insight%2520into%2520Virus%2520Life%2520Cycle%26jtitle%3DJ.%2520Virol%26date%3D2008%26volume%3D82%26spage%3D10262%26epage%3D10270%26doi%3D10.1128%2FJVI.01360-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stray, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopek, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotnick, A.</span></span> <span> </span><span class="NLM_article-title">An <i>In Vitro</i> Fluorescence Screen to Identify Antivirals that Disrupt Hepatitis B Virus Capsid Assembly</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">358</span>â <span class="NLM_lpage">362</span>, <span class="refDoi">Â DOI: 10.1038/nbt1187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1038%2Fnbt1187" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=358-362&author=S.+J.+Strayauthor=J.+M.+Johnsonauthor=B.+G.+Kopekauthor=A.+Zlotnick&title=An+In+Vitro+Fluorescence+Screen+to+Identify+Antivirals+that+Disrupt+Hepatitis+B+Virus+Capsid+Assembly&doi=10.1038%2Fnbt1187"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnbt1187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1187%26sid%3Dliteratum%253Aachs%26aulast%3DStray%26aufirst%3DS.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BM.%26aulast%3DKopek%26aufirst%3DB.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DAn%2520In%2520Vitro%2520Fluorescence%2520Screen%2520to%2520Identify%2520Antivirals%2520that%2520Disrupt%2520Hepatitis%2520B%2520Virus%2520Capsid%2520Assembly%26jtitle%3DNat.%2520Biotechnol.%26date%3D2006%26volume%3D24%26spage%3D358%26epage%3D362%26doi%3D10.1038%2Fnbt1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towne, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrior, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, D. J.</span></span> <span> </span><span class="NLM_article-title">Application of a High-Content Multiparameter Cytotoxicity Assay to Prioritize Compounds Based on Toxicity Potential in Humans</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">527</span>â <span class="NLM_lpage">537</span>, <span class="refDoi">Â DOI: 10.1177/1087057108318428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1177%2F1087057108318428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=18566484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt1eiurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=527-537&author=V.+C.+Abrahamauthor=D.+L.+Towneauthor=J.+F.+Waringauthor=U.+Warriorauthor=D.+J.+Burns&title=Application+of+a+High-Content+Multiparameter+Cytotoxicity+Assay+to+Prioritize+Compounds+Based+on+Toxicity+Potential+in+Humans&doi=10.1177%2F1087057108318428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans</span></div><div class="casAuthors">Abraham, Vivek C.; Towne, Danli L.; Waring, Jeffrey F.; Warrior, Usha; Burns, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">527-537</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Prioritization of compds. based on human hepatotoxicity potential is currently a key unmet need in drug discovery, as it can become a major problem for several lead compds. in later stages of the drug discovery pipeline.  The authors report the validation and implementation of a high-content multiparametric cytotoxicity assay based on simultaneous measurement of 8 key cell health indicators assocd. with nuclear morphol., plasma membrane integrity, mitochondrial function, and cell proliferation.  Compds. are prioritized by (a) computing an in vitro safety margin using the min. cytotoxic concn. (IC20) across all 8 indicators and cell-based efficacy data and (b) using the minimal cytotoxic concn. alone to take into account concn. of drug in tissues.  Feasibility data using selected compds., including quinolone antibiotics, thiazolidinediones, and statins, suggest the viability of this approach.  To increase overall throughput of compd. prioritization, the authors have identified the higher throughput, plate reader-based CyQUANT assay that is similar to the high-content screening (HCS) assay in sensitivity of measuring inhibition of cell proliferation.  It is expected that the phenotypic output from the multiparametric HCS assay in combination with other highly sensitive approaches, such as microarray-based expression anal. of toxic signatures, will contribute to a better understanding and predictivity of human hepatotoxicity potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmmpX3J1LQGLVg90H21EOLACvtfcHk0ljiBn51jasoOQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt1eiurg%253D&md5=3dd6e876f6e82650178a35932513a5fb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F1087057108318428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057108318428%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DV.%2BC.%26aulast%3DTowne%26aufirst%3DD.%2BL.%26aulast%3DWaring%26aufirst%3DJ.%2BF.%26aulast%3DWarrior%26aufirst%3DU.%26aulast%3DBurns%26aufirst%3DD.%2BJ.%26atitle%3DApplication%2520of%2520a%2520High-Content%2520Multiparameter%2520Cytotoxicity%2520Assay%2520to%2520Prioritize%2520Compounds%2520Based%2520on%2520Toxicity%2520Potential%2520in%2520Humans%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2008%26volume%3D13%26spage%3D527%26epage%3D537%26doi%3D10.1177%2F1087057108318428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">OâBrien, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard-Cofield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krejsa, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeline, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hougham, C.</span></span> <span> </span><span class="NLM_article-title">High Concordance of Drug-Induced Human Hepatotoxicity with In Vitro Cytotoxicity Measured in a Novel Cell-Based Model Using High Content Screening</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">580</span>â <span class="NLM_lpage">604</span>, <span class="refDoi">Â DOI: 10.1007/s00204-006-0091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1007%2Fs00204-006-0091-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=16598496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVynurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=580-604&author=P.+J.+O%E2%80%99Brienauthor=W.+Irwinauthor=D.+Diazauthor=E.+Howard-Cofieldauthor=C.+M.+Krejsaauthor=M.+R.+Slaughterauthor=B.+Gaoauthor=N.+Kaludercicauthor=A.+Angelineauthor=P.+Bernardiauthor=P.+Brainauthor=C.+Hougham&title=High+Concordance+of+Drug-Induced+Human+Hepatotoxicity+with+In+Vitro+Cytotoxicity+Measured+in+a+Novel+Cell-Based+Model+Using+High+Content+Screening&doi=10.1007%2Fs00204-006-0091-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening</span></div><div class="casAuthors">O'Brien, P. J.; Irwin, W.; Diaz, D.; Howard-Cofield, E.; Krejsa, C. M.; Slaughter, M. R.; Gao, B.; Kaludercic, N.; Angeline, A.; Bernardi, P.; Brain, P.; Hougham, C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">580-604</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To develop and validate a practical, in vitro, cell-based model to assess human hepatotoxicity potential of drugs, we used the new technol. of high content screening (HCS) and a novel combination of crit. model features, including (1) use of live, human hepatocytes with drug metab. capability, (2) preincubation of cells for 3 days with drugs at a range of concns. up to at least 30 times the efficacious concn. or 100 Î¼M, (3) measurement of multiple parameters that were (4) morphol. and biochem., (5) indicative of prelethal cytotoxic effects, (6) representative of different mechanisms of toxicity, (7) at the single cell level and (8) amenable to rapid throughput.  HCS is based on automated epifluorescence microscopy and image anal. of cells in a microtiter plate format.  The assay was applied to HepG2 human hepatocytes cultured in 96-well plates and loaded with four fluorescent dyes for: calcium (Fluo-4 AM), mitochondrial membrane potential (TMRM), DNA content (Hoechst 33342) to det. nuclear area and cell no. and plasma membrane permeability (TOTO-3).  Assay results were compared with those from 7 conventional, in vitro cytotoxicity assays that were applied to 611 compds. and shown to have low sensitivity (<25%), although high specificity (â¼90%) for detection of toxic drugs.  For 243 drugs with varying degrees of toxicity, the HCS, sublethal, cytotoxicity assay had a sensitivity of 93% and specificity of 98%.  Drugs testing pos. that did not cause hepatotoxicity produced other serious, human organ toxicities.  For 201 pos. assay results, 86% drugs affected cell no., 70% affected nuclear area and mitochondrial membrane potential and 45% affected membrane permeability and 41% intracellular calcium concn.  Cell no. was the first parameter affected for 56% of these drugs, nuclear area for 34% and mitochondrial membrane potential for 29% and membrane permeability for 7% and intracellular calcium for 10%.  Hormesis occurred for 48% of all drugs with pos. response, for 26% of mitochondrial and 34% nuclear area changes and 12% of cell no. changes.  Pattern of change was dependent on the class of drug and mechanism of toxicity.  The ratio of concns. for in vitro cytotoxicity to maximal efficaciousness in humans was not different across groups (12Â±22).  Human toxicity potential was detected with 80% sensitivity and 90% specificity at a concn. of 30Ã the maximal efficacious concn. or 100 Î¼M when efficaciousness was not considered.  We conclude that human hepatotoxicity is highly concordant with in vitro cytotoxicity in this novel model and as detected by HCS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroZK_xw9EaJrVg90H21EOLACvtfcHk0ljiBn51jasoOQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVynurc%253D&md5=84df3243f11d3309cf86a2f3f6160533</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs00204-006-0091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-006-0091-3%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%2BJ.%26aulast%3DIrwin%26aufirst%3DW.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DHoward-Cofield%26aufirst%3DE.%26aulast%3DKrejsa%26aufirst%3DC.%2BM.%26aulast%3DSlaughter%26aufirst%3DM.%2BR.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DAngeline%26aufirst%3DA.%26aulast%3DBernardi%26aufirst%3DP.%26aulast%3DBrain%26aufirst%3DP.%26aulast%3DHougham%26aufirst%3DC.%26atitle%3DHigh%2520Concordance%2520of%2520Drug-Induced%2520Human%2520Hepatotoxicity%2520with%2520In%2520Vitro%2520Cytotoxicity%2520Measured%2520in%2520a%2520Novel%2520Cell-Based%2520Model%2520Using%2520High%2520Content%2520Screening%26jtitle%3DArch.%2520Toxicol.%26date%3D2006%26volume%3D80%26spage%3D580%26epage%3D604%26doi%3D10.1007%2Fs00204-006-0091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dandri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, J.</span></span> <span> </span><span class="NLM_article-title">Chimeric Mouse Model of Hepatitis B Virus Infection</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">493</span>â <span class="NLM_lpage">495</span>, <span class="refDoi">Â DOI: 10.1016/j.jhep.2011.05.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.jhep.2011.05.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=21801701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A280%3ADC%252BC387ltFSlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=493-495&author=M.+Dandriauthor=J.+Petersen&title=Chimeric+Mouse+Model+of+Hepatitis+B+Virus+Infection&doi=10.1016%2Fj.jhep.2011.05.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Chimeric mouse model of hepatitis B virus infection</span></div><div class="casAuthors">Dandri Maura; Petersen Jorg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hepatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">493-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSj20RUU6aR15PlX7E30qdzfW6udTcc2eaq3_eK3z7Iu7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387ltFSlsQ%253D%253D&md5=db3ca4789af611c30bc7b7c88dcb1d21</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2011.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2011.05.037%26sid%3Dliteratum%253Aachs%26aulast%3DDandri%26aufirst%3DM.%26aulast%3DPetersen%26aufirst%3DJ.%26atitle%3DChimeric%2520Mouse%2520Model%2520of%2520Hepatitis%2520B%2520Virus%2520Infection%26jtitle%3DJ.%2520Hepatol.%26date%3D2012%26volume%3D56%26spage%3D493%26epage%3D495%26doi%3D10.1016%2Fj.jhep.2011.05.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rath, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinoda, W.</span></span> <span> </span><span class="NLM_article-title">Identification of Factors Promoting HBV Capsid Self-Assembly by Assembly-Promoting Antivirals</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">328</span>â <span class="NLM_lpage">337</span>, <span class="refDoi">Â DOI: 10.1021/acs.jcim.7b00471</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.7b00471" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslShug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2018&pages=328-337&author=S.+L.+Rathauthor=H.+Liuauthor=S.+Okazakiauthor=W.+Shinoda&title=Identification+of+Factors+Promoting+HBV+Capsid+Self-Assembly+by+Assembly-Promoting+Antivirals&doi=10.1021%2Facs.jcim.7b00471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Factors Promoting HBV Capsid Self-Assembly by Assembly-Promoting Antivirals</span></div><div class="casAuthors">Rath, Soumya Lipsa; Liu, Huihui; Okazaki, Susumu; Shinoda, Wataru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-337</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Around 270 million individuals currently live with hepatitis B virus (HBV) infection.  Heteroaryldihydropyrimidines (HAPs) are a family of antivirals that target the HBV capsid protein and induce aberrant self-assembly.  The capsids formed resemble the native capsid structure but are unable to propagate the virus progeny because of a lack of RNA/DNA.  Under normal conditions, self-assembly is initiated by the viral genome.  The mode of action of HAPs, however, remains largely unknown.  In this work, using mol. dynamics simulations, we attempted to understand the action of HAP by comparing the dynamics of capsid proteins with and without HAPs.  We found that the inhibitor is more stable in higher oligomers.  It retains its stability in the hexamer throughout 1 Î¼s of simulation.  Our results also show that the inhibitor might help in stabilizing the C-terminus, the HBc 149-183 arginine-rich domain of the capsid protein.  The C-termini of dimers interact with each other, assisted by the HAP inhibitor.  During capsid assembly, the termini are supposed to directly interact with the viral genome, thereby suggesting that the viral genome might work in a similar way to stabilize the capsid protein.  Our results may help in understanding the underlying mol. mechanism of HBV capsid self-assembly, which should be crucial for exploring new drug targets and structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojAFTMtxGuMbVg90H21EOLACvtfcHk0ljBi4DX5wG6Ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslShug%253D%253D&md5=c3e2991026b1bbdecfa73c8ad0027f44</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.7b00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.7b00471%26sid%3Dliteratum%253Aachs%26aulast%3DRath%26aufirst%3DS.%2BL.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DOkazaki%26aufirst%3DS.%26aulast%3DShinoda%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520Factors%2520Promoting%2520HBV%2520Capsid%2520Self-Assembly%2520by%2520Assembly-Promoting%2520Antivirals%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2018%26volume%3D58%26spage%3D328%26epage%3D337%26doi%3D10.1021%2Facs.jcim.7b00471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salminen, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissberger, A.</span></span> <span> </span><span class="NLM_article-title">The Reaction of 3-Chlorosulfonylbenzoyl Chloride with Amines</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">4131</span>â <span class="NLM_lpage">4133</span>, <span class="refDoi">Â DOI: 10.1021/ja01153a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01153a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1951&pages=4131-4133&author=C.+R.+Barrauthor=I.+F.+Salminenauthor=A.+Weissberger&title=The+Reaction+of+3-Chlorosulfonylbenzoyl+Chloride+with+Amines&doi=10.1021%2Fja01153a023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja01153a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01153a023%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DC.%2BR.%26aulast%3DSalminen%26aufirst%3DI.%2BF.%26aulast%3DWeissberger%26aufirst%3DA.%26atitle%3DThe%2520Reaction%2520of%25203-Chlorosulfonylbenzoyl%2520Chloride%2520with%2520Amines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1951%26volume%3D73%26spage%3D4131%26epage%3D4133%26doi%3D10.1021%2Fja01153a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.-C.</span></span> <span> </span><span class="NLM_article-title">Chemoselective Synthesis of Aryl Carboxamido Sulfonic Acid Derivatives</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2640</span>â <span class="NLM_lpage">2646</span>, <span class="refDoi">Â DOI: 10.1016/j.tet.2013.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;key=10.1016%2Fj.tet.2013.01.028" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=2640-2646&author=Y.-L.+Yangauthor=B.+Rajagopalauthor=C.-F.+Liangauthor=C.-C.+Chenauthor=H.-P.+Laiauthor=C.-H.+Chouauthor=Y.-P.+Leeauthor=Y.-L.+Yangauthor=J.-W.+Zengauthor=C.-L.+Ouauthor=P.-C.+Lin&title=Chemoselective+Synthesis+of+Aryl+Carboxamido+Sulfonic+Acid+Derivatives&doi=10.1016%2Fj.tet.2013.01.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2013.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2013.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.-L.%26aulast%3DRajagopal%26aufirst%3DB.%26aulast%3DLiang%26aufirst%3DC.-F.%26aulast%3DChen%26aufirst%3DC.-C.%26aulast%3DLai%26aufirst%3DH.-P.%26aulast%3DChou%26aufirst%3DC.-H.%26aulast%3DLee%26aufirst%3DY.-P.%26aulast%3DYang%26aufirst%3DY.-L.%26aulast%3DZeng%26aufirst%3DJ.-W.%26aulast%3DOu%26aufirst%3DC.-L.%26aulast%3DLin%26aufirst%3DP.-C.%26atitle%3DChemoselective%2520Synthesis%2520of%2520Aryl%2520Carboxamido%2520Sulfonic%2520Acid%2520Derivatives%26jtitle%3DTetrahedron%26date%3D2013%26volume%3D69%26spage%3D2640%26epage%3D2646%26doi%3D10.1016%2Fj.tet.2013.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i60"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00654">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82184"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00654">10.1021/acs.jmedchem.8b00654</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures for the synthesis of compound <b>8</b>, <b>9</b>, <b>11</b>â<b>13</b>, <b>17</b>â<b>27</b>, <b>62</b>, <b>64</b>, and <b>65</b>; LC-MS methods, list of retention times, and purities of tested compounds; details on JNJ-632 modeling; experimental details on the anti HBV cellular assay; experimental details on the size exclusion chromatography; experimental details on the biochemical fluorescence quenching; fluorescence quenching curve for representative compounds; experimental details on determination of metabolic stability in liver microsomes, kinetic solubility, and pharmacokinetic assessment; experimental details on the determination of the anti-HBV activity of JNJ-632 in chimeric mice (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf">PDF</a>)</p></li><li><p class="inline">List of molecular formula strings and associated biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_001.csv">jm8b00654_si_001.csv (4.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00654/suppl_file/jm8b00654_si_002.pdf">jm8b00654_si_002.pdf (1.46 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00654&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00654%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00654" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799aa9f4d523d6c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
